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ABSTRACT 
Diarrheal diseases are the second leading cause of childhood deaths globally. 
Rotavirus is a leading cause of severe dehydrating diarrhea which is particularly 
associated with morbidity and mortality among children under five years of age in 
low- and middle-income countries. The rotavirus vaccine was introduced into 
Kenya’s public immunization program in July 2014, with a two-dose schedule at six 
and ten weeks of age. Estimating the burden of rotavirus-associated disease before 
vaccine introduction is essential for assessing the population-level impact of 
vaccination programs. The aim of this dissertation is to estimate the burden of 
diarrheal illness among children under five years of age before the introduction of 
rotavirus vaccine in Kenya and to provide baseline information on health care 
seeking, prevalence, hospitalizations, and potential complications of childhood 
diarrhea to help evaluate the impact of rotavirus vaccine program implementation 
in Kenya.  
This dissertation consists of four original studies. In Study I, we conducted 
household interviews with caretakers of 1,043 children under five in a baseline 
cross-sectional survey (April–May 2007) and of more than 20,000 children on five 
subsequent surveys between May 2009 and December 2010 to assess healthcare-
?????????????????????????????????????????????????????????????????????????????????? 
In Study II, we conducted inpatient surveillance of children with acute 
gastroenteritis (AGE) (diarrhea and/or one or more episodes of unexplained 
vomiting occurring within seven days of admission) to estimate hospitalization and 
mortality rates due to all-cause and rotavirus acute gastroenteritis (RVAGE). 
Person-years of observation from an active Health and Demographic Surveillance 
System (HDSS) in western Kenya were used as denominators. In Study III, we 
conducted hospital-based surveillance of children under five years with acute, non-
dysenteric moderate-to-severe diarrhea (MSD) to assess factors associated with 
rotavirus gastroenteritis and to describe illness severity. We defined non-dysenteric 
MSD as diarrhea with one or more of the following: sunken eyes, skin tenting, 
intravenous rehydration, or hospitalization, and acute to mean seeking care for the 
diarrhea episode within seven days of illness onset at a study sentinel health center 
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located within the HDSS. Stool specimens from participants enrolled in Studies II 
and III were tested for rotavirus using an enzyme immunoassay. To describe the 
epidemiology and risk factors for intussusception-related mortality, we 
retrospectively reviewed medical chart data of patients under five years old 
diagnosed with intussusception in 12 Kenyan leading referral hospitals (Study IV). 
Our results showed that the two-week population-based incidence proportion 
of any diarrhea during the study period ranged from 26% at baseline (2007) to 4–
11% during 2009–2010. A key finding of the surveys was that less than half of the 
children with diarrheal illness received care at a healthcare facility. Caretakers were 
actually less likely to seek health care outside the home for infants with diarrhea 
than for older children. Seeking care outside the home for childhood diarrhea was 
significantly more common for children who had sunken eyes during their 
diarrheal episode. Substantial proportion of children with diarrhea were given less 
food and drink than normally, even when vomiting accompanied their diarrheal 
episode. They were also not offered oral rehydration solution (ORS) at home. 
Mothers with formal education, however, were more likely than those without 
formal education to provide their children with ORS at home and to take them to a 
health care facility. Furthermore, caretakers sought care from a healthcare facility 
when their child`s diarrheal illness became more severe— possibly as a 
consequence of giving no remedy at home. Infants 6–11 months had the highest 
population-based incidence rates for hospitalization and mortality due to AGE and 
RVAGE. Rotavirus-positive cases were younger (median age, 8 vs. 13 months), 
had more severe illness, and had to be hospitalized more frequently than those 
who were negative for rotavirus. Independent factors that were associated with 
rotavirus disease included being an infant and presenting with vomiting 3 or more 
times within 24 hours during the diarrhea episode. Two-thirds of intussusception 
cases treated from 2002 through 2013 were infants who presented with at least one 
of the following symptoms: vomiting, diarrhea, or blood in stool. The case-fatality 
proportion was 6.4%. Compared with patients who survived, patients who died 
were younger, more likely to seek care late after illness symptom onset, to report 
history of fever on admission or, to have undergone surgery. 
In summary, the studies in this thesis demonstrate that diarrhea among young 
children presenting to health care facilities is a significant public health problem in 
Kenya. However, the cases attending health care facility are only the tip of an 
iceberg. Our findings that suggest delay in seeking care for the child`s severe 
diarrheal illness are disconcerting. In addition, among children with severe disease 
symptoms and intussusception patients who died had sought care later after 
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symptom onset than those who survived. Our data also confirmed that morbidity 
and mortality associated with AGE, RVAGE, and intussusception was most 
common among infants. These findings supported the Kenyan Ministry of 
Health’s decision to introduce a rotavirus vaccination program in July 2014. They 
are also consistent with the WHO recommendation to administer rotavirus 
vaccines to children at six and ten weeks of age, before the peak of disease 
incidence in Kenya. As a whole, the results of this thesis provide a comprehensive 
baseline data on occurrence, risk factors and complications of rotavirus diarrhea 
among young children in Kenya against which the population-level vaccine 
program impact can be evaluated in the future. Continuing surveillance efforts 
aimed at demonstrating the real-world impact and value of rotavirus vaccines need 
to take into consideration the observed trends in health care utilization. 
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TIIVISTELMÄ 
Ripulitaudit ovat toiseksi yleisin alle viisivuotiaiden lasten kuolinsyy 
maailmanlaajuisesti. Rotavirus on tärkein lasten vakavien, kuivumista aiheuttavien 
ripulitautien aiheuttajista ja merkittävä kansanterveysongelma etenkin matalan ja 
keskitulotason maissa. Rotavirusrokotukset aloitettiin Kenian kansallisessa 
rokotusohjelmassa heinäkuussa 2014 (kaksi annosta, kuuden ja kymmenen viikon 
ikäisenä). Rotaviruksen aiheuttaman tautitaakan perustason määrittäminen 
paikallisesti ennen rokotusten aloittamista on välttämätöntä, jotta rokotusohjelman 
vaikuttavuutta väestötasolla voidaan jatkotutkimuksissa arvioida. Tämän 
väitöskirjatyön tavoitteena oli arvioida kattavasti alle viisivuotiaiden lasten 
ripulitaudin ja rotaviruksen aiheuttamaa tautitaakkaa, hoitoon hakeutumista ja 
komplikaatioita ennen rotavirusrokotusten aloitusta Keniassa. Väitöskirjan 
tutkimuksissa käytettiin Kenian lääketieteellisen tutkimuslaitoksen (Kenya Medical 
Research Institute, KEMRI) ja USA:n tautikeskuksen (Centers for Disease Control 
and Prevention, CDC) länsi-Keniassa sijaitsevan väestöpohjaisen, aktiivisen 
seurantajärjestelmän tietoja. Näiden tietojen perusteella määritettiin hoitoon 
hakeutumisen syyt ja yleisyys, taudin ilmaantuvuus ja riskitekijät, sekä sairaalahoidot 
ja kuolleisuus. Lisäksi vakavan ripulitaudin aiheuttamien komplikaatioiden 
(suolentukkeuma - intussusception) esiintyvyyttä ja ennusteeseen vaikuttavia 
tekijöitä arvioitiin takautuvasti sairaalojen potilaskertomustietojen avulla. 
Tutkimusten tavoitteena oli muodostaa kattava kuva rotavirustaudin 
epidemiologiasta, jota voidaan jatkotutkimuksissa käyttää vertailukohtana 
arvioitaessa rotavirusrokotusohjelman kansanterveydellistä vaikuttavuutta Keniassa. 
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Väitöskirja koostuu neljästä alkuperäistutkimuksesta (I-IV). Väestöpohjaisessa 
kenttätutkimuksessa (I) haastateltiin ensin 1 043 alle viiden vuoden ikäisen lapsen 
huoltajaa (yleensä äitiä) poikkileikkaustutkimuksessa (huhti–toukokuu 2007) lasten 
ripulitauteihin liittyvän hoitoon hakeutumisen käytäntöjen määrittämiseksi (ripulin 
mää????? ?? ?? ?? ??????? ?????????? ??? ??????? ????????? ?????? ???????? ???? ?? 000:n 
lapsen huoltajia haastateltiin viidessä peräkkäisessä poikkileikkaustutkimuksessa 
toukokuun 2009 ja joulukuun 2010 välisenä aikana.  
Tutkimuksessa (II) tunnistettiin sairaalahoitoon tulleet potilaat, joilla oli äkillinen 
ripulitauti (akuutti gastroenteriitti, AGE) - potilaalla ripuli ja/tai yksi/useampi 
selittämätön oksenteluepisodi seitsemän päivän sisällä sairaalaan tulosta. 
Tutkimuksessa määritettiin sairaalahoitoa vaativan akuutin gastroenteriitin sekä 
rotaviruksen aiheuttaman gastroenteriitin (RVAGE) ilmaantuvuudet ja niihin 
liittyvä kuolleisuus. Nimittäjätiedot saatiin länsi-Kenian terveys- ja 
demografiatietojen seurantajärjestelmästä (HDSS).  
Sairaalapohjaisessa tutkimuksessa (III) selvitettiin rotaviruksen aiheuttaman 
ripulitaudin riskitekijöitä ja taudinkuvan vakavuutta. Seurannassa tunnistettiin 
sairaalahoitoon tulleet lapset, joilla oli akuutti, ei-verinen kohtalaisen vakava tai 
vakava ripulitauti (MSD). Rotavirus taudinaiheuttajana tunnistettiin tutkimuksiin II 
ja III osallistuneiden lasten ulosteenäytteistä EIA-määrityksellä. Takautuvassa 
tutkimuksessa (IV) selvitettiin potilaskertomustietojen avulla suolentukkeumaan 
liittyviä tekijöitä ja tapauskuolleisuutta alle viiden vuoden ikäisillä potilailla, joilla oli 
diagnosoitu suolentukkeuma 12 Kenialaisessa keskussairaalassa vuosina 2002-2013. 
Väestöpohjainen ripulin ilmaantuvuusosuus kahden viikon aikana vaihteli 
ensimmäisen seurantavuoden (2007) 26%:sta 4–11%:iin vuosina 2009–2010. Alle 
puolet ripulitautia sairastavista lapsista hoidettiin terveydenhuollon yksiköissä. 
Huoltajat veivät imeväisikäisiä lapsiaan hoitoon kodin ulkopuolelle merkitsevästi 
harvemmin kuin vanhempia lapsia. Hoitoon vieminen kodin ulkopuolelle oli 
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kuitenkin yleisempää niillä lapsilla, joiden silmät olivat painuneet sisään kuivumisen 
takia ripulijakson aikana. Merkittävälle osalle sairaista lapsista annettiin myös 
vähemmän nestettä ja ruokaa kuin normaalisti, eikä heille tarjottu nestelisää suun 
kautta (oral rehydration solution - ORS) kotona. Koulutetut äidit antoivat kuitenkin 
useammin lapsilleen kotona ORS nestettä ja veivät heidät hoitoon 
terveydenhuollon yksikköön kuin kouluttamattomat äidit. Akuuttia gastroenteriittiä 
ja rotavirusripulitautia sairastavien lasten joutuminen sairaalahoitoon oli yleisintä 6–
11 kuukauden iässä. Myös kuolleisuus oli suurin tässä ikäryhmässä. Rotavirus-
positiiviset potilaat olivat nuorempia (mediaani-ikä, 8 vs. 13 kuukautta), heillä oli 
vakavampi tauti ja he joutuivat sairaalahoitoon merkitsevästi useammin kuin ne 
potilaat, joiden ulosteviljely oli negatiivinen rotaviruksen suhteen. Rotavirusripulin 
itsenäisiä riskitekijöitä olivat imeväisikä ja runsas oksentelu. Kahdessatoista 
Kenialaisessa sairaalassa vuosina 2002-2013 hoidetuista suolentukkeumapotilaista 
kaksi kolmasosaa oli vauvoja, joilla oli ainakin yksi seuraavista oireista: oksentelu, 
ripuli tai verta ulosteessa. Suolentukkeuman tapauskuolleisuus oli 6,4%. Verrattuna 
potilaisiin, jotka toipuivat, menehtyneet potilaat olivat nuorempia, heillä oli 
kuumetta ja he tulivat hoitoon myöhemmin oireiden puhkeamisen jälkeen. Heitä oli 
myös hoidettu kirurgisesti useammin kuin taudista selviytyneitä. 
Yhteenvetona tämän tutkielman tutkimukset osoittavat, että lasten akuutti 
ripulitauti ja etenkin rotaviruksen aiheuttama vaikeaoireinen ripuli ovat merkittävä 
kansanterveysongelma Kenialaisten pikkulasten keskuudessa. Terveydenhuollon 
piiriin tulevat tautitapaukset ovat kuitenkin vain jäävuoren huippu. Siksi on 
huolestuttavaa, että monien lasten huoltajat viivyttivät hoitoon hakeutumista 
ripuliepisodin alettua ja jopa vähensivät nesteen ja ruoan antamista. Myös 
suolentukkeumaan kuolleiden potilaiden hoitoon hakeutuminen oireiden alkamisen 
jälkeen oli viivästynyt. Tutkimukset vahvistivat gastroenteriitin, rotavirusripuliin ja 
suolentukkeumaan liittyvän sairastuvuuden ja kuolleisuuden olevan yleisintä 
imeväisiässä.  
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Tulokset tukivat Kenian terveysministeriön päätöstä aloittaa 
rotavirusrokotusohjelma heinäkuussa 2014. Ne ovat myös linjassa Maailman 
Terveysjärjestön (WHO) suosituksen kanssa, jonka mukaan rotavirusrokotteet 
tulee antaa kuuden ja kymmenen viikon ikäisenä. Näin lapset saavat rokotteet 
ennen kuin taudin ilmaantuvuus on Keniassa huipussaan. Kokonaisuutena 
väitöskirjan tutkimusten tulokset muodostavat kattavan perustason, johon 
vertaamalla Kenian rotavirusrokotusohjelman väestötason vaikuttavuutta 
rotavirustaudin esiintyvyyteen, riskitekijöihin ja komplikaatioiden yleisyyteen 
voidaan jatkotutkimuksissa täsmällisesti arvioida. Tutkimusten perusteella 
arvioinneissa ja ehkäisyohjelmissa on erityisesti otettava huomioon havainnot 
vakavasti sairastuneiden lasten huoltajien terveydenhuoltoon hakeutumisen 
käytännöistä ja hoidon viivästymisestä. Jatkuva väestöpohjainen seuranta on 
avainasemassa rotavirusrokotusohjelman kansanterveydellisen vaikuttavuuden 
osoittamiseksi Keniassa.  
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1 INTRODUCTION 
Rotavirus is a major cause of severe dehydrating diarrhea and remains the main 
cause of hospitalization and death associated with diarrhea among children 
worldwide, accounting for approximately two million hospitalizations and 215,000 
annual global deaths in 2013 among children under five years of age (Tate, Burton 
et al., 2016). Oral rehydration therapy (ORT) is vital to combating dehydration 
caused by severe diarrhea (Forsberg et al., 2007). Despite Kenya’s presence in the 
top ten countries for rotavirus-associated mortality (Tate, Burton et al., 2016), the 
country has seen some of the largest declines in ORT use rates in the world 
(Forsberg et al., 2007). Vaccination is the best way to prevent severe rotavirus 
disease and the deadly, dehydrating diarrhea associated with it (WHO, 2013b). Two 
licensed rotavirus vaccines have shown 85–98% efficacy in large clinical trials 
conducted in the United States and Europe (WHO, 2013b). These vaccines have 
since been recommended by WHO for inclusion in national immunization 
programs, although they are not recommended for infants with a history of 
intussusception or intestinal malformations that could predispose for 
intussusception (WHO, 2013b).  
A few studies have quantitatively evaluated population-based health care-
seeking behavior among caretakers of young children with diarrheal disease in 
Kenya or other middle-income countries. These studies can provide a rate 
multiplier that can be used to adjust for and extrapolate disease incidence rates in 
the source population based on the proportion of diarrhea episodes that were not 
evaluated at sentinel health centers (SHCs), which is a limitation of most case-
control studies and hospital-based surveillance (Burton et al., 2011). Data on 
intussusception in Kenya are rare and incomplete. If the international community 
and national, regional, and intergovernmental authorities are to meet the post-2015 
millennium development agenda under the Sustainable Development Goals 
(SDGs), reliable data will be essential (L. Liu et al., 2015). Without such data, 
governments will not be able to measure progress against the goals or to redesign 
or maintain relevant policies to make attaining them likely. To ensure that the 
limited resources in the low- and middle-income countries of sub-Saharan Africa, 
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where the burden of diarrheal disease is unacceptably high, are not wasted on 
ineffective interventions, thorough evaluation of new diarrhea interventions such 
as rotavirus vaccine programs is even more important. Furthermore, monitoring 
the impact of such interventions requires reliable data collected over a meaningful 
time frame. For example, describing the baseline rates and epidemiology of 
intussusception among children under five years old prior to rotavirus vaccine 
implementation in Kenya could serve as a useful basis for monitoring vaccine 
safety. Continued documentation of rotavirus epidemiology and estimates from 
hospital-based surveillance studies for incidence rates of all-cause and rotavirus 
diarrhea-associated hospitalizations and deaths can provide data for national 
authorities and programs whose role is to make decisions regarding vaccines; they 
can serve as a baseline for assessing vaccine impact (WHO, 2008). Data generated 
from such studies are rarely available globally, a gap that is even more pronounced 
in Kenya. Even where data exist, there are notable deficiencies, including short 
study periods that do not take into account seasonality patterns, use of non-
standardized methods that do not allow for population inference in estimating 
disease rates, and unclear denominators for the population under study, which can 
be useful to estimate and adjust population-based disease burden and to monitor 
epidemiological trends. Such data could help inform targeted diarrhea interventions 
by policymakers and programs in both Kenya and similar settings. 
In this thesis, we determined the factors associated with seeking health care for 
childhood diarrhea, estimated rates of hospitalizations and deaths associated with 
all-cause acute gastroenteritis (AGE) and  rotavirus acute gastroenteritis (RVAGE), 
determined factors associated with rotavirus disease, and described the 
epidemiology of and factors associated with death among children hospitalized 
with intussusception in Kenyan referral hospitals prior to the introduction of the 
rotavirus vaccine. 
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2 LITERATURE REVIEW 
2.1 Diarrheal Disease in Children 
2.1.1 Definitions of diarrheal disease 
According to the World Health Organization (WHO), diarrhea is defined as the 
passage of ????loose or liquid stools (or more frequent passage than is normal for 
the individual) within a 24-hour period (WHO, 2005c, , 2018a). Diarrhea, also 
known as AGE, is usually a symptom of an infection in the intestinal tract. Neither 
the frequent passing of formed stools nor the passing of loose, pasty stools by 
breastfed infants (WHO, 2018a) qualify as diarrhea.  
From the clinical and epidemiological standpoints, there are three main types of 
diarrhea: acute watery diarrhea that lasts several hours or days and includes cholera; 
acute bloody diarrhea (also called dysentery); and persistent diarrhea, which lasts 14 
days or longer (WHO, 2005c, , 2018a). Acute diarrhea usually manifests as an 
increase in the frequency and volume of abnormally loose stools (WHO, 2018a). 
The majority of diarrhea deaths are caused by dehydration. However, more than 
90% of dehydration caused by acute diarrhea of any etiology regardless of patient 
age can be treated effectively using oral rehydration solution (ORS), except when it 
is severe (WHO, 2005c). The WHO defines severe dehydration in a child as 
diarrhea with at least two of the following signs: lethargy or unconsciousness, 
sunken eyes, difficulty or inability to drink, and a skin pinch that only returns to 
normal in two seconds or longer (WHO, 2018a). 
2.1.2 Rationale for studying etiologies of acute diarrhea 
Understanding the etiologies and distribution of acute diarrheal diseases is an 
important tool for public health management and for advising control 
interventions in settings where the disease burden is highest (Yongsi, 2008). 
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Although non-microbes can cause diarrhea, the most important group of 
microbiologic agents (pathogens) known to cause diarrhea in children under five 
years old are generally classified as bacterial, viral, and parasitic organisms (WHO, 
2018a); see Table 1. While the incubation period after host exposure to ingested 
non-microbes—mainly chemicals—is only a few minutes, most microbes have 
been shown to have incubation periods lasting between a few hours and five days, 
depending on infection dose and host immunity level (WHO, 2005c). Detection of 
diarrhea pathogens requires specific laboratory analysis, as described elsewhere 
(Vila et al., 2009); the latest methods such as TaqMan Array Cards (TACs) have 
even provided opportunities for concurrent genotyping of most etiologic agents 
for diarrhea (J. Liu et al., 2013). 
2.1.3 Predominant pathogens associated with acute diarrhea 
2.1.3.1 Bacterial agents 
Children in developing countries are exposed to and suffer from a wide range of 
bacterial pathogens causing diarrhea at a very early age (Bonkoungou et al., 2013). 
The predominant bacterial pathogens vary with child age, season, secular trends, 
and geographical variations (Kotloff et al., 2013; Podewils et al., 2004). The 
diarrheagenic Escherichia coli Shigella spp., Campylobacter spp., Vibrio spp., and 
Salmonella are among the most commonly recognized bacterial causes of diarrhea 
among infants and young children worldwide (Podewils et al., 2004; Kotloff et al., 
2013; J. Liu et al., 2016). 
Diarrheagenic E. coli   is the predominant facultative anaerobe of human colonic 
flora and has been shown to be capable of colonizing the infant gastrointestinal 
tract within hours of birth; it remains prevalent in children with acute diarrhea at all 
age groups (Sanchez-Villamil & Navarro-Garcia, 2015; Bonkoungou et al., 2013). 
While some E. coli   strains have been shown to be harmless or even beneficial to 
their human hosts, several highly adapted clones are capable of causing diarrheal 
illness (Lomasney & Hyland, 2013; Keskimaki et al., 2001; Nataro & Kaper, 1998). 
Diarrheagenic E. coli   may present with different clinical symptoms and frequency 
in both developed and developing countries (Nataro et al., 2006; Kotloff et al., 
2013). In developing countries, E. coli   accounts for more cases of AGE among 
infants than any other cause and remains a major cause of travelers’ diarrhea 
worldwide (Nataro & Martinez, 1998; Kotloff et al., 2013). 
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Shigella has been associated with moderate-to-severe diarrhea (MSD) in children  
under five, mostly in developing countries, and is the diarrhea pathogen most 
frequently associated with bloody diarrhea (WHO, 2005c), especially in Asia and 
sub-Saharan Africa (Kotloff et al., 2013). Toddlers and older children have been 
shown to be at greater risk of infection than infants and non-breastfeeding children 
(WHO, 2005b; Lindsay et al., 2015; Kotloff et al., 2013; WHO, 2005c). The four 
subgroups of Shigella capable of causing severe disease are S. flexneri, S. sonnei, S. 
boydii, and S. dysenteriae (Kotloff et al., 2013). 
AGE caused by vibrio cholera differs from that with other causes in three main 
ways: it occurs in large epidemics; it may be spontaneous and involve more cases of 
both children and adults; it presents with more voluminous watery diarrhea than 
diarrhea caused by other pathogens, leading rapidly to dehydration that can result 
in hypovolemic shock and death if not managed in time (WHO, 2005c). Generally, 
routine use of antimicrobials for treatment of diarrhea in children should be 
avoided since it is not clinically possible to distinguish diarrhea caused by 
unresponsive pathogens such as rotavirus or cryptosporidium (WHO, 2005c). 
However, diarrhea cases with severe dehydration from cholera and bloody diarrhea 
from possible Shigella infection may require appropriate antimicrobial drugs to 
shorten the duration of the illness and prevent further spread of the pathogens 
(WHO, 2005c). 
2.1.3.2 Viral agents 
Enteric viral pathogens are responsible for causing the majority of acute diarrhea 
episodes in developed countries and remains the main cause of non-bloody 
diarrhea in developing countries, most commonly due to poor hygiene and 
sanitation in such settings (Podewils et al., 2004; Kotloff et al., 2013; Cunliffe et al., 
1998; J. Liu et al., 2016). Viruses are the most important etiology of MSD and are 
estimated to account for approximately 70% of AGE episodes in children under 
five (Webb & Starr, 2005). 
Although there are over twenty different types of viruses associated with 
childhood diarrhea, rotavirus has been shown to be the leading etiologic agent 
associated with AGE among children under five before rotavirus vaccine 
introduction in many settings worldwide (Kotloff et al., 2013; Wilhelmi et al., 2003; 
Walker et al., 2013; Mohan et al., 2017). Furthermore, approximately 39% (range by 
country, 20–73%) of children under five years old hospitalized with severe diarrhea 
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in different regions of the world test positive for rotavirus (Widdowson et al., 
2009). 
2.1.3.3 Parasitic agents 
Parasites account for a relatively small proportion of diarrhea cases compared to 
bacterial and viral agents. Cryptosporidium parvun and Entamoeba histolytica are the 
parasites most frequently seen in stool samples from diarrhea cases; by contrast, 
Giardia lamblia has recently been observed to be less common in children with 
diarrhea than those without diarrhea residing in sub-Saharan Africa and southeast 
Asia (Kotloff et al., 2013; Bodhidatta et al., 2010). Despite these observations, 
findings from two recent and highly influential diarrhea studies in the world?the 
Rotavirus Infection and Disease in a Multisite Birth Cohort (MAL-ED) (Mohan et 
al., 2017) and the Global Enteric Multicenter Study (GEMS) (Kotloff et al., 
2013)—have reaffirmed that, before vaccine programs, rotavirus accounted for the 
majority of acute MSD in infants and children under two years old in regions with 
high disease burdens, largely in South America, south east Asia, and sub-Saharan 
Africa. 
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Table 1.  The most important microbial causes of acute diarrhea in infants and children under 
five, before the rotavirus vaccine was introduced  
Source: (WHO, 2005c). 
Agent Incidence Pathogenesis 
Viruses   
Rotavirus Responsible for 15-25% of diarrhea episodes 
in children aged 6-24 months visiting 
treatment facilities but only 5-10% of cases 
in the same age group in the community. 
Prevalence is worldwide and spreads is by 
faecal , oral transmission or possibly by 
airborne droplets. Peak incidence in cold or 
dry seasons 
Causes patchy damage to the epithelium 
of the small intestine, resulting in blunting 
of the villi. 
Illness ranges from asymptomatic infection 
to acute dehydrating diarrhea that may 
lead to death.  
Bacteria   
Shigella Causes 10-15% of acute diarrhea in children 
< 5years and the most common cause of 
bloody diarrhea. Transmission occurs from 
person-to-person contact since the infectious 
dose is low (10 to 100 organisms). 
Foodborne and waterborne also occurs in 
warmer seasons 
Invades and multiplies within colonic 
epithelial cells, causing cell death and 
mucosal ulcers. Occasionally invades the 
blood stream.  
Escherichia coli 
(E. Coli) 
E. Coli causes up to one quarter of all 
diarrhea in developing countries. 
Transmission usually occurs through 
contaminated food and water. Enteroxigenic 
Escherichia coli (ETEC) are the major cause 
of acute watery diarrhea in children in 
developing countries during warm and wet 
seasons 
Two important virulent factors of ETEC are: 
colonization factors that allow ETEC to 
adhere to electrocytes of small bowel, and 
enterotoxins. ETEC produce heat-labile 
(LT) and/or heat stable (ST) enterotoxins 
that cause secretion of fluid and 
electrolytes, resulting in watery diarrhea. 
ETEC do not destroy the brush border or 
invade the mucosa. 
Campylobacter 
jejuni 
C.jejuni cause 5-15% of diarrhea in infants 
worldwide, but because it is also found in 
many without diarrhea, the true proportion of 
cases due to C.jejuni is unknown. 
Transmission is mainly from chicken and 
other animals. 
C.jejuni probably produces diarrhea by 
invasion of the ileum and the large 
intestine. Two types of toxin are produced: 
a cytotoxic and a heat-labile enterotoxin. 
Vibrio cholera 
O1 and O139 
Cholera is endemic in many countries of 
Africa, Asia and Latin America, where 
epidemics often occur annually usually 
during the hot, wet season. Transmission 
occurs mainly through contaminated water 
and food, person-to-person transmission is 
much less common. 
Because of potential for epidemic spread, 
confirmed or suspected cases of cholera) 
including severe dehydration in patients 
should be reported promptly to public 
health authorities. 
Protozoa   
Cryptosporidium Accounts for 5-15% of childhood diarrhea in 
developing countries. It`s transmitted through 
the faecal-oral route. 
Cryptosporidium attach to the microvillus 
surface of enterocytes and produce 
mucosal damage, which causes mal-
absorption and fluid secretion. 
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2.1.4 Risk factors associated with acute diarrhea in children 
Although some children with diarrhea failed to show any pathogenic infection in 
their stool samples in laboratory-based studies, infection with a microbiologic agent 
causing acute diarrhea remains the primary risk factor for diarrhea occurrence in 
children (Kotloff et al., 2013; WHO, 2005c; Mohan et al., 2017). Five pathogens 
(rotavirus, Shigella, enterotoxigenic E. coli producing heat-stable toxin [ST-ETEC], 
Cryptosporidium, and typical enteropathogenic E. coli  ) account for the majority of 
MSD cases in children under five in Asia and sub-Saharan Africa (Kotloff et al., 
2013). It has been estimated that interventions targeting at least four of these 
pathogens—rotavirus, Shigella, Cryptosporidium, and ST-ETEC—were likely to 
reduce MSD by 40% during the first two years of life (Kotloff et al., 2013). While 
viral diarrhea appears to be transmitted primarily from person to person, bacterial 
diarrhea appears to be mainly foodborne (Ethelberg et al., 2006; WHO, 2005c). In 
general, factors associated with increased risk of diarrhea in children include low 
socio-economic status (and low education level of parents or caretakers) mediated 
by poor sanitation (Genser et al., 2006), recent foreign travel, and contact with 
domestic animals and symptomatic persons (Ethelberg et al., 2006). A lack of 
rotavirus immunization and having another member of the family with diarrhea 
have also been linked to increased risk of diarrhea (Mbonye, 2004; Sobel et al., 
2004). 
2.1.5 Clinical features associated with acute diarrhea in children 
Understanding clinical features associated with AGE are important tools for 
clinicians in establishing possible diagnosis and treatment options for infectious 
agents in setting with sub-optimal laboratory capacity (WHO, 2005c). The 
symptoms can be combined in a stepwise manner using clinical history to identify 
patients with high probability of having either viral, bacterial or AGE caused by 
other etiologies (WHO, 2018a, , 2005c). While the most predominant clinical 
characteristic of AGE in children generally include; loose, watery stool and 
abdominal pain, clinical presentation usually depend on etiology and host factors 
(WHO, 2018a). For example, non-bloody watery diarrhea presenting with mainly 
vomiting, and fever have been associated with viral etiologies, most commonly 
rotavirus (L. J. Liu et al., 2005). However, mucus or bloody stools are routine 
features of bacterial infection, especially Shigella  (WHO, 2005c). Symptoms 
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associated with other diarrhea etiologies are further described elsewhere (WHO, 
2005c). 
2.2 Diarrhea Epidemiology 
2.2.1 Global burden of childhood diarrheal diseases 
Globally, there are approximately 1.7 billion episodes annually of diarrhea among 
children under five (WHO, 2018a). Each year, diarrhea kills approximately 525,000 
children under five (WHO, 2018a). Children in sub-Saharan Africa and South Asia 
face the highest risk of dying before their fifth birthday (UNICEF, 2017); see 
Figure 1. Despite progress at the global, regional, and national levels following the 
successes in striving for Millennium Development Goals (MDGs), populations in 
low- and middle-income countries still continue to bear the greatest burden of 
infectious diseases — the leading cause of death in children under five worldwide 
(L. Liu et al., 2015).  
Figure 1.  Mortality rates (deaths per 1,000 live births) by country, 2016.  
Source: (UNICEF, 2017).  Accessed on 25 April 2018 https://www.unicef.org/publications/index_101071.html 
Diarrhea has continued to be a leading cause of preventable morbidity and 
mortality among children under five and, accounts for 8–9% of total global deaths 
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and approximately 20% of child deaths worldwide (Fischer Walker et al., 2012; 
Black et al., 2003; Black et al., 2010; L. Liu et al., 2012; UNICEF, 2018). According 
to UNICEF’s 2017 global mortality estimates, diarrhea was the second most 
common cause of mortality among children under five (UNICEF, 2017); see 
Figure 2. Children with MSD, unlike those without diarrhea, are likely to encounter 
linear growth faltering and an increased chance of death within 60 days of an MSD 
episode (Kotloff et al., 2013). Each episode of diarrhea leads to nutritional insult 
and causes growth retardation; as a result, diarrhea causes malnutrition, and 
malnourished children are at increased risk of further diarrhea and resultant death 
(WHO, 2018a). 
 
Figure 2.  Global distribution of deaths among children under five, by cause, 2016. 
Source: (UNICEF, 2017). Accessed on 25 April 2018 https://www.unicef.org/publications/index_101071.html 
Understanding the epidemiology of diarrhea among children living in high disease 
burden regions could contribute to more effective approaches to saving children’s 
lives (Black et al., 2003). Continued efforts to improve diarrhea case management 
are important to reduce childhood deaths from the disease (Forsberg et al., 2007; 
Black et al., 2010). Furthermore, expanding effective preventive and curative 
interventions targeted to high disease burden regions is an important step to 
accelerate reductions in child morbidity and mortality. Such efforts may be more 
effective if the interventions focus on the main causes of child morbidity and 
mortality and on the most vulnerable groups: infants and children under five, 
especially in high disease burden regions (UNICEF, 2017).  
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2.2.2 The burden of childhood diarrheal disease in Kenya 
In Kenya, diarrhea is the third leading cause of death among children under five, 
after pneumonia and malaria (UNICEF, 2010). Every Kenyan child under 5 years 
old has an average of 3 episodes of diarrhea annually; an estimated 86 children die 
daily from diarrhea, with rotavirus alone killing approximately 7,500 Kenyan 
children under five annually in the pre-rotavirus vaccine era (UNICEF, 2010). 
Furthermore, findings from the GEMS study estimated the mean cost of a single 
episode of diarrhea among children under five to be US$6.24 in Kenya, compared 
to only US$4.11 in Mali and US$2.63 in The Gambia (Rheingans et al., 2012). This 
observation suggests that families living in settings like Kenya, where the daily 
household income is less than a dollar a day, may be forced to forgo purchase of 
essentials for household at the expense of treating a child with diarrhea.Consistent 
with the recent global estimates (Tate, Burton et al., 2016), data from Kenya 
demonstrate that rotavirus is a leading pathogen associated with dehydrating 
diarrhea in children under five (Kotloff et al., 2013; Tate, Rheingans et al., 2009). 
Therefore, an improved understanding of the population-based disease burden of 
diarrhea and the risk factors for rotavirus diarrhea in Kenya is needed to support 
decisions involving future allocation of the country’s limited resources toward 
diarrhea- and rotavirus-specific interventions. Furthermore, knowledge of the 
consequences of acute diarrhea and rotavirus disease in children from high disease 
burden regions of the world like Kenya (Figures 3 and 4) should aid in the design 
and evaluation of potential interventions to improve child health (Black et al., 
2010). 
Figure 3.  WHO-reported rates of child mortality due to diarrhea, 2013.  
Source: (UNICEF, 2017). Accessed on 25 April 2018 https://www.unicef.org/publications/index_101071.html 
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2.3 Rotavirus Diarrhea in Children 
2.3.1 Epidemiology of rotavirus 
Rotavirus was first identified as an enteric pathogen by Ruth Bishop and colleagues 
in 1973 (Bishop, 1973). Since then, it has been widely reported as the most 
common cause of severe gastroenteritis in infants and children under two years old 
in many settings worldwide before the introduction of rotavirus vaccine (Kotloff et 
al., 2013; Tate, Burton et al., 2016; Tate, Burton et al., 2012; Fletcher et al., 2013). 
Globally, it is recognized that by the age of five, every child in most places 
worldwide will have been infected with rotavirus at least once (WHO, 2008). Other 
authors have also observed that at least 1 and up to 3 prior rotavirus infections 
have the potential to confer up to 74% protection against subsequent infection, 
even in settings where rotavirus vaccine immunization is not yet in place (Mohan et 
al., 2017; Velazquez et al., 1996). These findings may in part be related to neonates 
and children who are infected with rotavirus and remain asymptomatic or less 
severely symptomatic, especially in settings where diarrhea was a major problem in 
the pre-vaccine era (Velazquez et al., 1996). 
2.3.1.1 Hospitalization associated with rotavirus 
The rationale for focusing on hospitalization is that hospital-based data are 
important in evaluating the need for a vaccine. Once a rotavirus vaccine becomes 
available, hospital-based surveillance data would permit reliable and rapid 
assessment of the success or failure of a given vaccine program (WHO, 2008). 
Hospitalization data make it easier to quantify the occurrence of severe rotavirus 
diarrhea from a catchment area, especially if the population is well defined, as they 
are likely to present to a hospital for treatment; even case finding will be easier than 
in community settings (WHO, 2008). Hospital surveillance also makes it easier to 
collect and test diarrhea patients’ stool samples for rotavirus. Moreover, a system 
for monitoring hospitalizations attributable to AGE can easily be modified to 
incorporate intussusception surveillance, since these diseases occur in the same age 
group and are both likely to result in hospitalization (WHO, 2008). 
Before the introduction of rotavirus vaccine in Kenya, rotavirus infection was 
estimated to cause 19% (~9,000) of hospitalizations and 16% of clinic visits among 
children under five annually (Tate, Rheingans et al., 2009). Estimates of 
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hospitalization rates, outpatient care, and health care-seeking patterns are useful 
since they can help calculate country-specific estimates of the disease burden 
associated with hospitalization, as demonstrated in Kenya (Tate, Rheingans et al., 
2009). However, to update estimates on hospitalizations attributable to AGE and 
RVAGE prior to vaccine introduction in settings like Kenya requires a defined 
population that uses specific health care facilities or a single hospital with good or 
at least free access to health care services for children under five, such as the 
government hospitals as recommended by the WHO (WHO, 2008). 
2.3.1.2 Morbidity and mortality associated with rotavirus 
Despite the global decline in all-cause and rotavirus-specific diarrhea, recent data 
from several key studies show the continued relative importance of rotavirus as a 
major cause of vaccine-preventable diarrhea in the world’s high disease burden 
regions (Kotloff et al., 2013; Mohan et al., 2017). In previous observations, more 
than 80% of global rotavirus-related deaths occurred in middle-income countries, 
with South East Asia and sub-Saharan Africa accounting for 30% and 50%, 
respectively (Parashar et al., 2006; L. Liu et al., 2012). For example, 700,000 
episodes of all-cause diarrhea were reported worldwide in 2011; 72% led to death, 
with rotavirus the leading cause in 28% of all episodes (Walker et al., 2013). 
Although Tate and colleagues have recently estimated a decline in global mortality 
attributed to rotavirus from 528,000 in 2000 to 215,000 in 2013, Kenya remains 
among the ten countries with the highest number of reported rotavirus deaths 
(Tate, Burton et al., 2016); see Figures 4 and 5. 
Figure 4.  Distribution of rotavirus deaths among children under five in the ten countries with the 
highest rates, 2000–2013. Source: (WHO, 2018b). 
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Figure 5.  Causes of death among Kenyan children under five, 2010 . Source: (PATH, 2014). 
Accessed on 25 April 2018: http://www.path.org/publications/files/VAD_rotavirus_kenya.pdf 
2.3.1.3 Economic Impact of rotavirus disease 
Although the economic impact of rotavirus diarrhea is expected to decline after the 
introduction of a rotavirus vaccine, rotavirus diarrhea still places a significant 
burden on both household and national health infrastructures. For example, during 
the pre-rotavirus vaccine era in Kenya, rotavirus diarrhea among children under 
five cost the national healthcare system approximately US$10.8 million annually 
(Tate, Rheingans et al., 2009). It has been estimated that, in Kenya, a two-dose 
rotavirus vaccine regimen would prevent 55% and 65% of rotavirus-associated 
deaths and hospitalizations, respectively, at a cost of US$3 per series and US$2.1 
million in total medical costs annually (Tate, Panozzo et al., 2009). 
2.3.1.4 Seasonality of rotavirus diarrhea 
Understanding the seasonality of leading enteric pathogens such as rotavirus can 
help guide policymakers and others implementing vaccine intervention to identify 
periods of high disease transmission and decide on appropriate interventions and 
approaches to optimize prevention and case management strategies. Rotavirus has 
been shown to be seasonal in some settings, occurring more commonly during the 
dry season in sub-Saharan Africa (Ouedraogo et al., 2017; Mayindou et al., 2016; 
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Ngabo et al., 2014; Khagayi et al., 2014). The pattern of seasonality can even vary by 
region, peaking in the dry months in northern Africa and the Middle East (Zaraket 
et al., 2017) and in colder and drier months in tropical countries and South Asia 
(Levy et al., 2009; Jagai et al., 2012). In fact, rotavirus has been shown to peak in 
winter in places like Australia (Fletcher et al., 2013), the United States (MacNeil et 
al., 2009; Tate, Panozzo et al., 2009; de Oliveira et al., 2009), and China (Zeng et al., 
2010). These observations support the findings of a study by Patel and colleagues 
(Patel et al., 2013), which showed that there is no single unifying factor for global 
rotavirus seasonality patterns. On the other hand, there is increasing evidence that 
rotavirus vaccination has the potential to change the observed seasonality in a 
number of locations. For example, in the United States, the rotavirus season has 
been shown to be delayed, to be shorter, or to disappear altogether after vaccine 
introduction (Tate, Panozzo et al., 2009; Tate et al., 2011). These observations 
support the WHO’s call for worldwide implementation of rotavirus vaccines 
(WHO, 2013b). 
2.3.2 Clinical features associated with rotavirus infection 
Assessing and classifying diarrhea based on etiology and the clinical features 
presented by patients are useful and simple tools for identifying possible life-
threatening AGE (WHO, 2006). These criteria can readily be used by health care 
workers whose clinical training or access to diagnostic laboratory facilities may be 
limited, as is common in most low- and middle-income countries like Kenya, 
where most if not all clinicians do not routinely use laboratory results to guide 
patient management (Webb & Starr, 2005; WHO, 2005c; F. Odhiambo et al., 2014). 
Understanding the clinical features associated with rotavirus infection could also 
help support awareness among caretakers and health care workers of the need to 
promote timely care seeking and management of patients who have RVAGE. Pre-
vaccine data could also help evaluate whether the introduction of rotavirus 
vaccination in a given area alters the clinical characteristics of RVAGE among 
children under five years old (Parashar et al., 2015). 
Rotavirus has a short incubation period (usually less than 48 hours; (WHO, 
2005c). Children presenting with rotavirus compared to non-rotavirus diarrhea 
more often present with vomiting and severe dehydrating diarrhea preceded by 
abdominal pain and fever (Webb & Starr, 2005). In Africa, AGE that presents with 
fever, vomiting, and dehydration is commonly associated with rotavirus infection 
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(Bonkoungou et al., 2010; Nakawesi et al., 2010). Likewise, in developed countries 
in Europe and elsewhere, fever, vomiting, and severe dehydration (Aristegui et al., 
2016; Schael et al., 2009)—regardless of malnutrition or poverty status (Schael et al., 
2009)—are the predominant clinical symptoms among AGE patients with 
rotavirus infection. In Asia, vomiting and fever have also been found to be 
associated with rotavirus infection among children with AGE (Dhiman et al., 2015). 
However, in some settings in Uganda, higher maternal education and 
breastfeeding, which have been widely reported to offer protection against AGE 
and RVAGE (Webb & Starr, 2005), have actually been shown to be associated 
with rotavirus infection (Nakawesi et al., 2010). In general, vomiting, fever, and 
dehydration are the clinical features most commonly associated with RVAGE 
illness (Table 2).  
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Table 2.  Risk factors for rotavirus infection among children aged under five: summary of 
evidence from prospective observational studies. 
2.3.3 Rotavirus prevention 
2.3.3.1 Diagnosis and treatment for rotavirus 
Although the currently preferred routine diagnostic test for rotavirus is detection 
of rotavirus antigen in fecal stool specimens by enzyme-linked immunoassay (EIA), 
other techniques including electron microscopy and reverse transcription 
Reference, 
Country, World 
Region 
Study 
setting 
Age of 
study 
subjects 
Study design Outcomes assessed Main findings 
(Aristegui et al., 
2016), Spain, 
Europe 
Out/in-
patient 
 </=3years Prospective 
hospital-based 
study 
Factors 
associated with 
RVAGE 
Fever, vomiting, dehydration, 
hospitalization, higher cost of 
treatment was associated with 
RVAGE than non-RVAGE. 
 (Schael et al., 
2009), 
Venezuela, 
Europe 
 In/out-
patient 
 < 5years Prospective 
hospital-based 
study 
Socio-
demographic and 
clinical 
characteristics of 
RVAGE 
Severe dehydration regardless of 
malnutrition and poverty and age 
being infants were associated with 
RVAGE than non-RVAGE 
(Paul et al., 
2014), India, 
Asia 
Population-
based study 
 <5 years Prospective 
cohort 
Risk factors for 
symptomatic and 
asymptomatic 
rotavirus 
infection 
Rotavirus was associated with 
15% of mild diarrhea, 40% of 
moderate diarrhea and 67% of 
very severe diarrhea 
(Salim et al., 
2014), India, 
Asia 
 In-patient  < 5years  Prospective 
hospital-based 
study 
Risk factors for 
symptomatic 
infection 
Vomiting and male gender were 
risk factors for rotavirus infection. 
Good nutrition and breastfeeding 
were protective against rotavirus 
infection 
(Abebe et al., 
2014),Ethiopia, 
sub-Saharan 
Africa 
 In-patient  <5years  Prospective 
hospital-based 
study 
 Risk factors for 
rotavirus disease 
Children aged 6-12 months had 
the highest infection rates and 
Vomiting was associated with 
rotavirus infection 
 (Bonkoungou et 
al., 2010), 
Burkina Faso, 
sub-Saharan 
Africa 
Out/in-
patient 
 < 5years Prospective 
hospital-based 
study 
Epidemiology of 
RVAGE 
Fever, vomiting and hospitalization 
were associated with RVAGE than 
non-RVAGE. 
(Mohan et al., 
2017),  8 sites in 
developing 
countries 
Out/in-
patient 
 < 5years Prospective 
longitudinal 
study 
Risk factors for 
rotavirus and 
duration of 
protection 
Household overcrowding and high 
pathogen load were associated 
with rotavirus infection and 
disease. 
Prior rotavirus infection conferred 
74% of protection against 
subsequent infection in the 
absence of vaccination. 
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polymerase chain reaction (RT-PCR), have been used to detect rotavirus in stool 
samples (WHO, 2013a, , 2008). Children with rotavirus infection commonly 
present with dehydrating diarrhea, which often needs to be treated with ORS and 
in severe cases with IV fluid administration; otherwise, they are at risk of dying 
(WHO, 2005c). Such urgent health care services are often inaccessible, unavailable, 
or scarce in developing countries where diarrhea case management is also generally 
poor (Forsberg et al., 2007). Rotavirus prevention through vaccination is thus 
critical to saving children’s lives in such areas (Parashar et al., 2016). 
2.3.3.2 Rotavirus vaccines 
As the post-2015 MDGs take hold, continued surveillance of the leading 
pathogens associated with acute childhood diarrhea remains a priority for 
infectious disease specialists (L. Liu et al., 2015). Moreover, prioritizing 
implementation of licensed interventions like rotavirus vaccines and instituting 
follow-up studies to monitor the impact of such interventions are increasingly 
urgent to help document benefits that can guide new interventions to address 
emerging needs. Increasing evidence for the efficacy and effectiveness of rotavirus 
vaccination against morbidity and mortality among children under five from all 
MDG regions has continued to be reported (Lamberti et al., 2016). The efficacy of 
rotavirus vaccination against severe rotavirus diarrhea has been shown to range 
from 90.6% (95% confidence interval [CI]: 82.3–95.0) in developed regions to 
88.4% (95% CI: 67.1–95.9) in eastern and south eastern Asia, 79.6% (95% CI: 
71.3–85.5) in Latin America and the Caribbean, 50.0% (95% CI: 34.4–61.9) in 
South Asia, and 46.1% (95% CI: 29.1–59.1) in sub-Saharan Africa (Lamberti et al., 
2016). 
Given the above evidence and observations from other settings, the 
epidemiology of AGE and RVAGE disease is expected to change with time 
(Lamberti et al., 2016; Patel & Parashar, 2009). Monitoring disease trends for 
several years before and after vaccine introduction in a country with a view to 
assessing vaccine impact would therefore require active gastroenteritis surveillance 
and hospitalization surveillance data that would support the realization of the goals 
detailed in Table 3 (Patel & Parashar, 2009). 
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Table 3.  Objectives and rationale for assessing postlicensure performance of rotavirus. 
 
Source:(Patel & Parashar, 2009) 
Vaccines are the best rotavirus prevention tools available today, since the 
improvements in drinking water, sanitation, and hygiene (including good hand 
washing) that have been shown to be effective in preventing other forms of 
gastroenteritis do not adequately prevent the spread of rotavirus (WHO, 2006, , 
2005c; Churgay & Aftab, 2012). Efforts to realize the goal of a vaccine started with 
the first rotavirus vaccine (RotaShield [Wyeth Lederle Vaccines, Philadelphia, 
USA]) which was approved, licensed, and introduced to all infants as part of 
routine immunization schedules in the United States in 1998 (Hochwald & Kivela, 
1999; Svensson et al., 1999). However, in July 1999, the US Centers for Disease 
Control and Prevention (CDC) reported 15 cases of intussusception (an intestinal 
invagination resulting in obstruction) in recipients of RotaShield (CDC, 1999), 
which informed the subsequent decision to withdraw the vaccine from use and 
recommend further studies (Kapikian, 2001). Although additional follow-up 
evaluation data revealed a small excess risk and temporal association between the 
first dose of RotaShield vaccine and intussusception in infants (Rha et al., 2014; 
Tate, Yen et al., 2016; Patel et al., 2011), some available data have shown no 
evidence of an association between increased intussusception and admissions of 
infants during the period of RotaShield availability in the United States (Simonsen 
et al., 2001). However, randomized clinical trials (RCTs) have also failed to rule out 
very small relative risks of an association between two recent rotavirus vaccines—
Rotarix® (GlaxoSmithKline Biologicals, UK) and RotaTeq® (Merck Vaccines,  
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New Jersey, USA)—and intussusception (Soares-Weiser et al., 2010; Buttery et al., 
2011; Soares-Weiser et al.).  
Despite the fact that both RCTs and post-marketing safety monitoring data in 
both developed and developing countries do not indicate a significant risk of 
intussusception after vaccination, a low-level risk cannot be ruled out, according to 
other follow-up studies (Patel et al., 2009; Tate, Steele Ad Fau - Bines et al., 2012; 
Peter & Myers, 2002), even though the benefits of these two vaccines have been 
demonstrated to far outweigh the estimated small risks of intussusception (Soares-
Weiser et al.; Patel et al., 2011). It is worth noting that this risk has not been 
observed when the vaccine is administered earlier (Oberle et al., 2014), suggesting 
the need for timely administration of these vaccines.  
To limit intussusception risk among vaccine recipients, it is recommended that 
the first dose of rotavirus vaccine be administered before 12 weeks of age and the 
series be completed by 24 weeks (Rotarix®) or 32 weeks (RotaTeq®) (WHO, 
2002; Wood, 2005). Finally, these two vaccines have now been licensed and 
recommended for routine use through immunization programs to prevent 
rotavirus gastroenteritis globally (WHO, 2013b). African countries are increasingly 
introducing these vaccines with the assistance from GAVI, the Vaccine Alliance 
(Steele et al., 2012). Monitoring intussusception before and after rotavirus vaccine 
introduction is important for understanding any epidemiological changes in this 
medical condition (Huppertz et al., 2006; Escolano et al., 2015). Intussusception 
surveillance studies in countries introducing rotavirus vaccines are therefore highly 
recommended to assess the safety of these vaccines and to identify any adverse 
events that may be associated with them (Soares-Weiser et al., 2012). 
2.4 Epidemiology of Intussusception in Children 
Intussusception—a condition in which a portion of the intestine invaginates into a 
distal portion (Lloyd, 2004); see Figure 8)—is the most common cause of intestinal 
obstruction among children from three months to five years old (Stringer & 
Holmes, 1992; DiFiore, 1999; Roeyen et al., 1999). Intussusception can take various 
forms: ileo-ileal, ileo-caecal, ileo-colic, ileocaeco-colic, jejuno-ileal, and colo-colic. It 
is estimated that approximately two-thirds of all intussusception cases occur in 
children under a year old, with a peak age of five to seven months and an incidence 
of 74 per 100,000 (range: 9–328) among infants worldwide (Jiang et al., 2013). 
While intussusception incidence rates may not be higher in sub-Saharan Africa 
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than elsewhere (Figure 6), the proportion of children with intussusception who die 
after presenting to the hospital is substantially higher in sub-Saharan Africa (9.4% 
to ~13%) than in Asia (0.2%), Central and South America (0.6%), the Eastern 
Mediterranean (0.8%), Europe (0.1%), North America (0.4%), and Oceania (0%) 
(Jiang et al., 2013).  
 
Figure 6.  Global distribution of intussusception incidence rates per 100,000 infants  
Source: (Jiang et al, 2013). 
2.4.1 Seasonality of intussusception 
Epidemiological studies conducted in 11 Latin American countries (Saez-Llorens et 
al., 2013) and in China (Cui et al., 2016), New Zealand (Chen et al., 2005), and 
Mexico (Velazquez et al., 2004), combined with observations from one of the most 
recent comprehensive literature review of studies conducted over 18 years in Africa 
and other parts of the world (Jiang et al., 2013), show that there is no clear global 
seasonality pattern for intussusception among children. On the other hand, one 
study conducted over a 10-year period in France did document a seasonality 
pattern among children diagnosed with intussusception (Serayssol et al., 2014). 
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2.4.2 Clinical features associated with intussusception in children 
Although many cases of intussusception self-resolve, others lead to more elaborate 
clinical symptoms, especially bowel obstruction that can be fatal if not treated 
urgently (Yen et al., 2016). Knowing the classic clinical symptoms commonly 
associated with intussusception is important in designing awareness programs to 
urge caretakers to seek care promptly (Escolano et al., 2015) and can assist health 
care workers in identifying potential cases for urgent treatment, if not referral 
(Bines et al., 2004). Furthermore, since intussusception is a rare disease, describing 
the most common clinical symptoms of the disease at the local level would inform 
decision makers and help parents in developing countries better recognize it (Glass 
et al., 2005). However, clinical presentation in patients with intussusception in 
many settings often includes a wide range of non-specific clinical symptoms 
(Waseem & Rosenberg, 2008). Predominant symptoms from the majority of 
intussusception patients have been shown to include ; vomiting, abdominal pain, 
and rectal bleeding, blood in stool, and abdominal mass and tenderness from 
physical examination (Waseem & Rosenberg, 2008; Klein et al., 2004). In other 
settings, most cases have presented with symptoms that include chronic but not 
acute abdominal pain and an absence of fever (Ahn et al., 2009). 
For a decade now, the most commonly reported clinical signs of 
intussusception in children from most observational studies in Asia (Cui et al., 
2016; Waseem & Rosenberg, 2008; Yousafzai et al., 2017; Yap Shiyi & Ganapathy, 
2017), Europe (Huppertz et al., 2006), and sub-Saharan Africa (Carneiro & Kisusi, 
2004) have been similar and include vomiting, abdominal mass/pain, and bloody 
stool or rectal bleeding occurring with abdominal tenderness. It is worth noting 
that plain radiograph findings in the absence of stool in the ascending colon could 
also be a predictor of intussusception (Klein et al., 2004; Yousafzai et al., 2017). 
Still, there remains no reliable prediction model that can accurately identify all 
patients with intussusception (Klein et al., 2004).  
2.4.3 Diagnosis and treatment options for intussusception 
Methods used to diagnose and treat intussusception have been shown to vary by 
global region (Jiang et al., 2013). Outside Africa, 95–100% of cases are diagnosed 
by radiographic methods like air-contrast enema, ultrasound, or computed 
tomography (Jiang et al., 2013). Although intussusception diagnosis normally relies 
first on clinical suspicion (Waseem & Rosenberg, 2008), approximately 70% of 
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intussusception cases in sub-Saharan Africa are diagnosed at the time of surgery; 
while a more desirable diagnostic modality that uses contrast enema or ultrasound 
is involved in diagnosing fewer than one in five cases (Steele et al., 2012). Despite 
surgery’s being the most commonly used treatment in African countries (Steele et 
al., 2012), other studies in African settings have shown that non-operative 
treatment of ileo-colic intussusception through ultrasound-guided reduction boasts 
higher success rates (75–95%) than surgery. In addition, this method carries no 
radiation risk and is safe, painless, quicker than surgery, and not associated with 
any complication, death, or recurrence of intussusception among patients (Mensah 
et al., 2011; Krishnakumar et al., 2006; Tander et al., 2007; Rohrschneider & Troger, 
1995). 
Other studies have shown that clinical manifestation and surgery are the 
predominant clinical methods intussusception management in Africa (Kuremu, 
2004; Carneiro & Kisusi, 2004). These findings departs radically from other parts 
of the world, where diagnosis and treatment of intussusception mainly uses 
modern radiographic methods that are associated with fewer or no fatalities (Jiang 
et al., 2013; N. Liu et al., 2018; Yousafzai et al., 2017). These observations may help 
explain the high differential in intussusception-related deaths between most 
African countries and other parts of the world. 
2.4.4 Etiology of intussusception among children 
The causes of intussusception in a majority of infants and young children remain 
unknown. However, some microbiologic infectious agents like respiratory 
adenovirus (Bines, Liem, Justice, Son, Kirkwood et al., 2006; Minney-Smith et al., 
2014; Ukarapol et al., 2016) and other enteric bacterial agents (Campylobacter spp., 
E. coli  , Salmonella spp., and Yersinia enterocolitica) have been associated with 
intussusception in other studies conducted in a variety of locations around the 
world (Nylund et al., 2010; May et al., 2014). Although viral respiratory infections 
have been associated with most intussusceptions in population-based studies, a 
number of studies have also shown that naturally occurring or wild-type rotavirus 
is not associated with intussusception in India (Bahl et al., 2009), New Zealand 
(Chen et al., 2005), or South Carlifornia (Chang et al., 2002). The observed 
geographical variations in these studies is not well defined, but a number of factors 
like genetic dispositions, circulating pathogens, differentials in feeding practices, 
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and differences in diagnostics and access to healthcare patterns could account for 
most of these variations (Jiang et al., 2013; Johnson et al., 2010). 
Post-marketing surveillance has identified a small increased risk of 
intussusception associated with rotavirus vaccines (Velazquez et al., 2012; Patel et 
al., 2011). For example, an association between RV1 and RV2 in the range of 1–6 
excess cases per 100,000 vaccinated infants (Rha et al., 2014) in high- and middle-
income countries has been documented, but the risk data from these affluent 
settings may not translate directly to developing countries. Further characterization 
of any associated risk following rotavirus vaccination, baseline rates, and death 
associated with intussusception is therefore desirable for low- and middle-income 
countries like Kenya (Parashar et al., 2015). As rotavirus vaccines are introduced in 
more developing countries, intussusception surveillance efforts in diverse settings 
will provide data that will improve our understanding of the risks and benefits of 
the vaccine and intussusception epidemiology beyond affluent settings.  
It is worth noting that the pattern of age distribution (peaking at ~5–7 months) 
follows the same pattern in rotavirus gastroenteritis and intussusception disease, as 
reported in a number of studies (Chouikha et al., 2009; Jiang et al., 2013; Tate et al., 
2008; Parashar et al., 2000; Mattei et al., 2017). Similarly, the predominance of the 
male gender appears to overlap as a factor associated with both conditions in 
diverse settings (Chouikha et al., 2009; Jiang et al., 2013; Huppertz et al., 2006; Chen 
et al., 2005). Although these observations may suggest biological plausibility, 
intussusception occurs with no clear seasonality (Jiang et al., 2013), unlike rotavirus 
(Velazquez et al., 2004; Nelson et al., 2002; Chang et al., 2002), which undermines 
any possible association between rotavirus and intussusception and confirms the 
existing gap in knowledge about the etiology of intussusception. 
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Table 4.  Intussusception-associated etiologies among children aged under five: summary of 
evidence from prospective observational studies. 
Author, year 
of publication, 
Country and 
World Region 
Age group 
of study 
subjects 
Study design Outcomes assessed Main findings 
(Vega Garcia et 
al., 2015), 
Spain, Europe 
95 Cases 
aged 
<2years 
Case-crossover Association between 
Intussusception and 
history of drug 
administration  
Drug administration 2-to-7 days before 
onset of symptoms in children <2years was 
associated with development of 
intussusception 
(Chen et al., 
2005), New 
Zealand, 
Europe 
< 3 years Prospective 
hospital 
surveillance 
To describe epidemiology 
of intussusception and its 
relationship to rotavirus 
hospitalization 
In contrast to rotavirus hospitalized cases, 
intussusception peaked at younger age and 
lacked seasonality. Wild-type rotavirus was 
observed not to have an association or 
trigger intussusception in young New 
Zealand children 
(Bhisitkul et al., 
1992) 
3 months-
5years 
Prospective 
case-control 
Possible relationship 
between intussusception 
and Adenovirus 40/41 
Association between intussusception and 
non-enteric adenovirus was observed 
(Bahl et al., 
2009), India, 
Asia 
Infants  Case-control To examine association 
between intussusception 
and natural rotavirus 
infection 
No association was observed to exist 
between natural rotavirus infection and 
intussusception in Indian children 
(Ukarapol et al., 
2016), 
Thailand, Asia 
40 cases 
aged 
Prospective 
cohort 
Determine association 
between gastroenteritis 
viruses and IS  
Significant association with adenovirus 
(subtype C)  was observed (OR=8.87, 
95%CI: 1.95-12.16) 
(Velazquez et 
al., 2004), 
Mexico, USA 
Infants  A prospective, 
multi-center 
case-control 
To determine whether 
natural rotavirus infection 
or any another 
enteropathogen is 
associated with 
Intussusception 
No association between natural rotavirus 
infection and IS was observed 
(Okimoto et al., 
2011), Japan 
Infants and 
children 
aged 4-47 
months 
Prospective 
hospital 
surveillance 
To determine association 
between viral infections 
with development of  IS 
Adenovirus infection, especially with the 
non-enteric types was observed to be a risk 
factor for developing intussusception 
among Japanese children , particularly 
those aged >2 years in Japan. 
2.4.5 Factors associated with death among children with intussusception 
Data on factors associated with death among children with intussusception are 
rarely available. However, where they do exist, most data support the position that 
delay in seeking care for intussusception after symptom onset is a risk factor for 
death, especially in sub-Saharan Africa (Carneiro & Kisusi, 2004; Gudeta, 1993; 
Ekenze et al., 2010). Similarly, delays in obtaining diagnosis, admission, and 
treatment (Ekenze et al., 2010) are the factors most commonly associated with 
death among some intussusception patients. Delay in seeking care for 
intussusception has also been observed to increase the chances of open surgery, 
especially intestinal resection, which is a non-operative diagnosis and treatment 
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method that is equally associated with death among children with intussusception 
(Lehnert et al., 2009; Jenke et al., 2011). Unlike surgery, other non-operative 
methods such as fluid and air enemas and ultrasound have been shown to be highly 
successful, reducing the chance of death and leading to minimal hospital stays with 
almost no fatalities (Justice et al., 2006; Al-Malki, 2005; Kruatrachue et al., 2011). 
Although surgery has also been successful in treating intussusception in some 
settings (Cui et al., 2016), it continues to be associated with high case fatality in 
African settings, where it is still used to treat 70–100% of children with 
intussusception, despite existence of other more efficient methods such as 
fluoroscopy (Steele et al., 2012; Adamou et al., 2017; Jiang et al., 2013). 
2.4.6 Intussusception and rotavirus vaccines 
Rotavirus vaccine with an improved safety profile was first recommended when 
the first and second doses of the three-dose, oral tetravalent rhesus-human 
reassortant vaccine (RRV-TV) was found to be associated with intussusception in 
the United States (Murphy et al., 2001). The first dose of the currently licensed 
rotavirus vaccines is recommended to be administered at 6–15 weeks of age. The 
lower rate of intussusception in this age group reported in studies to date appears 
to support the need for timely administration of vaccines to minimize their 
possible attributable risk. However, due to delays in vaccination that are common 
in sub-Saharan Africa and other settings, intussusception associated with vaccines 
could increase. As part of safety monitoring following possible vaccine-associated 
intussusception, data collected before and after rotavirus vaccine introduction in a 
given country may be key to helping monitor changes in the epidemiology of 
intussusception. The risk of intussusception and vaccine program implementation 
in affluent settings has been shown to vary by region, making reliable regional 
baseline data even more useful in tracking trends of intussusception (Buttery et al., 
2011; Jenke et al., 2011). Furthermore, it remains unknown whether an association 
between intussusception and currently licensed vaccines will be found after their 
introduction in low- and middle-income countries, so intussusception surveillance 
is even more important (Peter & Myers, 2002). An increase in intussusception 
hospitalization rates in children from 8 to 11 weeks old has been shown to overlap 
with age when the majority of first doses of vaccine were given in the Unites States 
(Tate, Yen et al., 2016). This supports the ongoing debate, as more countries 
prepare to introduce the two presently licensed vaccines, over whether rotavirus 
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vaccines are linked to a risk of intussusception among children. Age-stratified data 
on intussusception will be useful for interpreting whether any vaccine-associated 
risk exists and in calculating the number of cases that could be attributable to 
vaccines after their use in an immunization program (Yen et al., 2016). 
Table 5.  Future priorities for rotavirus vaccines and intussusception monitoring: 
recommendations from a meeting organized by The Rotavirus Organization of 
Technical Allies (ROTA) Council and its core partners, 23–24 July 2014, Washington, 
DC  
Source:  (Yen et al., 2016). 
2.5 Healthcare Seeking for Diarrhea in Children 
One fundamental reason for recognizing the predictors of healthcare seeking in a 
particular population is that they may offer information useful for increasing the 
uptake of healthcare services and enhancing child disease survival (Bayham et al., 
2017). For example, a delay of at least 4 hours in a caretaker’s seeking healthcare 
for a child’s diarrhea caused by cholera has been shown to increase the chance of 
death 17 times in patients in Nigeria ; mortality was especially pronounced among 
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those not reaching a healthcare facility for appropriate treatment (Djouma et al., 
2016).  
Dehydration caused by severe diarrhea is a major cause of morbidity and 
mortality among young children worldwide and even more so in Kenya (KDHS, 
2015), even though it can be easily treated with ORT (WHO, 2006). Early 
detection of dehydration, increasing food and fluid intake (including use of ORS), 
and seeking prompt medical attention when a child has dehydrating diarrhea are 
important factors in reducing child deaths (WHO, 2006, , 2005c; KDHS, 2015). 
Caretakers should prevent dehydration through early administration of increased 
amounts of appropriate fluids if available at home, including ORS (WHO, 2005c). 
Appropriate care-seeking behavior among caretakers of children who present at 
healthcare facilities with diarrhea and intussusception can influence disease 
outcome for both conditions (Qamar et al., 2016; Ogundoyin et al., 2016).  
Community-based surveys for diarrhea can help to determine population-based 
burden of disease and estimate the proportion of illness episodes that are ultimately 
either included or missed in hospital-based surveillance data (Burton et al., 2011; 
Breiman et al., 2014). As demonstrated in other settings (Breiman et al., 2014), since 
healthcare facility (hospital) surveillance data could underestimate the burden of 
disease, data from community-based surveys may provide a rate multiplier to adjust 
hospital surveillance data to account for disease episodes for which care was never 
sought (WHO, 2002). However, since children suffering from rotavirus diarrhea or 
intussusception disease cannot be diagnosed at the household level, establishing an 
active hospital-based surveillance system to provide pre- and post-vaccine data for 
rotavirus and intussusception could provide baseline data that would be useful in 
the evaluation of rotavirus vaccine safety (Cui et al., 2016). Current and accurate 
regional data describing caretakers’ healthcare-seeking behaviors for childhood 
diarrhea, the epidemiology of intussusception, and its burden in children are 
therefore needed to guide implementation and evaluation of rotavirus vaccines.  
2.5.1 Caretaker factors associated with care seeking 
Caretakers with higher education levels, people living in middle to higher ranges in 
the wealth index as suggested by income level and type of assets owned by a 
household, and mothers who are more alert to recognizing fever and vomiting as 
danger signs of disease have all been shown to be factors associated with increased 
likelihood of seeking care for a child’s diarrheal illness in Mozambique (Bayham et 
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al., 2017), Ethiopia (Adane et al., 2017), and several countries in Asia and sub-
Saharan Africa, including Kenya (Nasrin et al., 2013). Moreover, caretaker 
proximity to a healthcare facility, knowledge of community emergency plans, and 
greater alertness regarding the danger signs associated with severe disease have 
been shown to influence healthcare seeking for childhood diarrhea in Ethiopia 
(Bruce et al., 2014) and Kenya (Bigogo et al., 2010). However, qualitative data from 
India have also revealed that, when caretakers were shown pictures of danger signs 
like sunken eyes, reduced skin turgor, indrawn chest, rapid breathing, and bulging 
fontanel, care seeking was influenced by their “local beliefs,” which considered 
such symptoms untreatable by modern medicine alone (Awasthi et al., 2008). The 
same authors observed that use of traditional and home remedies were reasons for 
caretaker delays in seeking appropriate and timely medical care at a healthcare 
facility (Awasthi et al., 2008). Many caretakers of children with diarrhea in Kenya, as 
in other low- and middle-income countries, do not provide proper treatment to 
their children: supplying ORS and increasing fluid and food intake (Forsberg et al., 
2007; Ram et al., 2008). Despite the fact that sub-Saharan Africa and Asia are the 
two regions with the greatest burden of diarrheal disease among children 
(UNICEF, 2017), caretakers in parts of these areas have been shown to seek care 
for their child’s diarrhea only when the condition revealed life-threatening 
symptoms (Mbonye, 2003). Furthermore, more than half the countries in Asia and 
sub-Saharan Africa have recently shown either no significant improvement or a 
reduction in ORT coverage for diarrhea, and Kenya had the largest decrease in 
ORT use (Boschi-Pinto et al., 2009). 
2.5.2 Patient characteristics associated with care seeking 
Care seeking for childhood diarrhea has been shown to be more frequent for 
toddlers than infants and school-age children in Africa and Asia (Nasrin et al., 
2013). Young children who present with diarrhea accompanied with high-risk 
symptoms and clinical features that are perceived by caretakers to suggest severe 
disease, such as diarrhea with fever, have been shown to inspire care seeking more 
frequently than their counterparts, even in settings where medical care is free 
(Amarasiri de Silva et al., 2001; Breiman et al., 2011; Burton et al., 2011). However, 
in the absence of perceived severe signs of disease in a child with serious acute 
diarrhea, caretakers still tend to expect the presence of severe signs; otherwise, they 
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would most likely claim that diarrhea was not severe enough to warrant seeking 
care, especially in African settings. 
 
Figure 7.  Percentage change in use of ORT during two demographic and health surveys conducted 
from 1992- 2005.  
Source; (Forsberg et al., 2007).  
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Table 6.  Factors associated with seeking care for diarrhea among children under five: summary 
of evidence from observational studies. 
Reference, 
Country, World 
Region 
Age of 
study 
subjects 
Study design Outcomes assessed Main findings 
(Nasrin et al., 
2013), multisite 
study in 3 
countries in Asia 
and 4 countries in 
sub-Saharan 
Africa 
Children 
aged 0-
59 
months 
Randomized 
cross-sectional 
household 
survey 
To estimate the proportion of 
children with acute diarrhea 
who would present to sentinel 
health centers (SHCs) and to 
characterize healthcare seeking 
patterns 
Among children aged 0-11, 12-23 and 24-59 
months, proportions of children with acute 
diarrhea in 2-weeks prior to survey were; 0.7-
4.4%, 0.4-4.7% and 0.2-2.4% and the 
proportions for diarrhea that sought care  from 
a healthcare facility were; 15-56%, 17-64% 
and 7-33% across the age groups 
respectively. 
Caretakers perceived high cost of care and 
insufficient knowledge about diarrhea danger 
signs were associated with lack of any care-
seeking  
(Adane et al., 
2017), multiple 
surveys in 
Ethiopia, sub-
Saharan Africa 
Children 
< 5years 
Five rounds of 
community-
based cross-
sectional 
(house-hold) 
surveys study 
using multi-
stage 
systematic 
sampling 
method 
To assess the status of health 
facilities utilization and 
predictors for health-seeking 
behavior of mothers/caregivers 
of under-five children with acute 
diarrhea in slums of Addis 
Ababa, Ethiopia 
Maternal literacy, Caretakers who recognize 
fever and vomiting as danger diarrhea signs in 
???????????????????????? ???????????????????
$50, living within 15 minutes walking distance 
to the healthcare facility were significantly 
associated with health care-seeking 
(Das et al., 2013), 
Bangladesh, Asia 
Children 
< 5years 
A population-
based house-
hold survey 
To characterize caretakers 
health seeking behaviors for 
their child's diarrheal illness to 
inform hospital surveillance 
study design. 
Proportions of children <5years with acute 
diarrhea in 2-weeks prior to survey was 7% of 
whom  89% sought care outside home for the 
diarrhea. In general  50% sought care from a 
pharmacy and only 22.1% from a hospital or a 
healthcare facility. Caretakers perception that 
diarrhea was not severe enough and high cost 
of treatment were main reasons associated 
with not seeking care. 
(Burton et al., 
2011), rural 
western Kenya, 
sub-Saharan 
Africa 
Children 
< 5years 
A population-
based 
household 
survey 
To characterize healthcare-use 
and determine the proportion of 
diarrhea episodes not captured 
by health facility-based 
surveillance 
Proportion of under-five with diarrhea in two 
weeks was 14% of whom 33% sought care for 
acute diarrhea from at least a healthcare 
facility. Seeking healthcare at health facilities 
was more likely for children from households 
with higher socioeconomic status and with 
more symptoms of severe illness. 
2.5.3 Significance of care seeking for childhood diarrhea 
The primary benefit of community-based healthcare utilization surveys is that they 
can help determine what caretakers do if their children experience an episode of 
diarrhea, where caretakers take their children with diarrhea for treatment, the 
proportion of children with acute diarrhea who receive treatment at hospitals, and 
caretakers’ preferred healthcare facilities (WHO, 2008). Despite the relative 
importance of available diarrhea interventions, recognition of childhood diarrhea as 
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a cause of severe dehydration by caretakers remains stubbornly poor in low- and 
middle-income countries (Nasrin et al., 2013; Geldsetzer et al., 2014). This is a 
major problem for attempts to improve healthcare utilization in such settings 
(Geldsetzer et al., 2014). Poor healthcare utilization can also work against efforts to 
improve child survival. Diarrhea surveillance data from Kenya have shown that 
caretakers’ tendency to seek care first from non-licensed care providers can delay 
opportunities for early optimal intervention in appropriate healthcare facility 
settings (Breiman et al., 2012). It has been demonstrated that the introduction of 
rotavirus vaccine can reduce diarrhea-associated healthcare utilization and medical 
expenditures in other settings like the United States (Cortes et al., 2011). In Kenya, 
it has been estimated that a two-dose rotavirus vaccination series could avert 55% 
of deaths, 65% of hospitalizations, and 59% of clinic visits due to the disease (Tate, 
Rheingans et al., 2009). However, refusal of admission and delay in seeking care for 
MSD among caretakers of children under five have been shown to be associated 
with child death in Pakistan (Qamar et al., 2016). Care-seeking patterns in a 
catchment population is therefore an important indicator of appropriateness of 
settings for rotavirus surveillance activities to support estimates of AGE and 
RVAGE disease burdens before and after rotavirus vaccine introduction (WHO, 
2008, , 2005a). The most important threat posed by diarrhea in patients, regardless 
of age, is dehydration (WHO, 2018a). Rotavirus is the most common cause of 
severe dehydrating diarrhea in children under five (WHO, 2005c) and has been 
shown to account for the majority of MSD in children living in low- and middle-
income countries in Asia and sub-Saharan Africa (Kotloff et al., 2013). During an 
MSD episode, especially when rotavirus appears in the causal pathway, the rapid 
loss of water and electrolytes (sodium, chloride, potassium, and bicarbonate) 
through liquid stools, vomit, sweat, urine, and fast breathing leads to severe 
dehydration (WHO, 2018a). Since care-seeking behaviors and treatments for 
children with dehydrating diarrhea can vary considerably in different geographical 
settings and globally (WHO, 2008; Nasrin et al., 2013), updating knowledge on 
care-seeking patterns for children with diarrhea in a rotavirus surveillance setting is 
important. This information can help researchers and diarrhea intervention 
planners acknowledge the attitudes and practices of the local population regarding 
pediatric gastroenteritis (WHO, 2008) and provide crucial evidence to inform child 
survival intervention programs (Geldsetzer et al., 2014).  
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2.6 Healthcare Seeking for Intussusception in Children 
Intussusception is an emergency condition that requires urgent care seeking, 
diagnosis, and treatment to avoid unfavorable outcomes (Jenke et al., 2011). 
Symptoms associated with intussusception like vomiting, bloody stool, and 
abdominal pain are classic indicators of severe disease, as documented in literature 
reviews (Mpabalwani et al., 2017). Delays in care seeking and prompt medical 
intervention when a child presents with such symptoms may cause the illness to 
become more severe and can even lead to death (Gudeta, 1993; Lehnert et al., 
2009). 
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3 AIMS OF THE STUDY 
The purpose of this study was to estimate the burden of diarrheal illness among 
children under five years old before the introduction of rotavirus vaccines in Kenya 
and to provide baseline information on healthcare seeking, prevalence, 
hospitalizations, and potential complications of childhood diarrhea to help evaluate 
the impact of the implementation of a rotavirus vaccine program in Kenya. These 
data may also guide development of other interventions aimed at reducing 
morbidity and mortality associated with childhood diarrhea in Kenya. 
The specific objectives were: 
1. To estimate diarrhea prevalence and describe caretakers’ knowledge, 
attitudes, perceptions of illness, and patterns for seeking care from health 
facilities for young children with MSD in rural western Kenya and to 
evaluate factors associated with healthcare-seeking behavior (Study I). 
2. To estimate the population-based baseline incidence rates of AGE overall 
and RVAGE in particular, including associated hospitalizations and deaths 
among children under five in rural western Kenya (Study II). 
3. To assess factors associated with RVAGE among young children with MSD 
and describe the severity of illness in rural western Kenya (Study III). 
4. To describe the pre-rotavirus vaccine epidemiology and to evaluate factors 
associated with intussusception-related deaths among patients under five 
treated at emergency referral hospitals in Kenya (Study IV). 
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4 METHODS 
4.1 Study Settings 
Kenya is located in East Africa, between 5°S and 5°N latitude and 23°E and 31°E 
longitude. It has 400 kilometers of shoreline along the Indian Ocean and was 
divided into eight provinces until a 2010 constitutional reform. Nyanza, one such 
province, is located in the western part of the country, bordering Uganda to the 
northwest and Tanzania to the southwest (Figure 8). Studies I–III were conducted 
in Nyanza within an existing Health and Demographic Surveillance System (HDSS) 
area operated by the Kenya Medical Research Institute (KEMRI) in partnership 
with the CDC (Figure 8). The fourth study (IV) was conducted at Kenya’s leading 
referral hospitals, which are mainly operated by the Kenyan Ministry of Health 
(KMoH) or private hospitals located in the major towns of Nairobi, Mombasa, 
Kisumu, Nakuru, Eldoret, Kakamega, and Thika (Figure 9). 
 
Figure 8.  A series of maps showing Kenya’s location in Africa, the former Nyanza province location 
in western Kenya, and the locations of KEMRI–CDC jointly operated HDSS study areas 
(Asembo, Gem, and Karemo), where Studies I–III were conducted. 
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Figure 9.  Major towns and locations of the intussusception surveillance study (IV) sites in Kenya. 
4.1.1 Health and Demographic Surveillance System (HDSS) 
The HDSS study site jointly operated by KEMRI and CDC is situated about 60–65 
kilometers west of Kisumu and is managed from the KEMRI and CDC research 
station located 15 kilometers west of Kisumu (Figure 8). The KEMRI and CDC 
research partnership began in 1979 as a malaria and vector biology research center, 
but it has since expanded and currently known as the KEMRI Center for Global 
Health Research (CGHR). It now includes programs focusing on infectious 
diseases such as diarrhea, tuberculosis, HIV/AIDS, a refugee health program, and 
an HDSS. The HDSS initially started in Asembo in 2001, added Gem in 2002, and 
expanded to Karemo in 2007 (Figure 8). The HDSS area covers approximately 700 
km2 (Asembo ~200 km2, Gem ~300 km2, and Karemo ~200 km2). HDSS 
surveillance commences with baseline census enumeration, after which field 
workers visit the enumerated households three times a year to conduct a census of 
the population and update population denominators that are then used to estimate 
and extrapolate disease rates. The regular household census visits are used to 
update data on resident demographics and to capture vital events like births, 
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deaths, educational attainment changes, ownership of household assets, marital 
status, immunization status for children, causes of death through verbal autopsy 
(VA), in and out migration, and other health events such as diarrhea episodes 
among adults and children under five years old. Asembo, Gem, and Karemo 
residents comprise a culturally homogeneous population; more than 98% are 
members of the Luo ethnic group, and most people live in dispersed settlements. 
Houses are made of mud, cement, or brick with roofs of iron sheets or thatched 
grass (Ombok et al., 2010). These houses are predominantly clustered in 
compounds made up of houses for the male head of household, his wives, and his 
unmarried sons. The compounds are dispersed and lie next to the households’ 
agricultural fields (Adazu et al., 2005). In general, Gem and Karemo are hillier than 
Asembo, but all the three areas consist of gentle hills drained by small seasonal 
streams that drain into Lake Victoria (Ombok et al., 2010). Although all houses 
were mapped using a global positioning system (GPS) as part of the original 
insecticide-treated bednets (ITNs) trial (Hightower et al., 1998), maps were 
updated at least annually to take account of new construction; a unique location 
code was also painted on each house to identify the village, compound, specific 
house, and individual residents of the household (Adazu et al., 2005). Most HDSS 
residents earn their living through small-scale business, farming, or fishing 
(Lindblade et al., 2004). There are few paved or public transport roads in the area, 
so walking is the main means of transport (Ombok et al., 2010). The primary 
source of drinking water is the polluted Lake Victoria and nearby streams and 
rivers (Tate, Rheingans et al., 2009). 
4.1.2 Global Enteric Multicenter Study (GEMS) 
The GEMS was a prospective, age-stratified, matched case-control study of MSD 
among children under five years of age residing in well-defined populations at four 
sites in sub-Saharan Africa and three in South Asia (Levine et al., 2012). Cases with 
MSD seeking care at SHCs were recruited along with one to three randomly 
selected matched control children without diarrhea of the same age, gender, and 
residential location. A GEMS case was defined as a patient enrolled with MSD at a 
study clinic within 7 days of illness onset; MSD was defined as 3 or more loose 
stools in 24 hours with at least 1 of these characteristics: sunken eyes, skin tenting, 
dysentery, IV rehydration, or hospitalization. The GEMS Kenya study was 
conducted in Asembo and Gem for the first three years and in Asembo and 
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Karemo in the fourth year. Together, these areas form the jointly operated KEMRI 
and CDC HDSS study area (Figure 8). The GEMS Kenya setting and the HDSS 
have been described in detail elsewhere (Adazu et al., 2005; F. O. Odhiambo et al., 
2012), as have the GEMS rationale (Levine et al., 2012) and the clinical (Kotloff et 
al., 2012) and laboratory (Panchalingam et al., 2012) methods employed. 
The 2008 mid-year population of the HDSS at the start of our rotavirus 
surveillance among GEMS cases was 225,064, of whom 16.7% were children  
under five and 5.3% were adults 65 or older; females comprised 47.1% of cases, 
with a male-female ratio of 1:1.2 (unpublished data from the KEMRI and CDC 
jointly operated HDSS). 
The GEMS collected clinical and epidemiological data, anthropometric 
measurements, and fecal samples to identify enteropathogens at enrollment; a 
single home visit was made approximately 60 (range: 50-90) days later to ascertain 
vital status, clinical outcome, and interval growth. As part of GEMS and HDSS 
activity, we conducted healthcare utilization and attitude survey (Study I) in the 
Asembo and Gem HDSS areas. Rotavirus surveillance among GEMS cases (Study 
III) was subsequently performed in the Asembo, Gem, and Karemo HDSS areas, 
where GEMS Kenya MSD cases were enrolled from.  
4.1.3 Healthcare delivery and referral system in Kenya 
Kenya’s healthcare system is structured in a stepwise manner (Figures 10); 
complicated cases are referred to higher levels in the system (KMoH, 2014). 
Although some county referral hospitals may have had pediatric surgeons or 
medical specialists referred to as consultants, it is the top referral hospitals that 
have long been observed to be well equipped with these specialists and the 
diagnostic facilities  needed to provide specialized care of the kind demanded by 
intussusception. Therefore, intussusception surveillance (Study IV) was conducted 
at selected Kenyan referral hospitals (Figures 9 and 10) due to their ability to 
handle referrals related to pediatrics and the public knowledge that these facilities 
have resident pediatrician consultant surgeons who deal with child health 
complications. 
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Figure 10.  Organization of health service delivery and referral system in Kenya 
Source:  (KMoH, 2014). 
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4.2 Epidemiologic Study Designs 
The objectives, study settings, targeted population, epidemiological designs 
(including surveillance periods), and specific case definitions for the investigations 
conducted in this thesis are summarized in Table 7. Specific details for each study 
are described in separate sections below. 
4.2.1 Survey methods for estimating rates of healthcare seeking and 
prevalence for diarrhea (Study I) 
As part of the GEMS Kenya study, we performed a one-time detailed baseline 
population randomized sample cross-sectional survey referred to as the healthcare 
utilization and attitudes survey (HUAS) and repeated a shorter version called 
HUAS-Lite. The HUAS-Lite was a brief healthcare utilization survey conducted 
serially three times a year during the 2008–2011 period in concert with each round 
of the HDSS household census visits, using a whole population survey of resident 
children aged 0–59 months as denominator. The parent or primary caretaker of 
each child enrolled in each survey was asked whether the child had experienced a 
new episode of diarrhea during the preceding seven days, whether any signs and 
symptoms had presented during the diarrheal illness, whether they sought care 
outside the home, and, if so, where they sought care, including home management, 
for the child’s diarrhea illness. By pooling the data from serial surveys and based on 
the number of children in each age-gender stratum in the HDSS population, we 
calculated the proportion, designated as r (the rate multiplier), of children with any 
diarrhea and MSD (based on the MSD case definition) who were at least taken to a 
health facility within seven days of diarrhea illness onset during each round of the 
survey. 
4.2.2 Rotavirus surveillance among the GEMS Kenya case population 
(Study III) 
We used the initial HUAS baseline data to identify health facilities where caretakers 
preferred to seek care for their child’s diarrhea illness. We used data from the 
subsequent HUAS-Lite rounds to monitor the SHCs and healthcare seeking in the 
HDSS area during the GEMS-based rotavirus surveillance period. We used 
prospective, hospital-based surveillance to enroll children with MSD who visited 
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those SHCs for care from 2008 to 2012 to participate in our GEMS Kenya 
rotavirus surveillance and risk factor study (Study III).  
Case definition: a GEMS rotavirus surveillance study case was defined as a child 
enrolled in a GEMS clinic within 7 days of illness onset, with 3 or more loose 
stools in 24 hours with at least 1 of these characteristics: sunken eyes, skin tenting, 
IV rehydration, or hospitalization. This study was conducted in Asembo, Gem, and 
Karemo (Figure 11). 
 
Figure 11.  Locations of GEMS Kenya SHCs where the rotavirus surveillance (Study II) was 
conducted. 
4.2.3 Rotavirus surveillance in the HDSS-hospitalized population (Study II) 
Siaya County Referral Hospital (SCRH), formerly known as Siaya District Hospital, 
is the only public inpatient health facility located within easy reach from almost 
every location in the Karemo HDSS, due to a superior road network. Therefore, as 
part of the HDSS, we conducted a prospective, hospital-based inpatient 
surveillance study for rotavirus (Study II) at SCRH. The study targeted children 
under five admitted to SCRH using the WHO’s common protocol for rotavirus 
surveillance network countries, which has been described in detail elsewhere 
(WHO, 2008). In our study, AGE cases were defined as residents of the Karemo 
HDSS study area aged 0–59 months (Figures 8 and 11) who were hospitalized in 
the SCRH inpatient department with AGE, which was further defined as 3 or 
more looser-than-normal stools and/or 1 or more episodes of unexplained 
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vomiting followed by loose stool within a 24-hour period within the 7 days before 
seeking healthcare. Informed consent was obtained from caretakers of the eligible 
AGE cases before enrollment during the study period from 1 January 2010 to 31 
December 2013. 
4.2.4 Intussusceptions among pediatric patients in Kenya (Study IV) 
Data on intussusception from across Kenya were obtained retrospectively from 1 
January 2002 through 31 October 2013. The study sites were located at 12 
geographically dispersed leading referral hospitals in Kenya (Figure 9). We 
reviewed hospital records for patients diagnosed with intussusception from January 
2002 through October 2013. The review at each hospital varied based on when 
records were available and the filing system for patient records. 
An intussusception case was defined as a diagnosis of intussusception 
confirmed in the records of a patient under five years old who met the Brighton 
Collaboration level 1 criteria (Bines et al., 2004): “pediatric patients diagnosed with 
intussusception clinically and confirmed through imaging and/or at surgery at the 
time of admission or any time during hospital stay at the study sites”. Clinical case 
definition for diagnosis of acute intussusception is further detailed elsewhere 
(Bines et al., 2004). 
4.2.5 Data collection and management 
For the initial baseline HUAS and subsequent HUAS-Lite surveys (Study I), we 
collected demographic, clinical, epidemiological, and household information, 
including caretaker healthcare-seeking behaviors at enrollment.  
In the rotavirus surveillance studies (II and III), we collected clinical, 
household, environmental, and epidemiological data, along with stool samples, to 
identify rotavirus at enrollment. In Study III, a single follow-up home visit was 
made approximately 60 days (the targeted range was 50–90 days) following 
enrollment to assess each child’s health outcome after the acute diarrheal illness, as 
described elsewhere (Kotloff et al., 2012). For the HUAS-lite (part of study I) and 
study II at SCRH, we used a paperless questionnaire that was programmed into 
personal digital assistants or netbooks. The subsequent HUAS-Lite serial surveys 
were conducted during the GEMS case-control study, along with the routine 
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census surveys undertaken by the DSS team  as described elsewhere (F. O. 
Odhiambo et al., 2012). 
For the initial baseline HUAS part of Study I and the rotavirus surveillance among 
GEMS Kenya cases (Study III), demographic characteristics, clinical features, and 
illness history data were recorded on optical character recognition-enabled forms 
and then scanned and imported into a SAS software package. For the 
intussusception surveillance (Study IV), paper-based case report forms (CRFs) 
were used to abstract patients’ demographic characteristics, clinical features, illness 
histories, surgical options, and outcome information from medical records and 
theater logbooks. Data were collected by the pediatric surgeons who managed the 
surgical clinics and wards at each study site. After manual accuracy checks, data 
were entered into a Microsoft Access database and imported into SAS. 
4.3 Stool Sample Collection and Laboratory Methods (Studies II 
and III) 
The stool samples from the study participants were collected according to standard 
microbiology laboratory techniques. Whole stool collection was achieved via sterile 
plastic containers provided with screwcaps and spoons. Cary Blair Transport Media 
were used to preserve samples. Rotavirus was detected in the whole stool 
specimens collected from patients enrolled in Studies II and III by a well-validated 
commercial enzyme-linked immunosorbent assay (ELISA) (ProSpecT Rotavirus 
Kit, Basingstoke, Oxford, UK). Detailed laboratory methods for Study II (Khagayi 
et al., 2014) and Study III (Panchalingam et al., 2012) have been described 
elsewhere. Laboratory results were then linked to epidemiology data through 
unique HDSS identifiers before further analysis. 
4.4 Statistical Analysis 
4.4.1 Descriptive analysis 
For each HUAS-Lite survey, we estimated a two-week period prevalence of any 
diarrhea, MSD, proportion of diarrhea, and MSD seeking care outside the home, 
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and specifically from at least an SHC for Study III. Proportions and 95% CIs were 
calculated. The Cochran-Armitage test for trend was used to examine rate 
differences across rounds (Armitage, 1955). We used chi-square tests to examine 
associations between the characteristics of the child, caretaker knowledge, caretaker 
attitude, caretaker healthcare-seeking behaviors, clinical features, environmental 
factors, occurrence of any diarrhea, seeking care outside the home, use of ORS at 
home, and seeking care from a health facility. Similarly, we compared child and 
caretaker characteristics between rotavirus and non-rotavirus cases and occurrence 
of death preceding intussusception treatment and survival among children under 
five. Unadjusted odds ratios (ORs) and 95% CIs were used to assess the strength 
of the associations between categorical variables. We used Fisher’s exact test to 
compare characteristics of intussusception patients who died with those who 
survived. Medians were compared using the Wilcoxon rank sum test. For all 
statistical tests, a 2-sided p < 0.05 was considered statistically significant.  
4.4.2 Analysis of severity of diarrheal disease associated with rotavirus 
infection 
For Study II, we adapted the 20-point full scale analysis developed by Ruuska and 
Vesikari (Ruuska & Vesikari, 1990) to assess the severity of rotavirus diarrhea. For 
rotavirus severity analysis from GEMS rotavirus surveillance study cases in Study 
III, we applied a 17-point scoring system, referred to in this analysis as the GEMS-
modified Vesikari score system, which was adapted from the 20-point scale. Scores 
were calculated based on symptoms of diarrheal illness and the child’s 
characteristics at enrollment.  
4.4.3 Calculation of hospitalization and mortality rates for all-cause AGE 
and RVAGE 
4.4.3.1 Hospitalization rates for AGE and RVAGE 
As described elsewhere (Breiman et al., 2014), we used the person-years of 
observation (PYOs) contributed by all children under five who were residents of 
the Karemo region during the study period as the denominator. We limited our 
rate calculations to the Karemo area of the HDSS, as it has been shown to be 
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representative of the entire HDSS area and the immediate catchment population of 
SCRH, where our participants were enrolled. PYOs were calculated by totaling 
person-time for all children aged 0–59 months who met the HDSS residency 
requirement during the 4-year study period from 1 January 2010 or date of 
enrollment (if later) until they exited or lost their residency status through out-
migration or death; alternatively, they ceased being observed due to loss to follow-
up or reached the end of the observation period, set in this analysis at 31 
December 2014. HDSS residents who moved out of the HDSS area for four 
consecutive months were excluded from both the denominator and numerator. 
However if a new resident moved into or a former resident moved back to the 
study area and lived there for at least four consecutive months, that person was re-
enrolled to participate in the HDSS as a resident, and his or her PYOs were 
counted in this study.  
The crude incidence rates of AGE-associated hospitalization were calculated by 
dividing the total number of AGE hospitalizations by the PYOs contributed by 
children 0–59 months for the period that they met residency criteria for the HDSS, 
multiplied by 100,000 (and thus presented as cases per 100,000 PYOs). The crude 
rate of rotavirus-associated hospitalization was calculated by dividing the total 
rotavirus-positive AGE hospitalizations for those under five by the PYOs during 
the study period.  
We used two incidence rate adjustments. First, to account for possible bias 
arising from missed AGE case detection, we multiplied the crude rate of AGE and 
RVAGE by the proportion of all inpatients who met the stool collection criteria, 
whether a sample was collected or not. The second adjustment accounted for 
children with AGE or possibly RVAGE and who did not reach a healthcare 
facility, as reported from repeated healthcare utilization and diarrhea attitude 
surveys that were conducted alongside census household visits during the hospital 
surveillance study period. For this adjustment, we further multiplied the rate of 
AGE and RVAGE hospitalizations by the proportion of those who sought care 
for AGE from a healthcare facility, as reported from the household healthcare 
utilization survey. The products are reported as the final adjusted incidence rates 
for AGE and RVAGE. The 95% CIs were calculated around crude rates using the 
PEPI software method (Abramson, 2011) and around adjusted rates using the 
Delta method (Long, 2005 ; WHO, 2008). We categorized the participants as 0–5 
months, 6–11 months, 12–23 months, 24–59 months, 0–11 months, and 0–59 
months.  
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4.4.3.2 AGE and RVAGE mortality rates 
Deaths were recorded at the household level through regular interviews with 
HDSS residents. Diarrhea as a cause of death was derived from VA, using a 
validated VA methodology (Byass et al., 2015). The VA methodologies, coding, 
and interpretation used in our study are described elsewhere (Byass et al., 2012). 
Upon the death of an HDSS resident, a village-based reporter sent a notification. 
After allowing for a mourning period of at least three weeks, an interviewer 
approached the most appropriate interviewee who was closest to the deceased to 
administer a detailed questionnaire on the deceased’s final disease, signs, 
symptoms, and medical history. The data were collected electronically, validated, 
and processed using an Inter-VA program, which is a probabilistic computer-based 
expert opinion algorithm that determines the most probable cause of death (Byass 
et al., 2012). We calculated the number of deaths attributable to rotavirus by 
multiplying the total deaths among HDSS residents under five years old in the 
study area by the proportion of deaths attributable to diarrhea by VA and the 
proportion of hospitalized AGE episodes attributable to rotavirus in that specific 
age group, as shown below.  
Number of deaths 
attributable to RV = 
(Total under-five deaths among HDSS residents in study area) 
* (proportion of deaths attributable to diarrhea) 
* (proportion of hospitalized AGE episodes attributable to RV)  
Mortality rates associated with RVAGE were obtained by dividing the number of 
deaths attributed to rotavirus by the total PYOs in each age group, as adopted 
from the WHO (WHO, 2005a) and described above. 
4.5 Ethical Considerations 
The HUAS and HUAS-Lite (Study I) and prospective health facility-based 
rotavirus surveillance among GEMS cases (Study III) were sub-studies conducted 
under the GEMS protocol, which was reviewed and approved by the institutional 
review boards (IRBs) of KEMRI, the University of Maryland School of Medicine 
(UMB), and the CDC through deferral to UMB (KEMRI IRB Protocol 
#1801/1155; CDC IRB Protocol #3308; UMB IRB Protocol #HP-00040030). 
The HDSS hospital (inpatient) rotavirus surveillance (Study II) was approved by 
the KEMRI and CDC IRBs as part of the KEMRI HDSS protocol (KEMRI IRB 
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Protocol #1801). The intussusception study protocol (Study IV) was reviewed and 
approved by the IRB of the Kenyatta National Hospital (Protocol 
#P514/09/2012). For each study, written informed consent was obtained from 
every parent or primary caretaker of each case child who met eligibility criteria 
before any research activity was performed. In cases where the parent or primary 
caretaker was illiterate, an impartial third party witnessed the consenting process 
and signed the consent document after the caretaker made an informed decision. 
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5 RESULTS 
5.1 Healthcare Utilization and Knowledge, Attitude, and Practice 
Surveys (Study I) 
5.1.1 Baseline prevalence of diarrhea among children under five in the 
HUAS population (Study I) 
During the initial baseline HUAS conducted between April and May 2007, 1,043 
caretakers of children under five participated in the survey (Figure 12). Our 
weighted analysis of the baseline HUAS estimates showed that, of the 
approximately 20,000 children under five living in the HDSS during that study 
period, 4,612 (22%) had any diarrhea and that 3,155 (68%) of those cases met the 
MSD case definition. Figure 12 details the enrollment flow for the HUAS study. 
5.1.2 Caretaker knowledge of, attitudes about, and perceptions of illness 
In the 2 weeks preceding the survey, 275 children had any diarrhea reported by 
their caretakers; of those, 82.2% had 3–6 loose stools per day. We asked the 
caretakers of all 1,043 children who participated in the survey what they would 
look for to see whether a child was dehydrated; 716 (68.6%) indicated that they 
would look for lethargy, 481 (46.1%) sunken eyes, 369 (35.4%) wrinkled skin, 297 
(28.5%) dry mouth, and 297 (28.5%) thirst. In total, only 206 (19.8%) of the 1,043 
caretakers said they would look for both thirst and dry mouth to see whether a 
child was dehydrated. Furthermore, when we asked the 1,043 caretakers about who 
makes the decision to take a sick child to a healthcare facility, 809 (78%) of 1,041 
respondents at baseline responded with the child’s mother, while 232 (22%) said 
other relatives, including the child’s father, make the decision. We asked all 1,043 
caretakers who participated in the baseline HUAS if they thought that vaccines 
were important to their child’s health; 99% answered in the affirmative. 
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We asked caretakers of children with any diarrhea what they offered the child to 
eat and drink during the diarrheal illness. Of the 275 children with any diarrhea, 41 
(15%) of caretakers said they offered the child more to drink than usual, 51 (19%) 
reported offering the usual amount, and 183 (67%) reported that they offered the 
child less than usual to drink. Of those offered less than usual, 96 (52%) were 
offered somewhat less, 69 (38%) much less, and 18 (10%) were offered nothing to 
drink during their diarrheal illness. Of 269 caretakers who reported what they 
offered their child to eat during the diarrheal episode, 3 (1%) offered more than 
usual, 43 (16%) the usual amount, and 223 (83%) less than usual. Of those who 
offered less than usual, 74 (33%) offered somewhat less, 67 (30%) offered much 
less, and 82 (37%) offered nothing to eat during the diarrhea illness. According to 
their caretakers, 66 (37%) of the 180 and 77 (35%) of the 220 children who were 
offered less than usual to drink and eat, respectively, had vomiting accompanying 
the diarrhea episode. We estimated that 2,822 (89%) of children with MSD (3,155) 
in the HDSS sought care outside the home, 1,683 (60%) of whom reached a 
healthcare facility as a source of care for that MSD episode. 
5.1.3 Symptoms in children with any diarrhea and illness outcomes 
Most caretakers (86.2%) of the 275 children said that those who had an episode of 
any diarrhea in the preceding 2 weeks had 3 to 6 loose stools per day. The main 
symptoms they reported included lethargy (n = 225, 81.8%), fever (n = 201, 
73.1%), being very thirsty (n = 193, 70.7%), mucus or pus in stool (n = 194, 
70.6%), dry mouth (n = 188, 68.4%), rice-watery stool (n = 163, 59.7%), sunken 
eyes (n = 162, 58.9%), decreased urination (n = 102, 40.2%), wrinkled skin (n = 
92, 33.7%), vomiting (n = 89, 32.7%), coma or loss of consciousness (n = 67, 
24.6%) and blood in stool (n = 34, 12.4%). Overall, 6.7% of children with any 
diarrhea were hospitalized, and 47% of the hospitalized cases received IV fluids. 
Seeking healthcare outside the home for diarrheal illness was less common for 
infants than for children aged 24-59 months (aOR 0.33, CI: 0.12-0.87). 
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Figure 12.  Study enrollment flow diagram for the initial cross-sectional HUAS of caretakers of children 
under five in western Kenya, 25 April–9 May 2007. 
5.1.4 Factors associated with children seeking care for diarrhea from a 
healthcare facility (Study I) 
Factors that were associated with seeking care for diarrhea from any healthcare 
facility are shown in Table 8. In summary, seeking care for any diarrhea from a 
healthcare facility was observed to be significantly more common among infants 
than school-age children, children whose caretakers had formal education, children 
whose caretakers offered no remedies at home, and those who presented with 
severe symptoms, particularly lethargy, during the diarrhea episode. 
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Table 8.  Factors associated with seeking care from a health facility for children under five with 
any diarrhea in the HUAS in western Kenya, 2007* [N = 214]. 
Variable† Sought care outside home 
for any diarrhea at a health 
facility 
Unadjusted Odds 
Ratio  
(95% CI§) 
Adjusted  
Odds Ratio‡ 
(95% CI) 
 n/N Weighted %   
Child’s age group 
0-11 months 
12-23 months 
24-59 months 
 
53/76 
46/90 
24/48 
 
69.7 
51.8 
49.98 
 
2.30 (1.08–4.93) 
1.08 (0.52–2.22) 
Reference 
 
5.06 (1.88–13.61) 
1.35 (0.57–3.21) 
Reference 
Child’s gender 
Male 
Female 
 
77/123 
46/91 
 
54.7 
54.5 
 
1.03 (0.59–1.80) 
 
 
0.65 (0.32–1.34) 
 
Caretakers education 
???? ?????????????????????????????????? 
<Primary school (no formal education) 
 
67/104 
56/110 
 
65.1 
44.2 
 
2.35 (1.25–4.44) 
 
3.32 (1.56–7.07) 
Caretakers looks to see if the child is thirsty to 
assess dehydration 
Yes 
No 
 
 
34/65 
89/149 
 
 
43.3 
59.4 
 
 
0.52 (0.27–1.03) 
 
 
 
0.21 (0.09–0.47) 
 
Caretaker perceives that blood in stool can 
cause harm or death in a child 
Yes 
No 
 
 
112/186 
11/28 
 
 
57.9 
31.8 
 
 
2.95 (1.15–7.60) 
 
 
 
3.25 (1.16–9.09) 
 
Caretaker never endures circumstances that 
make it difficult to reach their health facility of 
choice 
Yes 
No 
 
 
 
32/42 
91/172 
 
 
 
69.7 
50.6 
 
 
 
2.25 (0.93–5.44) 
 
 
 
 
3.90 (1.47–10.35) 
 
Lethargy as a symptom during diarrheal illness 
Yes 
No 
 
 
112/185 
11/29 
 
 
57.6 
36.1 
 
 
2.41 (0.92–6.30) 
 
 
5.73 (1.79–18.42) 
 
Child was offered ORS at home for diarrheal 
illness 
Yes 
No 
 
 
43/56 
80/158 
 
 
75.5 
46.8 
 
 
3.50 (1.57–7.84) 
 
 
6.99 (3.01–16.22) 
 
Child was offered no special remedies at home 
for diarrheal illness 
Yes 
No 
 
 
22/27 
101/187 
 
 
79.1 
50.4 
 
 
3.73 (1.17–11.86) 
 
 
 
10.17 (2.84–36.37) 
 
*Weighted analysis. †Based on the inclusion criteria, 14 variables were initially included in the model with results shown for the significant variables, 
controlling for age and gender. §Confidence interval. ‡Adjusted OR, whereby all ORs control for other factors in the model. 
5.1.5 Factors associated with ORS use among children with any diarrhea 
(Study I) 
Most (89.5%) caretakers of children with diarrhea indicated that ORS works well in 
treating it. However, only 63 (22.9%) of the 275 children with diarrhea of any 
severity were offered ORS at home, according to their caretakers. A higher 
proportion of children with MSD (46 of 182, 25.3%) than those with just any 
diarrhea (17 of 93, 18.3%) were offered ORS at home (p > 0.05).  
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We examined factors associated with the use of ORS at home for the child’s 
diarrheal illness. In the multivariate weighted analysis from the baseline HUAS, 
caretakers were less likely to use ORS at home for infants than for older children 
(aOR 0.35, CI: 0.14–0.89). However, they were more likely to use ORS at home if 
the primary caretaker had some formal education than those whose caretakers had 
informal education (aOR 3.01, CI: 1.41–6.42), if the caretaker perceived that 
dehydration could result in harm or death (aOR 5.54, CI: 2.23–13.73), if the child 
?????????????? 3 times per day during their diarrheal episode (aOR 3.33, CI: 1.56–
7.11), if the caretaker knew of a child who had died of bloody diarrhea (aOR 2.73, 
CI: 1.20–6.20), if the child was offered the usual or less than usual amount to eat 
during the diarrheal episode (aOR 8.24, CI: 1.80–37.73), and if the caretaker 
believed that breastfeeding prevents diarrheal illness (aOR 16.19, CI: 1.32–199.21). 
5.1.6 HUAS-Lite 
From 22 May 2009 through 31 August 2011, we conducted seven whole 
population-based cross-sectional surveys, repeated at least two or three times each 
year as part of the HUAS extension (Study I; see Table 9). The enrollment flow is 
detailed in Figure 13. In brief, a 2-week period prevalence of any diarrhea in the 
HDSS decreased from 22% at the baseline HUAS in 2007 to 3% in 2011, while 
that of MSD increased significantly from 68% to 73%, and the proportion of 
children seeking care for MSD from a healthcare facility increased from 60% to 
79% during the same surveillance period. The overall proportion of children aged 
0–59 months seeking care for MSD from a healthcare facility during the hospital 
surveillance (Studies II and III) was 64%. The HUAS-Lite data further revealed 
that the rate of seeking care for MSD from a healthcare facility was highest for 
children aged 6–11 months (70%), followed by 0–5 months (69%), 12–23 months 
(66%), and 24–59 months (57%) during the rotavirus hospital-based surveillance 
(Studies II and III) period. The proportion and trends of any diarrhea, MSD, and 
healthcare seeking for MSD are further detailed in Table 9. 
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Figure 13.  HUAS-Lite study enrollment profile in western Kenya, 22 May 2009–31 August 2011. 
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5.2 All-Cause- and Rotavirus Diarrhea-Associated 
Hospitalization and Mortality Rates (Study II) 
From 1 January 2010 to 31 December 2013, 7,760 all-cause hospitalizations for 
children aged 0–59 months living in the 3 HDSS areas were registered at SCRH. 
The enrollment flow for the rotavirus surveillance in Study II is shown in Figure 
14. In general, the proportion of all-cause hospitalizations associated with AGE 
decreased in each subsequent year of the study. However, the proportion of AGE 
decreased with increases in child age (Table 10). RVAGE-associated 
hospitalizations were highest in 2010 and increased by decreases in child age in a 
pattern very similar to the reduction in AGE-associated hospitalizations (Table 10 
and Figure 21). 
In brief, our prospective hospital-based rotavirus surveillance data (Study II) 
showed that 21% of the overall hospitalizations in children were due to AGE of all 
causes and that 26% of hospitalized AGE patients were rotavirus-positive 
(RVAGE) during the study period. Consistent with the data presented in Table 10, 
our data further revealed that both all-cause AGE- and RVAGE-specific 
hospitalizations were most commonly observed in infants and that rotavirus 
infection was less likely in older children. 
Table 10.  Characteristics of children under five hospitalized at SCRH with all-cause morbidity, 
AGE, and RVAGE in the Karemo HDSS area in western Kenya, 2010—2013. 
Characteristics All Cause 
Hospitalizations 
from Karemo DSS 
(N=3793) 
AGE 
Hospitalizations 
(N=805) 
AGE specimen 
collected and  
tested for RV ? 
(N=544) 
Proportion tested 
RV Positive 
(N=143)  
Sex n n (row%) n (row%) n (row%) 
Male 2066 461 (22%) 312 (70%) 87 (28%) 
Female 3793 344 (20%) 232 (67%) 56 (24%) 
Year     
2010 920 224 (24%) 149 (67%) 43 (29%) 
2011 1335 313 (23%) 207 (66%) 53 (26%) 
2012 822 147 (18%) 93 (63%) 26 (28%) 
2013 716 121 (17%) 95 (79%) 21 (22%) 
Age (Months)     
0-5 536 205 (38%) 143 (70%) 45 (31%) 
6-11 781 285 (36%) 204(72%) 57 (28%) 
12-23 1110 205 (18%) 139 (68%) 30 (22%) 
24-36 687 70 (10%) 40 (57%) 9 (23%) 
37-59 679 40 (6%) 18 (45%) 2 (11%) 
?Three samples were not tested due to inadequate stool. 
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Figure 14.  Flow diagram of Karemo DSS residents under five who were hospitalized and enrolled in 
the study from SCRH, western Kenya, 2010–2013. 
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Figure 15.  Rotavirus-positive cases among AGE-hospitalized children under five among Karemo 
HDSS residents population seeking care from SCRH, western Kenya, 2010–2013. 
We calculated all-cause and rotavirus diarrhea-associated hospitalization rates using 
PYOs from the HDSS. We further adjusted the rates by using population-based 
data on healthcare utilization and the proportion of stools collected from patients 
who met the case definition at the surveillance hospital. Mortality rates for 
RVAGE were calculated by applying the percentage of those positive for rotavirus 
among AGE hospitalizations to estimated diarrhea deaths. The overall adjusted 
incidence rate of all-cause AGE-associated hospitalization was 2,413 cases per 
100,000 children, while RVAGE accounted for 429 cases per 100,000 children 
aged 0–59 months (Tables 11 and 12, respectively). Infants and especially children 
aged 6–11 months experienced the highest AGE hospitalization rates of 7,798 
cases per 100,000 hospitalizations and 558 cases per 100,000 deaths. Although 
infants in general had the highest hospitalization rates due to all-cause AGE, 
children aged 6–11 months experienced the greatest burden of all-cause AGE 
hospitalization. The highest annual rate of hospitalizations due to all-cause AGE 
(per 100,000) was observed in 2011 (3,782), followed by 2010 (2,718), 2012 (1,745), 
and 2013 (1,437). The rates of hospitalizations due to all-cause AGE during the 
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study period and by specific age groups are shown in Table 11. Infants aged 6–11 
months had the highest RVAGE incidence: 1,560 cases per 100,000 person-years 
in the HDSS. When estimates of hospitalizations due to RVAGE were compared 
by year, the highest rates were observed in 2011, followed by 2010 and 2012, with 
the lowest rate in 2013 (Table 12). 
Table 11.  Unadjusted and adjusted† rates and 95% CIs of hospitalization attributed to AGE per 
100,000 person-years among inpatients aged 0–59 months and residing in the rural 
Karemo HDSS in the pre-vaccine introduction era in Kenya, 2010–2013. (The 
estimates in brackets are the 95% CIs). 
†Adjusted by applying the proportion of samples collected from all AGE admissions to the hospital and health-seeking behavior in the HDSS for children with 
reported diarrhea at home 
 
 
 
 
 
 
 
Year Unadjusted Rates  and 95% Confidence interval † of Hospitalization attributed to AGE 
  0-5 months 6-11 months 0-11 months 12-23 months 24-59 months 0-59 months 
2010 5942 (5313-6572) 5928 (5299-6556) 5934 (5305-6563) 5107 (4523-5690) 353 (199-506) 1740 (1399-2080) 
2011 6506 (5818-7193) 8622 (7831-9413) 7639 (6894-8384) 8643 (7851-9435) 528 (332-724) 2421 (2001-2840) 
2012 3963 (3278-4649) 3793 (3122-4463) 3868 (3191-4545) 3226 (2607-3844) 208 (51-365) 1117 (753-1481) 
2013 2487 (1912-3062) 3735 (3030-4439) 3158 (2510-3806) 1954 (1444-2463) 272 (82-461) 919 (570-1269) 
2010-
2013 4696 (4064-5329) 5459 (4776-6141) 5112 (4451-5772) 4696 (4064-5329) 340 (170-510) 1544  (1181-1907) 
Year Adjusted Rates  and 95% Confidence interval † of Hospitalization attributed to AGE 
              
  0-5 months 6-11 months 0-11 months 12-23 months 24-59 months 0-59 months 
2010 8612 (7854-9370) 8468 (7717-9220) 8478 (7726-9230) 7622 (6909-8335) 619 (416-822) 2718 (2292-3144) 
2011 9428 (8601-10256) 12317 (11371-13263) 10913 (10023-11803) 12900 (11932-13868) 927 (667-1186) 3782 (3258-4306) 
2012 5744 (4918-6569) 5418 (4617-6220) 5526 (4716-6335) 4815 (4599-5570) 365 (157-573) 1745 (1290-2200) 
2013 3604 (2912-4296) 5335 (4493-6178) 4512 (3737-5286) 2916 (2294-3539) 476 (225-728) 1437 (1000-1874) 
2010-
2013 6806 (6045-7568) 7798 (6983-8614) 7302 (6513-8091) 7010 (6236-7783) 597 (371-822) 2413 (1959-2866) 
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Table 12.  Unadjusted and adjusted† rates and 95% CIs of hospitalization attributed to RVAGE 
per 100,000 person-years among inpatients aged 0–59 months and residing in the 
rural Karemo HDSS in the pre-vaccine introduction era in Kenya, 2010–2013. (The 
estimates in brackets are the 95% CIs). 
 Year Unadjusted Rates and 95% Confidence interval † of Hospitalization attributed to RVAGE by age and year 
 0-5 months 6-11 months 0-11 months 12-23 months 24-59 months 0-59 months 
2010 1486 (1373-1598) 1078 (982-1174) 1263 (1159-1367) 429 (368-489) 25 (11-40) 334 (280-387) 
2011 1208 (1105-1311) 1853 (1725-1981) 1554 (1437-1671) 445 (382-508) 74 (48-99) 410 (350-470) 
2012 922 (827-1016) 584 (508-659) 733 (649-817) 236 (188-284) 25 (9-40) 198 (154-241) 
2013 533 (476-590) 915 (840-990) 738 (671-806) 76 (55-98) 12 (4-21) 160 (128-191) 
2010-2013 1031 (938-1123) 1092 (997-1187) 1064 (970-1158) 294 (245-343) 34 (17-51) 274 (227-322) 
Year 
  
Adjusted Rates  and 95% Confidence interval † of Hospitalization attributed to RVAGE by age and year 
  0-5 months 6-11 months 0-11 months 12-23 months 24-59 months 0-59 months 
2010 2153 (2017-2289) 1540 (1425-1654) 1804 (1680-1928) 640 (566-714) 44 (25-64) 522 (455-589) 
2011 1751 (1627-1875) 2648 (2495-2800) 2220 (2080-2360) 664 (588-741) 129 (96-163) 640 (565-716) 
2012 1336 (1222-1449) 834 (744-923) 1047 (946-1148) 352 (148-410) 43 (23-63) 309 (254-363) 
2013 772 ( 703-841) 1307 (1217-1396) 1055 (974-1135) 114 (87-140) 22 (10-33) 249 (210-289) 
2010-2013 1494 (1383-1606) 1560 (1446-1673) 1520 (1408-1632) 439 (379-499) 60 (37-82) 429 (369-488) 
†Adjusted by applying the proportion of samples collected from all AGE admissions to the hospital and health-seeking behavior in the HDSS for children with 
reported diarrhea at home.  
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Mortality rates due to all-cause AGE were highest among infants and decreased 
with increasing age. Although the overall mortality rate increased from 2010 to 
2011, with a small drop in 2012, we observed an increase in overall rates from 2011 
to 2013, with a notable threefold increase in mortality rates among children aged 
six to eleven months from 2012 to 2013 (Table 13).  
Table 13.  Crude rates of mortality attributed to all-cause AGE per 100,000 person-years by age 
group and year in rural Karemo during the pre-vaccine era in Kenya, 2010–2013. (The 
estimates in brackets are the 95% CIs). 
 
 
 
 
 
 
 
Although the overall annual mortality rates per 100,000 person-years due to 
RVAGE increased slightly between 2010 and 2012, we observed a substantial 
increase in the rate between 2012 and 2013, with the increase highest among 
children aged 6–11 months, before the rotavirus vaccine was introduced in Kenya 
(Table 14).  
Table 14.  Mortality rates attributed to RVAGE per 100,000 person-years, by age group and year 
in Karemo during the pre-vaccine era in Kenya, 2010–2013. (The estimates in 
brackets are the 95% CIs). 
Year Mortality rate and 95% Confidence interval by child age in months 
 0-5 months 6-11 months 0-11 months 12-23 months 24-59 months 0-59 months 
2010 165 (140-190) 119 (97-140) 144 (121-168) 42 (29-55) 33 (22-44) 46 (33-59) 
2011 99 (80-119) 156 (132-181) 131 (109-154) 63 (48-79) 18 (10-26) 50 (36-64) 
2012 138 (115-161) 91 (72-110) 111 (90-131) 30 (20-41) 3 (0-6) 56 (41-70) 
2013 92 (73-111) 297 (263-331) 188 (161-215) 25 (15-34) 13 (7-20) 33 (22-44) 
2010-2013 124 (103-146) 156 (132-181) 144 (120-167) 46 (33-59) 14 (7-22) 45 (32-59) 
5.3 Rotavirus Infection by Wealth Quintiles and Age (Study III) 
In our hospital-based rotavirus surveillance (Study III), we found that 15% of 
children under five years old with MSD presenting at our study SHCs were 
infected with rotavirus. Moreover, the proportion of children with MSD who were 
infected with rotavirus from rich and poor households was similar (Figure 16). 
Year Mortality rates and 95% Confidence interval by child age in months 
 0-5 months 6-11 months 0-11 months 
12-23 
months 
24-59 
months 0-59 months 
2010 434 (393-474) 475 (432-517) 450 (409-492) 238 (140-117) 100 (80-120) 172 (146-198) 
2011 342 (306-378) 558 (512-604) 452 (411-494) 353 (316-389) 90 (72-109) 214 (185-242) 
2012 444 (403-486) 314 (280-349) 369 (331-407) 117 (96-138) 43 (30-56) 118 (97-140) 
2013 368 (331-406) 928 (869-988) 649 (599-699) 225 (195-254) 68 (52-84) 207 (178-235) 
2010-
2013 401 (362-441) 558 (511-604) 479 (436-521) 210 (181-238) 75 (58-92) 176 (150-202) 
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However, the proportion of those positive for rotavirus was significantly higher 
among infants than school-age children (Figure 17). We observed that the 
proportion of positives increased from birth to 20% at one month and remained at 
more or less at the same level through eight months, with a sharp drop-off in 
infants aged nine through eleven months (Figure 17).  
Figure 16.  Wealth quintiles for rotavirus-positive vs. rotavirus-negative MSD cases from rotavirus 
surveillance (Study III) in western Kenya, 2008–2012. 
Figure 17.  Rotavirus-positive and -negative cases among children with non-dysenteric MSD; number 
and percentage by age group, western Kenya, 2008–2012. 
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5.3.1 Factors associated with rotavirus diarrhea 
Compared with non-rotavirus cases, rotavirus MSD cases were more likely to 
present with a history of vomiting and to be treated with IV fluids. The factors 
associated with rotavirus infection in univariate and multivariable analysis are 
shown in Tables 15 and 16, respectively. Hospitalization was more commonly 
observed among MSD patients under one year of age who were rotavirus-positive 
than rotavirus-negative (67.6% [25/37] vs. 46.3% [62/134], p < 0.035) and among 
all rotavirus-positive vs -negative MSD cases, regardless of age (15.1% [37/245] vs. 
9.6% [134/1,392], p < 0.013). Our data showed that children with rotavirus 
diarrhea presented with conditions suggesting more severe disease than those with 
non-rotavirus diarrhea. The difference in severity between rotavirus and non-
rotavirus diarrhea is further described using a GEMS-modified Vesikari score, as 
detailed in Table 17. The stool samples collected during warm and dry months 
were twice as likely to be rotavirus-positive than those collected in typically cool 
and rainy months (142/691 [20.5%] vs. 70/673 [10.4%]; OR = 2.16, 95% CI: 1.58–
2.96). 
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Table 15.  Clinical characteristics of rotavirus-positive and -negative cases with non-dysentery 
MSD enrolled in GEMS rotavirus surveillance (Study III), western Kenya, 2008–2012. 
 
  Rotavirus positive 
N = 245 
Rotavirus negative 
N = 1,392 
unadjusted odds 
ratio, 
95%Confidence 
interval (OR, 
95%CI) 
Variable n % n % OR 
95%CI 
p-value 
Child`s age stratum (in months)             
0-11 156 63.7 626 45.0 5.67  
12-to-23 72 29.4 379 27.2 4.32  
24-59 17 6.9 387 27.8 Ref  
Median age in months 8 [IQR 5-14]   13 [IQR 7-25]    N/A  
Gender            
Female 120 49.0 591 42.5 1.3  
Male 125 51.0 801 57.5 Ref  
Clinical symptoms  in the child at 
enrollment             
?????????????? ????????            
Yes 171 69.8 627 45.0 2.82  
No 74 30.2 765 55.0 Ref  
Maximum no. of loose stools/24hrs            
????????? 78 31.8 333 23.9 1.49  
????????? 167 68.2 1059 76.1 Ref  
Child was admitted to hospital            
Yes 37 15.1 134 9.6 1.67  
No 208 84.9 1258 90.4 Ref  
 IV fluid given            
Yes 43 17.6 155 11.1 1.7  
no 202 82.4 1237 88.9 Ref  
Dehydration            
Moderate-to-severe 55/241 22.8 250/1333 18.8 1.28  
Mild 186/241 77.2 1083/1333 81.2 Ref   
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Table 16.  Factors associated with rotavirus positivity among children under five with non-
dysentery MSD enrolled in GEMS rotavirus surveillance (Study III), western Kenya, 
2008–2012. 
 
‡Adjusted for variables in the model. Six variables were initially entered in the model, of which two (above) were associated with rotavirus positivity. The four 
variables dropped were child offered IV fluid, dehydration, maximum stool in 24 hours, and gender. 
 
   
Characteristic † Rotavirus positive 
N=245 
(n/N, %) 
Rotavirus negative 
N= 1,392 
(n/N, %) 
Odds ratio (OR) for rotavirus detected in the 
stool  [95% confidence interval (CI)] 
      Unadjusted Odds Ratio Adjusted Odds Ratio ‡ 
      [OR] (95%CI) [aOR] (95%CI) 
Child age stratum          
0-11 months 156 (63.7) 626 (45.0) 5.67 (3.38-9.51) 5.41 (3.21-9.11) 
12-23 months 72 (29.4) 379 (27.2) 4.32 (2.50-7.47) 4.09 (2.36-7.10) 
24-59 months 17 (6.9) 387 (27.8) Ref. Ref. 
Child`s Gender         
Female 120 (49.0) 591 (42.5) 1.30 (0.99-1.71) 1.38 (1.04-1.83) 
Male 125 (51.0) 801 (57.5) Ref. Ref. 
Clinical symptoms child 
presented at the clinic/ 
enrollment visit         
?????????????? ????????         
Yes 171 (69.8) 627 (45.0) 2.82 (2.10-3.78) 2.66 (1.98-3.58) 
No 74 (30.2) 765 (55.0) Ref. Ref 
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Table 17.  Numerical GEMS-modified Vesikari score system for severity of diarrhea among 
rotavirus-positive and -negative children with non-dysenteric MSD, western Kenya, 31 
January 2008–30 September 2012. 
†Denominator = 1,636. ††Denominator = 1,574. †††Median calculated for children without missing information (rotavirus-positive = 241; rotavirus-negative = 
1,332). ‡A child was considered mildly dehydrated if two or more of the following were present: restless or irritable on arrival or admission; sunken eyes; 
thirsty; drank eagerly; skin pinch returns to normal slowly (one or two seconds). ‡‡A child was considered moderately to severely dehydrated if two or more of 
the following were present: lethargic or unconscious on arrival or admission; sunken eyes; drank poorly or unable to drink; skin pinch returns to normal very 
slowly (longer than two seconds). 
5.4 Pre-Rotavirus Vaccine Epidemiology and Factors 
Associated with Intussusception-Related Deaths Among 
Children Under Five in Kenya (Study IV) 
5.4.1 Background characteristics of study participants 
The records of 305 patients treated for intussusception from 1 January 2002 to 31 
December 2013 at the 12 leading referral hospitals in Kenya were screened for 
eligibility and enrollment (Figure 18). We found that approximately sixty percent of 
 Child characteristics Points 
assigned 
Rotavirus-
positive  
Rotavirus-negative  p-value 
  (N=17) N=245 N=1,392 
 
  n % n %  
Duration of diarrhea (days)      
 
1-4 1 221 90.2 1,247 89.6 0.954 
5 2 14 5.7 85 6.1  
?? 3 10 4.1 60 4.3  
Max no. diarrhea /24 hrs.       
3-6 2 167 68.2 1,059 76.1 0.010 
?? 3 78 31.8 333 23.9  
Vomited 3+ times/24 hrs.       
Yes 3 171 69.8 627 45.0 <0.001 
No 0 74 30.2 765 55.0  
Fever †       
<37.0 0 82 33.5 550 39.5 <0.001 
37.1-38.4 1 128 52.2 534 38.4  
38.5-38.9 2 17 6.9 112 8.1  
>=39 3 18 7.4 195 14.0  
Dehydration††       
 Moderate/Severe‡‡ 3 55 22.8 250 18.8 0.156 
Mild‡ 2 186 77.2 1,083 81.2  
Treatment       
Out-patient without IV fluid 0 198 80.8 1,215 87.3 0.023 
Out-patient with IV fluid 1 10 4.1 43 3.1  
Hospitalization with or without IV fluid 2 37 15.1 134 9.6 0.013 
Median Score ††† N/A 9 
[IQR] 
8-10 
 8 [IQR] 6-
10 
 <0.001 
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patients under five treated for intussusception in those hospitals were originally 
referred to other hospitals, mainly district-level hospitals (Table 18). 
A total of 280 (91.8%) of the 305 records screened for possible intussusception 
cases were included in our analysis, as shown in Figure 18. Most patients were 
infants. Our analysis showed that intussusception peaked at approximately six 
months of age and that disease occurrence declined with an increase in child age 
(Figure 19). A majority (40%) of intussusception cases were aged 6–11 months and 
were (67%) predominantly males (Table 19). Intussusception occurred throughout 
the year, without a clear seasonality pattern (Figure 20).  
Table 18.  Cases of intussusception retrospectively identified among pediatric patient records at 
12 referral hospitals in Kenya, 2002–2013. 
Hospital / Study Centre  
Period that 
records were 
reviewed 
Screened 
Children† 
Eligible 
Children† 
Referral from other 
district level hospital 
Yes 
n/N (%)†† 
(N=305) (%) (N=280) (%) (n=165) 58.9 
Coast Provincial General Hospital 2002-2013 76 24.9 67 23.9 29 43.3 
Kenyatta National Hospital 2008-2013 56 18.4 56 20.0 32 57.1 
Moi Teaching and Referral 
Hospital 2009-2013 55 18.0 49 17.5 
40 81.6 
Nakuru Provincial General Hospital 2002-2013 40 13.1 40 14.3 19 47.5 
Jaramogi Oginga OdingaTeaching 
and Referral Hospital 2009-2013 23 7.5 23 8.2 
 
20 
 
86.9 
Gertrude’s Children's Hospital 2009-2013 22 7.2 19 6.8 19 100 
Kijabe Mission Hospital 2008-2013 11 3.6 9 3.2 2 22.2 
Thika District Hospital 2003-2013 8 2.6 6 2.1 1 16.7 
Kiambu District Hospital 2009-2013 5 1.6 3 1.1 0 0 
Nyeri Provincial General Hospital 2010-2013 4 1.3 4 1.4 1 25.0 
Embu Provincial General Hospital 2010-2013 3 1.0 3 1.1 2 66.7 
Kakamega Provincial General 
Hospital 2009-2013 2 0.7 1 0.4 
0 0 
Year of consultation (Number of 
hospitals reporting data)-Eligible 
cases      
  
2002 (2 hospitals) N/A N/A  6 2.1 N/A N/A 
2003 (3 hospitals) ‘’ ‘’  11 3.9 ‘’ ‘’ 
2004 (3 hospitals) ‘’ ‘’  7 2.5 ‘’ ‘’ 
2005 (3 hospitals) ‘’ ‘’  7 2.5 ‘’ ‘’ 
2006 (3 hospitals) ‘’ ‘’  8 2.9 ‘’ ‘’ 
2007 (3 hospitals) ‘’ ‘’  14 5.0 ‘’ ‘’ 
2008 (5 hospitals) ‘’ ‘’  30 10.7 ‘’ ‘’ 
2009 (10 hospitals) ‘’ ‘’  40 14.3 ‘’ ‘’ 
2010 (12 hospitals) ‘’ ‘’  38 13.6 ‘’ ‘’ 
2011 (12 hospitals) ‘’ ‘’  48 17.1 ‘’ ‘’ 
2012 (12 hospitals) ‘’ ‘’  40 14.3 ‘’ ‘’ 
2013§ (12 hospitals) ‘’ ‘’  31 11.1 ‘’ ‘’ 
Note: †Denominator is the sum from all sites, unless otherwise indicated. ††The percentages shown above are individual hospital proportions of eligible cases 
referred (i.e., “yes”) to that site. §Data collected only from January through November 2013. 
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Figure 18.  Flow diagram of retrospective intussusception cases identified among pediatric patient 
records presenting at selected Kenyan referral hospitals, 2002–2013. 
 
Figure 19.  Number of intussusception cases by age (in months) among pediatric patients under 5 
years old treated at 12 referral hospitals in Kenya (N = 280), 2002–2013. 
Intussusception cases screened at 12 Kenyan referral hospitals, 2000-2013 
N=305 
Records included in the analysis with aged 0-59 months 
N=280 (91.8%) 
Records excluded from the analysis 
N=25 (8.2%) 
1   Missing age; N=12 
2  Aged>60 months; N=12 
3  Episode occurred before 2002; N=1 
N=23 (7.5%) Age distribution in months 
0-11: 192 (68.6 %) 
12-23: 43 (15.3 %) 
24-59: 45 (16.1 %) 
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Figure 20.  Distribution of intussusception cases by month of treatment among pediatric patients 
treated at the 12 referral hospitals in Kenya (N = 280), 2002–2013. 
5.4.2 Clinical presentations in intussusception patients and care seeking 
Most intussusception cases (75–88%) presented with vomiting, blood in stool or 
rectal bleeding, and abdominal distension (Table 19). As to seeking care, 3.7%, 
16%, 33%, and 50% of patients sought care within 1 day, 2 days, 3 days, and 4 days 
after illness symptom onset, respectively (data not shown). The median number of 
days until seeking care was 3 (interquartile range: 2–6) days after illness onset. 
Further clinical features, diagnosis, treatment, and characteristics of the 
intussusception patients are detailed in Table 19. 
5.4.3 Survival in intussusception patients by demographic and clinical 
characteristics 
Eighteen (6.4%) patients died during hospitalization or on discharge after seeking 
care, most of whom (15, or 83%) were infants, generally aged 0–5 months. 
Compared with intussusception patients who survived, patients who died were 
more likely to be young infants, those for whom care was sought late after 
symptom onset, those who had a reported history of fever, those who had clinical 
fever on admission, and those who had bowel surgery. However, treatment 
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through manual reduction was inversely associated with fatal outcomes. The 
differences and factors associated with death among intussusception patients under 
5 years old who were treated at the 12 leading referral hospitals in Kenya from 
2002 to 2013, prior to rotavirus vaccine introduction, are shown in Table 19. 
Table 19.  Characteristics of children aged 0–59 months with intussusception who died vs. those 
who survived at the 12 referral hospitals in Kenya, 2002–2013. 
Background Characteristics All Case fatality proportion, n/N (%) 
Survived n/N 
(%) P-value 
Demographic characteristics N=280 [N (%)] (N=18) (N=262)  
Child age in months               
0-5 81 28.9 9 50 72 27.4 0.195  
6-11  11 39.6 6 33.3 105 40.1   
12-23  43 15.4 2 11.1 41 15.7   
24-59 45 16.1 1 5.6 44 16.8   
Median age of patients in months (IQR) 7.0 (5-14) 5.5 (4.0-9.0) 7.0 (5.0-14.0) 0.04 
Gender††               
Male 186 66.7 11 61.1 175 67 0.611 
Female 93 33.3 7 38.9 86 33   
Median days to seeking care (IQR) 3 (2-6) 5 (3-9) 3 (2-5) 0.04 
Median days to death/ discharge upon 
recovery after admission (IQR) 5 (3-8) 2 (1-6) 6 (4-8) 0.01 
Clinical features (% yes)               
Fever 177 63.2 17 94.4 160 61.4 <0.01 
Temperature§               
<  37.0 38 17 1 6.2 37 18 0.01 
37.0-38.4 125 56.1 5 31.2 120 58   
38.5-38.9 21 9.4 3 18.8 18 8.7   
??????  39 17.5 7 43.8 32 15.5   
Vomiting 247 88.2 17 94.4 230 87.8 0.71 
Diarrhea 209 74.6 13 72.2 196 74.8 0.78 
Blood in stool 227 81.1 13 72.2 214 81.7 0.35 
Abdominal Pain 178 63.6 10 55.6 168 64.1 0.46 
Abdominal distension 210 75 16 88.9 194 74 0.26 
Abdominal mass 111 39.6 5 27.8 106 40.5 0.33 
Rectal mass 80 28.6 4 22.2 76 29 0.79 
Type of Intussusception               
Ileocolic 132 47.1 10 55.6 122 46.6 0.76 
Colocolic 40 14.3 5 27.8 35 13.4   
Ileo-ileal 22 7.9 2 11.1 20 7.6   
Diagnosis methods, ‡               
Ultra-Sound 91 32.5 10 55.6 81 30.9 0.04 
Abdominal X-ray 152 54.3 14 77.8 138 52.7 <0.05 
Treatment  method (operative)               
Bowel resection 91 32.5 12 66.7 79 30.2 <0.01 
Manual reduction 128 45.7 4 22.2 124 47.3 <0.05 
Ileostomy 5 1.8 1 5.6 4 1.5 0.28 
Treatment  method (Non-operative)               
Air reduction 0 0 0 0 0 0 N/A 
Contrast Fluid enema 5 1.8 0 0 5 1.9 1 
Unknown treatment method 73 26.1 1 5.6 72 27.5 0.049 
††One child’s gender was missing. §N = 223. IQR = interquartile range, ‡Multiple diagnosis methods possible. CFR = Case fatality proportion. 
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6 DISCUSSION 
In this chapter, the key findings from our studies are summarized. Next, the 
strengths and limitations of our studies are discussed, and our findings are 
compared with those from other studies and then interpreted. Finally, conclusions 
from our findings and practical implications for future research are presented. 
6.1 Summary of Key Findings 
Our finding that caretakers were less likely to seek healthcare outside the home for 
infants than for older children with diarrhea is important because severe AGE- and 
intussusception-related mortality are more likely in the younger group. Timely 
access to healthcare can lead to life-saving rehydration for diarrhea (Geldsetzer et 
al., 2014; WHO, 2006), and possible use of non-invasive interventions for 
treatment of intussusception (Mpabalwani et al., 2017; Menke & Kahl, 2015). Our 
study also showed that fewer than half of children with diarrheal disease received 
care at a licensed healthcare facility and that a substantial proportion of children 
with diarrhea were given less food and drink than normal; only 23% were offered 
ORS at home. Moreover, caretakers who did not report looking for thirst as a sign 
of dehydration were less likely to seek care from a healthcare facility for a child’s 
diarrheal illness. 
However, sunken eyes and lethargy as symptoms during diarrheal illness were 
both associated with seeking care outside the home. Caretakers with formal 
education were more likely than those without it to seek care from a healthcare 
facility for a child’s diarrhea and to give ORS. Children who were offered 
antimicrobial drugs and those who were not offered ORS at home for diarrheal 
illness were more likely to have care sought from a healthcare facility. Seeking care 
for MSD from a healthcare facility was most common for infants aged 6–11 
months. Taken together, these observations suggest that deficiencies in the 
caretaker management of children’s diarrhea illness at home could be associated 
with severe disease and adverse outcomes. These findings are particularly 
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important for infants? an age group that accounted for more than 70% of 
hospitalizations due to all-cause AGE and more than 60% of rotavirus infections 
among children with MSD in our study. Moreover, our study showed that infants 
accounted for more than 70% and 80% of all intussusception case-patients who 
were enrolled and died, respectively. Infants with rotavirus-associated MSD were 
twice as likely to be hospitalized as those with non-rotavirus MSD and tended to 
have more severe disease, as measured by GEMS-modified Vesikari scores. The 
intussusception case fatality rate was 6.4%. Mortality among intussusception 
patients was associated with late care seeking, presentation with fever, and 
undergoing bowel surgery. However, in assessing these outcomes, our study was 
unable to control for likely confounding factors, such as severity at presentation to 
care, as demonstrated by Chrsti and colleagues (Chisti et al., 2014). 
6.2 Methodological Considerations 
6.2.1.1 Strengths of the study 
Studies I–III used reliable, age-specific population denominators from a well-
updated HDSS (F. O. Odhiambo et al., 2012). Surveillance systems with accurate 
population denominators are necessary for estimating disease burden and 
evaluating the impact of interventions such as vaccines. Such HDSS platforms are 
rare in the developing world (WHO, 2005a; Baschieri et al., 2019). Furthermore, 
due to its longitudinal nature, an HDSS has the additional advantage over other 
common study designs in tracking and monitoring the health indicators that could 
be relevant for estimating progress like the achievement of MDGs or SDGs as 
described from most of the low-middle-income countries where they exists (Arthur 
et al., 2013; F. O. Odhiambo et al., 2012; Kabudula et al., 2017; Sankoh et al., 2014; 
Sankoh, 2014). Our baseline and repeated HUAS (Study I) helped to characterize 
healthcare seeking in our catchment population. We first established baseline rates 
of diarrheal disease by using a comprehensive population-based study, followed by 
a short version of HUAS that supported conducting efficient hospital-based 
surveillance (Studies II and III). To our knowledge, this study is the first 
comprehensive, age-stratified, complete population-based healthcare utilization 
survey using a standard protocol. Furthermore, it was conducted over the longest 
time period in a well-defined population compared to similar studies in sub-
Saharan Africa (Kenya, Mozambique, Mali, and The Gambia) and Asia (India, 
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Bangladesh, and Pakistan) before rotavirus vaccine introduction in these settings 
(Nasrin et al., 2013). 
Our hospital-based rotavirus surveillance study (II) calculated population-based 
incidence rates of all-cause and rotavirus diarrhea hospitalizations and deaths. 
Reliable estimates of the proportion of children with all-cause and rotavirus 
diarrhea from the HDSS who were seen at the SHCs provided the basis for using a 
rate multiplier, as recommended by the WHO (WHO, 2008). The accurate age-
specific assessment of the rotavirus disease burden before rotavirus vaccine 
introduction presented in our study provides a baseline for robust future 
assessment of long-term direct and indirect effects of the vaccination program in 
Kenya (WHO, 2008). 
The hospital-based surveillance study design as applied in Studies II–IV 
provided detailed epidemiologic, seasonality, and risk factor data for rotavirus 
infection and intussusception-associated mortality. Another unique aspect of Study 
III was that most hospital-based studies lack a follow-up component to evaluate 
treatment outcomes. To obtain data beyond the acute period, we incorporated a 
60-day follow-up home visit after enrollment to monitor illness outcomes beyond 
the acute phase.  
The laboratory procedures used in hospital-based surveillance (Studies II and 
III) included using whole and fresh stool samples and avoiding the use of rectal 
swabs. Use of rectal swabs and other non-EIA methods to detect rotavirus has 
been discouraged since they have been associated with up to a 50% decrease in 
sensitivity of detecting rotavirus (WHO, 2002, , 2008). Furthermore, adoption of 
whole, fresh stool sample collection and the use of the ELISA method for testing 
rotavirus supports comparison of our findings to those from similar studies 
(WHO, 2002, , 2008).  
Our studies incorporated WHO-recommended standard case definitions for 
diarrhea, MSD, and intussusception (WHO, 2005c, , 2006; Bines, Liem, Justice, 
Son, Carlin et al., 2006). Use of standard case definitions as recommended by the 
WHO (WHO, 2008) enhanced data quality and reliability and enabled comparison 
of our findings with those from other settings across the world. Furthermore, this 
effort will ensure effective comparison of disease burden before and after rotavirus 
vaccine introduction in Kenya when assessing possible vaccine impact. Our studies 
provide high-quality baseline data collected over an extended period of time (a 
range of 4–10 years) before rotavirus vaccine introduction in Kenya. These data 
account for seasonal variations and cover children aged 0–59 months. Finally, our 
studies contribute to fulfilling the call by WHO and Gavi, the Vaccine Alliance for 
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timely and quality pre-vaccine baseline surveillance data. This information could 
form the basis for monitoring systems to assess vaccine impact and safety that are 
needed to inform post-vaccine era decisions, as detailed elsewhere (WHO, 2013a; 
Patel & Parashar, 2009; WHO, 2008). 
6.2.1.2 Limitations of the study 
Our HUAS relied on caretakers’ recall of the occurrence of a child’s diarrhea 
episode during the preceding two-week period. In classifying diarrhea as MSD, we 
assumed that caretakers were sufficiently familiar with the signs and symptoms of 
diarrhea, an assumption that may have resulted in misclassification. Many 
rotavirus-associated fatalities are likely associated with delay in healthcare seeking 
(WHO, 2013), as our study also showed. Furthermore, the lack of a qualitative 
component in the study prevented a deeper understanding of factors associated 
with diarrhea management and care seeking, as detailed in Table 20. The VA 
method used in Study II relies on signs, symptoms, and circumstances prior to 
death to assign a cause of death. As applied in our study, the VA method is thus 
subject to misclassification error and may have led to over- or underestimation of 
diarrhea-associated mortality (WHO, 2005d).  
Our methodology for estimating diarrhea deaths attributable to rotavirus was 
based on three assumptions: (i) in the absence of treatment, the hospitalized severe 
cases would not have survived; (ii) the treatment effect on survival of severe 
diarrhea is equal for rotavirus and non-rotavirus diarrhea; and (iii) the rotavirus-
attributable fractions of severe diarrhea observed in the sentinel hospital are 
generalizable to the source population within each age stratum (WHO, 2005d). 
Interpreting these estimates with caution is important since such assumptions may 
affect the validity and generalizability of the estimates to the general population. 
However, there are currently no reliable data for the direct measurement of the 
proportion of diarrhea deaths that are attributable to rotavirus (WHO, 2005d, , 
2008), especially in the high disease burden regions that are largely found in low- 
and middle-income countries (Tate, Burton et al., 2016). We believe that our 
methodology is reasonably robust and applicable as recommended by the WHO 
(WHO, 2005d, , 2008). Moreover, previous observations suggest that patients 
seeking care from our surveillance hospital reasonably represent the HDSS area, 
which was our source population (Khagayi et al., 2014). 
The GEMS-modified Vesikari score system in Study III should be interpreted 
with caution. The information on the duration of vomiting and the maximum 
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number of vomiting episodes over a 24-hour period was not collected as a 
continuous variable but a categorical one. Although we resolved this by modifying 
the Vesikari score based on a reconstructed 17-point scoring system, the 
incomplete capture of information did not allow us to calculate traditional full 20-
point Vesikari scores (Ruuska & Vesikari, 1990).  
Our hospital-based rotavirus diarrhea surveillance (Study III) nested in the 
GEMS was not originally equipped to assess risk factors for rotavirus infection, 
which may have influenced our results one way or the other. As described 
elsewhere (WHO, 2013b), approximately 90% of all rotavirus-associated fatalities 
occur in low- and middle-income countries, mostly in Africa. As suggested by our 
HUAS (Study I), most of our enrolled cases in Studies II–IV may have had 
illnesses that were severe enough to worry their caretakers into seeking care from 
healthcare facilities. Furthermore, our intussusception surveillance (Study IV) may 
also have underreported baseline rates of the disease due to the possibility of delays 
and low care-seeking patterns that are commonly seen in Kenya. These 
observations suggest the possibility that some children may have died without 
seeking hospital care for MSD or intussusception at the sites under surveillance. 
Hospital-based studies tend to capture information on the most severe illnesses 
among patients who have access to healthcare—a characteristic that could prompt 
questions about generalizability of Studies II–IV (Crump et al., 2008). 
6.3 Comparison of Main Results with Previous Studies and 
Interpretation of the Findings 
6.3.1 Comparison of Main Results with Previous Studies  
The inappropriate caretaker practices in home management of childhood diarrhea 
that could lead to poor outcomes, such as not giving ORS and decreasing fluid and 
food intake, are vitally important. Considered in addition to the observed delays in 
seeking care for severe diarrheal illness, caretakers who do not know the classic 
symptoms of intussusception, as we observed in our study, remain a pressing 
problem in Kenya (KDHS, 2015, , 2010; Kuremu, 2004). These findings are similar 
to those reported by previous studies conducted in rural and urban Kenya (Ram et 
al., 2008; Breiman et al., 2011) and are not unlike other findings from sub-Saharan 
Africa showing that diarrhea is often inadequately managed at home in these 
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settings (Forsberg et al., 2007; Ram et al., 2008). Furthermore, other studies have 
shown that caretaker delays in seeking care for a child’s acute diarrhea (Nasrin et 
al., 2013) and intussusception (Mpabalwani et al., 2017) are common problems in 
many settings in sub-Saharan Africa.  
On the other hand, over-prescription of antimicrobial drugs and their 
inappropriate use by caretakers at home before seeking care has previously been 
reported in many studies from Kenya (Shapiro et al., 2001; Brooks et al., 2006; 
Njuguna et al., 2013; F. Odhiambo et al., 2014). Our finding that 14% of children 
who reached a healthcare facility had already been given a non-prescribed 
antimicrobial drug is comparable with those reports. Inappropriate use of 
antimicrobials is associated with emergence of resistance: a previous study in our 
study setting found that approximately 70% of children under five visiting 
healthcare facilities for diarrhea episodes were prescribed antimicrobial drugs, 
regardless of etiology (Beatty et al., 2009). Moreover, up to 100% of clinicians in 
Kenya reportedly do not routinely use laboratory results to guide diarrhea case 
management (F. Odhiambo et al., 2014), despite recommendations to that effect 
(WHO, 2005b).  
The findings of another qualitative study conducted in our HUAS study area 
suggest that most caretakers of children who die from diarrhea-related 
complications visited a traditional healer first and returned to them repeatedly, only 
visiting a healthcare facility later, after the child`s condition became more severe 
(Garg et al., 2001). When caretakers did not report barriers to care seeking, the 
median duration from symptom onset to seeking care was two days, regardless of 
whether the source of care was traditional or a healthcare facility (Garg et al., 2001). 
In other parts of Kenya, most children under five with diarrhea had care sought 
late from a healthcare facility and had more severe symptoms upon reaching the 
facility. In the same study, about half the caretakers cited a lack of money as the 
reason for delay in care seeking (Breiman et al., 2011). A study that applied 
complementary (qualitative and quantitative) methodology in Pakistan found that 
caretaker delays in seeking care and refusal of admission for children under five 
with dehydrating diarrhea were associated with death (Qamar et al., 2016).  
Findings from intensive qualitative studies involving focus group discussions 
and in-depth interviews with caretakers of children with diarrhea in sub-Saharan 
Africa showed that there are many factors that could influence care seeking for 
childhood diarrhea. These include diverse cultural beliefs (especially regarding 
traditional medicine), perceived illness severity, and the efficacy and cost of 
treatment (Cunnama & Honda, 2016; Scott et al., 2014) including caretaker 
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concerns over frequent drug stock-outs and the distance to healthcare facilities 
(Bedford & Sharkey, 2014). Another qualitative study in Ethiopia showed that 
mothers stated a preference for using the health facility, but they were unable to do 
so because of objections or alternative care-seeking preferences of gatekeepers, 
often mothers-in-law and husbands (Shaw et al., 2016). On the other hand, a 
qualitative intervention study observed an increase in healthcare seeking after 
intensive community mobilization and use of community health worker peer 
support groups (Langston et al., 2014). These studies demonstrate the value of 
undertaking qualitative studies when more detailed data on factors influencing 
healthcare seeking may be warranted (see Table 20), due to the common limitations 
inherent in using quantitative data to study factors associated with care seeking. 
However, these observations reaffirm the quantitative findings from systematic 
reviews (Geldsetzer et al., 2014) that caretakers’ poor recognition of symptoms, 
inappropriate home management, and delays in seeking care for children with 
severe disease in low- and middle-income countries continue to pose major 
challenges for child survival efforts in these settings. Taken together, all these 
observations suggest significant barriers to compliance with the current WHO 
recommendations for diarrhea management in Kenya and similar settings in Africa 
(WHO, 2005c, , 2006, , 2018a).   
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Table 20.  Factors associated with seeking care for diarrhea among children under five: summary 
of evidence from qualitative observational studies. 
In our study, the highest morbidity and mortality associated with all-cause diarrhea 
and rotavirus-specific diarrhea was among infants aged 6–11 months. The risk of 
rotavirus infection was highest among infants and decreased in older children. 
Rotavirus was also associated with more severe dehydrating diarrhea than non-
rotavirus infection. These findings are consistent with other pre-rotavirus vaccine 
Reference
, Country, 
World 
Region 
Age of 
study 
subjects 
Study design Outcomes assessed Main findings 
(Colvin et 
al., 2013) 
sub-
Sahara 
Africa 
Children 
 < 5years 
Meta-analysis of 
literature reviews on 
qualitative data 
Qualitative evidence on the factors 
influencing household recognition and 
response to child diarrhea, pneumonia 
and malaria in sub-Saharan Africa 
Factors observed to influence household 
care seeking include: cultural beliefs and 
illness perceptions; perceived illness 
severity and efficacy of treatment; rural 
location, gender, household income and 
cost of treatment 
(Scott et 
al., 2014), 
Sierra 
Leone, 
west Africa 
Children 
 < 5years 
A rapid community-
based ethnographic 
assessment 
Qualitative factors associated influencing 
caretakers healthcare seeking patterns 
When a child becomes sick, households 
work within their geographic, social and 
financial context to seek care from sources 
including home treatment, herbalists, 
religious healers, drug peddlers and facility-
based providers. 
(Bedford & 
Sharkey, 
2014), 
Kenya, 
Nigeria 
and Niger, 
Sub-
Saharan 
Africa 
Children 
 < 5years 
Multi-country 
qualitative approach 
using thematic in-
depth interviews 
and FGDs of 
caretakers and 
health care service 
providers  
To determine the barriers caregivers face 
in accessing treatment for these 
conditions;  to identify local solutions that 
facilitate more timely access to 
treatment; and to present these findings 
as a platform from which to develop 
context-specific strategies to improve 
care-seeking for childhood illness 
Despite that, a national policy exists that 
provided free treatment  for children under 
5 years at any point of delivery in all 
government health facilities, caretakers 
claimed no knowledge about that, hence 
did not find that policy as motivator to 
seeking care. 
Belief in traditional medicine, unaffordable 
cost of treatment, frequent drug stock-outs, 
distance to health care facility 
(Cunnama 
& Honda, 
2016), 
South 
Africa 
Children  
< 5years  
Qualitative FGDs 
with mothers of 
children < 5 year, 
healthcare service 
providers, 
community 
members 
To qualitatively examine the beliefs 
surrounding and perceived quality of 
healthcare accessed for children's acute 
diarrhea 
Seeking healthcare from traditional 
practitioners was found to be deeply 
ingrained in the culture of the society. 
People’s beliefs about the causative agents 
of diarrhea are at the heart of seeking care 
from traditional practitioners, often in order 
to treat supposed supernatural causes. A 
combination of care-types is acceptable to 
the community, but not necessarily to 
modern practitioners, who are concerned 
about the inclusion of unknown ingredients 
and harmful substances in some traditional 
medicines, which could be toxic to children.  
(Langston 
et al., 
2014), 
Rwanda 
Children 
 < 5years 
Qualitative and 
quantitative analysis 
of Demographic and 
Health Surveys in 6 
districts in Rwanda 
To evaluate factors and strategies that 
can improve healthcare seeking 
Intensive supervised and monitoring of 
community Health Worker  peer support 
groups and community mobilization was 
observed to increase healthcare seeking 
significantly 
(Shaw et 
al., 2016), 
Ethiopia 
Children  
< 5years 
Qualitative using 
rapid ethnographic 
approach 
To elicit a country-wide perceptions and 
experiences of caregivers to better 
understand reasons for low utilization of 
the integrated community case 
management of childhood illness 
strategy by Health extension workers to 
treat children in rural health posts 
Although many mothers stated a 
preference for using the health post, they 
unable to do so due to objections or 
alternative care-seeking preferences of 
gatekeepers, often mothers-in-law and 
husbands 
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data from studies in sub-Saharan Africa, as well as other settings in Asia and South 
America—regions that are known to experience the highest diarrhea disease 
burdens in the world (Mohan et al., 2017; Kotloff et al., 2013; UNICEF, 2017).  
Our study found that before rotavirus vaccine introduction in Kenya, children 
under one year of age experienced the greatest burden of intussusception-
associated morbidity and mortality, and that the disease peaked at four to seven 
months of age. These findings are similar to observations from other settings in 
Africa showing intussusception peaks between three and nine months (Steele et al., 
2012; Ngendahayo et al., 2014) and a literature review of observational 
intussusception studies conducted in sub-Saharan Africa, which also found that the 
peak age for intussusception was 5–8 months (Mpabalwani et al., 2017). In 
addition, according to global estimates, two-thirds of intussusception cases occur 
among children under a year old with a peak age of five to seven months (Jiang et 
al., 2013). Intussusception without a history of vaccination has been shown to be 
rare in the first three months of life in Bangladesh (Zaman et al., 2009) and globally 
(Jiang et al., 2013); it has been reported to begin occurring between two and four 
months of age in sub-Saharan Africa (Mpabalwani et al., 2017).  
Knowledge of clinical symptoms associated with intussusception in a setting 
like Kenya is important to ensure awareness among caretakers of the need for 
prompt care seeking (Escolano et al., 2015) and can assist local healthcare 
professionals in prioritizing potential cases for urgent treatment or referral (Bines et 
al., 2004). Most observational studies conducted in Asia (Cui et al., 2016; Waseem 
& Rosenberg, 2008; Yousafzai et al., 2017; Yap Shiyi & Ganapathy, 2017), Europe 
(Huppertz et al., 2006), and sub-Saharan Africa (Carneiro & Kisusi, 2004) has 
shown that vomiting, abdominal pain, rectal bleeding, blood in stool, and 
abdominal mass and tenderness are the predominant traditional symptoms 
associated with childhood intussusception in almost all these areas (Waseem & 
Rosenberg, 2008; Klein et al., 2004). Consistent with these observations, our study 
showed that 71–92% of intussusception patients presented with at least one of the 
following: vomiting, diarrhea, blood in stool, and abdominal distension 
accompanied by fever. Taking into consideration that there are some existing 
arguments that these signs are mostly associated with late presentation of 
intussusception (Levinson et al., 2019), these findings—together with an observed 
average duration of three days from symptom onset to healthcare contact in our 
study—may also suggest late presentation. These findings may help explain 
frequent surgery through intestinal resection, as further observed in our study. 
Other research has also shown that symptoms lasting more than a day before 
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seeking care for intussusception are associated with increased likelihood of surgery, 
particularly intestinal resection (Meier et al., 1996; Ekenze et al., 2010; Carneiro & 
Kisusi, 2004; Kaiser et al., 2007).  
Although our study did not assess surgery outcomes, its use may be advisable 
when radiological reduction is contraindicated (DiFiore, 1999). However, despite 
its well-documented association with poor prognosis and increased mortality, 
surgery continues to be the most common method of intussusception management 
in sub-Saharan Africa (Jiang et al., 2013; Mpabalwani et al., 2017). On the other 
hand, recent studies from China (N. Liu et al., 2018) and elsewhere in Asia (Yap 
Shiyi & Ganapathy, 2017), where more than 70% of intussusception patients are 
managed through air enema, have reported a case-fatality rate close to 0%. 
Furthermore, a recent systematic literature review of global estimates showed that 
mortality in intussusception cases in sub-Saharan Africa continues to be higher at 1 
death per 10 hospital admissions than in the rest of the world, where it ranges from  
1 death per 100 to 1 death per 200 hospital admissions (Clark et al., 2019).  
 
6.3.2 Interpretation of the Findings 
Our household survey data indicated that a mother’s level of education has an 
important influence on the likelihood of a child’s being offered ORS at home and 
seeking care from a healthcare facility. A similar observation that children of 
mothers who lack education are 2.6 times more likely to die before their fifth 
birthday than children of mothers with secondary or higher education has recently 
been published (UNICEF, 2018). Furthermore, data presented in this thesis 
showed that infants accounted for; >70% of hospitalizations due to all-cause AGE, 
>60% of rotavirus infections among children with MSD, and >70% and >80% of 
all intussusception case-patients who were enrolled and died respectively. 
Moreover, infants with rotavirus associated MSD were twice more likely to be 
hospitalized than those with non-rotavirus MSD and tended to have more severe 
disease as measured by Vesikari scores. These findings reaffirm that infants are at 
increased risk of diarrhea and intussusception morbidity and associated mortality 
,and that their delay in seeking care from healthcare facilities can result in severe 
dehydration— the most critical life-threatening condition.(WHO, 2018a; KDHS, 
2010; WHO, 2013b). Furthermore, these findings reaffirm rotavirus as a leading 
pathogen associated with diarrheal disease leading to hospitalization among 
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children under five years old in Kenya as also observed from other similar settings 
before rotavirus vaccine introduction (WHO, 2005c; Kotloff et al., 2013; Mohan et 
al., 2017; WHO, 2013b). 
As confirmed by our data, the burden of acute diarrhea and rotavirus disease is 
usually high in low- and middle-income countries (Webb & Starr, 2005; WHO, 
2018b). In these enteric pathogen-endemic settings, infants receive passive 
protection from trans-placental and breast milk antibodies for the first six months 
of life (Walker et al., 2013). As this passive immunity wanes, the child’s first 
exposure to a rotavirus infection often results in severe disease. Subsequent 
infections are generally milder, and the illness is less likely to result in severe 
dehydration, admission to hospital, and death, according to data from recent 
studies conducted in countries with high disease burdens (Mohan et al., 2017; 
Kotloff et al., 2013). Our study finding that the case-fatality proportion among 
children hospitalized with rotavirus diarrhea was not significantly different from 
children with non-rotavirus diarrhea suggests that rotavirus diarrhea may not be 
associated with increased mortality in hospital-based studies, as described 
elsewhere (WHO, 2005c). This finding supports the assumption that prompt care 
seeking for rotavirus diarrhea from a healthcare facility enables access to 
appropriate rehydration, reducing the risk of death (WHO, 2005c).  
The reasons for some caretakers preferring use of antimicrobials instead of 
ORT for a child with diarrhea are complex, according to qualitative studies (see 
Table 20), and data that might answer the question are limited, so more research 
may be warranted. Furthermore, this practice may increase the cost and duration of 
treatment, contribute to treatment failure, and waste household and national 
resources, as observed from other quantitative data from Kenya (Sang et al., 2012; 
Beatty et al., 2009; F. Odhiambo et al., 2014). These observations suggest that more 
rigorous policies and strategies governing the use of antimicrobial drugs in Kenya 
for treatment of diarrhea diseases are urgently needed. 
The common use of intestinal resection for treatment of intussusception and its 
association with high case-fatality as observed in our current study may be related 
to the delay in seeking care and slow referral in Kenya (KMoH, 2014) . Such delay 
in presentation with intussusception increases the chance for bowel rupture, as 
commonly observed from excessive pressure (Mercer & Carpenter, 1982), limiting 
chances of reduction of the intussusception through non-operative procedure. 
Instead such delay necessitates surgery , particularly in infants who have higher risk 
of perforation as observed in our current study consistent with data from other 
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settings mainly from sub-Saharan Africa (Kincaid et al., 2004; Ekenze et al., 2010; 
Kruatrachue et al., 2011; Carneiro & Kisusi, 2004) 
It is worth noting that even studies in countries where case-fatality rates among 
children with intussusception remain below 1% have shown that success rates with 
non-operative treatment also decrease with increases in the amount of time from 
symptom onset to care seeking for appropriate intervention (Jenke et al., 2011; 
Carneiro & Kisusi, 2004; Kruatrachue et al., 2011). These observations suggest that 
prompt care seeking for childhood intussusception—as for diarrhea—may be a key 
factor in treatment outcome and child survival. 
In summary, the sub-optimal caretaker practices when their children had 
diarrhea and its associated consequences as demonstrated from data presented 
from these studies demonstrate that severe diarrhea are important problems during 
pre-rotavirus vaccine introduction era in Kenya and are mainly due to; poor 
recognition of danger signs and delay in presentation for appropriate management 
of these illnesses.  
6.4 Public Health Implications of the Research 
From the program perspective, our HUAS findings suggest that improving 
caretaker knowledge of home management of diarrhea could prevent progression 
of the illness and reduce severe adverse outcomes. Our findings also suggest that 
community education is needed to ensure that parents provide appropriate food 
and drink and  avoid unnecessary, unprescribed antimicrobials for children—
particularly infants—with diarrhea. Engaging complementary qualitative and 
quantitative research methods may be useful in generating data that could help 
reveal in greater detail the factors associated with caretakers’ low use of ORT and 
care-seeking patterns in this setting after vaccine introduction. Furthermore, 
creating awareness in parents and mobilization of healthcare workers and surgeons 
to recognize signs and symptoms of intussusception could help improve early care 
seeking and prompt decisions for appropriate referral for, diagnosis of, and 
treatment of intussusception in Kenya. Such efforts could lead to better outcomes, 
especially with possible frequent use of alternative non-operative approaches that 
have been shown to be associated with fewer or even no fatalities in other settings 
(Jiang et al., 2013; N. Liu et al., 2018). From the research perspective, the data 
presented from these studies could provide the basis for evaluating future national 
prevention and treatment guidelines for all-cause and rotavirus diarrhea and 
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intussusception among children under five years old in Kenya. Moreover, our study 
findings support the need for continued surveillance for both AGE- and rotavirus-
specific diarrhea to support measuring the impact of introducing the rotavirus 
vaccine in Kenya. The existing HDSS platforms, including rotavirus and 
intussusception disease surveillance networks in Kenya and other locations in sub-
Saharan Africa as described in this thesis, may present a rare opportunity for 
investigating the etiology of intussusception and post-vaccine introduction changes 
in the diarrhea landscape among children under five. Furthermore, similar 
platforms and surveillance networks could offer powerful data to appraise and 
prioritize future needs; they could even measure the impact of other vaccines, such 
those for norovirus and even Shigella, targeted at reducing further childhood enteric 
disease in such settings. 
Future strategies, policies, and interventions to reduce childhood diarrheal 
disease should take into consideration that the current generation of caretakers in 
Kenya (and perhaps similar settings) are not familiar with the critical importance of 
appropriate home management of diarrhea, especially for infants who may be at 
the highest risk of poor outcomes. Therefore, future research and intervention 
programs that target reductions in the morbidity and mortality associated with 
childhood diarrheal disease may need to step up efforts to address caretaker 
knowledge gaps around the lack of ORT use and poor recognition of the danger 
signs of severe disease. The studies presented in this thesis have demonstrated that 
estimates of the proportion of children with diarrheal disease for whom care was 
sought at the SHCs provide a basis for using a rate multiplier to adjust incidence 
rates to account for cases that may have been missed in the hospital surveillance 
methodology. This methodology could be applicable in future studies looking at 
the post-rotavirus vaccine disease burden to account for children not seeking care 
due to the inherent factors observed in our current study and those that may apply 
in other similar settings. Although it remains beyond the scope of our current 
studies, stool samples from our hospital-based surveillance offer the potential 
opportunity for analysis for additional pathogens in efforts to look for co-
infections and their contribution to rotavirus-associated disease including rotavirus 
genotype distribution. Similarly, future studies may be developed to assess 
nutritional constituents that limit or exacerbate disease. Moreover, given the recent 
advances in understanding the human microbiome, future studies may need to 
investigate its contribution to clinical outcome. Collectively, these mechanistic 
studies may also indicate which factors contribute to vaccine efficacy in Kenya.  
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Finally, the baseline data from studies presented in this thesis could be used to 
support evaluation of the impact and safety of rotavirus vaccine introduction in 
Kenya in several ways. For example, a comparison of the proportion of stool 
samples from our hospital-based surveillance system that are rotavirus-positive and 
the use of Vesikari score analysis from rotavirus cases before and after vaccine 
introduction could provide a better understanding of any possible short- or long-
term decline in rotavirus disease, changes in seasonality, and disease severity in 
Kenya, as demonstrated by Tate and colleagues (Tate, Patel et al., 2016). Moreover, 
regular census home visits and surveillance platforms as described in this thesis can 
provide opportunities to gather age-specific data on diarrhea, healthcare seeking, 
nutrition, and child survival variables that can be linked to vaccination data 
confirmed from either caregiver-held child health cards or hospital vaccination 
registers and causes of death ascertained by VA. Such a database could then be 
used to estimate trends in morbidity and vaccine impact on all-cause and rotavirus-
specific diarrhea before and after vaccine introduction, as further demonstrated 
elsewhere (WHO, 2008). Similarly, intussusception rates before and after rotavirus 
vaccine introduction could be evaluated as already described by Tate and 
colleagues (Tate, Yen et al., 2016), and the association between the vaccine and 
intussusception could also be assessed and monitored further using the case-series 
approach as further described (Tate & Parashar, 2019). 
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7 CONCLUSIONS 
Enteric viruses account for approximately 70% of episodes of acute infectious 
diarrhea in children under five worldwide. Rotavirus has been shown to be the 
leading cause of severe AGE before rotavirus vaccine introduction almost 
everywhere in the world. The work described in this thesis contributes to the 
understanding of the epidemiology and burden of diarrhea illness and provides 
baseline information on healthcare seeking, incidence, hospitalizations, and 
complications associated with all-cause and rotavirus-specific diarrhea and 
intussusception among children under five before rotavirus vaccine introduction in 
Kenya. 
The four main research questions we address in this thesis are as follows:  
1. What are the factors associated with (i) home management of childhood 
diarrhea and (ii) caretakers’ healthcare seeking for a child’s diarrheal illness 
among children under five from a healthcare facility located in a well-defined 
population? 
The results presented in this thesis demonstrate that caretakers’ perceptions and 
knowledge of diarrhea, including their educational level, may influence their 
decisions regarding management of and care-seeking behaviors for their child`s 
diarrheal illness. We also found that a child’s age, clinical presentation, severity of 
diarrhea episode, and mother’s education were all independent factors that 
influenced caretakers’ decisions on illness management options and seeking care 
outside the home at a healthcare facility.  
2. (i) What are the age-specific population-based incidence rates for 
hospitalization and death due to all-cause and rotavirus-specific diarrhea 
among children under five, and (ii) which age group has the highest incidence 
rates in a setting with a censused population? 
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Our results showed that adjusted population-based incidence rates for 
hospitalization and deaths due to AGE and RVAGE among children under five 
were high in the study setting. Our data showed that infants had the highest 
incidence rates for hospitalizations and death compared with children aged 12–23 
and 24–59 months. Most important, even among the infant age group, both 
hospitalization and death rates were highest in infants aged 6 to 11 months. 
3. What are the factors associated with (i) the risk of rotavirus infection and (ii) 
the severity of rotavirus disease among children under five seeking care for 
non-dysenteric MSD diarrhea from healthcare facility settings located within a 
population whose demographic characteristics are well defined?  
Our results showed that independent factors associated with rotavirus infection 
were age (with risk decreasing as age increases) and vomiting. Furthermore, 
hospitalizations were more commonly observed among MSD patients under a year 
old who were rotavirus-positive versus -negative and among all rotavirus-positive 
versus -negative, regardless of age—an observation that was not biased since the 
clinicians who admitted these children were blinded of their rotavirus infection 
status. Our study demonstrated that rotavirus MSD presented with significantly 
higher median GEMS-modified Vesikari scores than non-rotavirus MSD; it was 
further characterized by clinical presentation of vomiting and maximum number of 
stools within 24 hours, including treatment with IV fluid, which were all associated 
with rotavirus compared to non-rotavirus MSD when assessed using the GEMS 
modified Vesikari score system. 
4. What are the epidemiology and factors associated with death among 
intussusception patients under five treated at referral hospitals in Kenya before 
rotavirus vaccine introduction? 
Our results showed that common signs of intussusception included diarrhea, blood 
in stool, abdominal distension, and vomiting, which were reported in more than 
70% of intussusception cases treated at the 12 referral hospitals during the 2002–
2013 period. Compared with intussusception patients who survived those who died 
were more likely to be young infants, to have had care sought late after symptom 
onset, to have a history of fever on admission, and to have been treated through 
bowel surgery. 
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In summary, the results presented in this thesis demonstrate that before rotavirus 
vaccine introduction in Kenya, children and specifically infants aged six to eleven 
months had the greatest burden of AGE-, RVAGE-, and intussusception-
associated hospitalization and death. The findings of this thesis offer powerful 
support of the KMoH’s decision to introduce the rotavirus vaccine into the 
Kenyan public immunization program in July 2014, following the two-dose 
schedule at six and ten weeks of age as recommended by the WHO (WHO, 
2013b), before peak disease incidence in terms of age. While the benefits of 
rotavirus vaccines have been documented in other African countries like Ghana 
(Armah et al., 2016) and South Africa (Groome et al., 2014), the population-level 
benefits of these vaccines are yet to be demonstrated in Kenya. Furtermore, 
evaluation of the impact of interventions such as rotavirus vaccine using hospital-
based studies without a defined source population, as described recently by 
Wandera and colleagues (Wandera et al., 2018; Wandera et al., 2017), renders such 
findings limited in terms of their generalizability beyond the hospital study 
population. This dissertation has demonstrated that household surveys for diseases 
such as diarrhea, when complemented with active sentinel surveillance studies, can 
provide useful data to guide the interpretation of future changes in the 
epidemiology, seasonality, severity, risk factors, hospitalization, and mortality 
incidence rates associated with all-cause and rotavirus-specific diarrhea following 
rotavirus vaccine introduction in Kenya.  
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Abstract. We interviewed caretakers of 1,043 children < 5 years old in a baseline cross-sectional survey (April to
May 2007) and > 20,000 children on five separate subsequent occasions (May of 2009 to December 31, 2010) to assess
healthcare seeking patterns for diarrhea. Diarrhea prevalence during the preceding 2 weeks ranged from 26% at baseline
to 4–11% during 2009–2010. Caretakers were less likely to seek healthcare outside the home for infants (versus older
children) with diarrhea (adjusted odds ratio [aOR] = 0.33, confidence interval [CI] = 0.12–0.87). Caretakers of children
with reduced food intake (aOR = 3.42, CI = 1.37–8.53) and sunken eyes during their diarrheal episode were more likely
to seek care outside home (aOR = 4.76, CI = 1.13–8.89). Caretakers with formal education were more likely to pro-
vide oral rehydration solution (aOR = 3.01, CI = 1.41–6.42) and visit a healthcare facility (aOR = 3.32, CI = 1.56–7.07).
Studies calculating diarrheal incidence and healthcare seeking should account for seasonal trends. Improving caretakers’
knowledge of home management could prevent severe diarrhea.
INTRODUCTION
Diarrhea causes an estimated 1.87 million deaths among
children < 5 years old annually, representing ~19% of all
child deaths1; 78% of the deaths occur in Africa and Asia.1
Recognizing the potential for dehydrating diarrheal illness
to rapidly progress to death led to the introduction of oral
rehydration solutions as the cornerstone of life-saving treat-
ment in 1979.2 Early recognition of dehydration, home use
of oral rehydration solutions (ORSs), increased fluids and
continued feeding, promotion of breastfeeding, and timely
medical attention for children with dehydration and diarrhea
are important determinants for reducing childhood deaths
from diarrhea.3 Few studies have evaluated patterns of health-
care use and home rehydration for young children with diar-
rhea in Kenya.4–6 As part of a multicenter, case-control study
of acute diarrhea in children 0–59 months of age called the
Global Enteric Multicenter Study (GEMS),7 we conducted
a one-time comprehensive cross-sectional Healthcare Utili-
zation and Attitudes Survey (HUAS) in 2007 followed by
five additional abbreviated surveys from May of 2009 to
December 31, 2010. The surveys were administered to care-
takers of young children residing in western Kenya within
the Health and Demographic Surveillance System (HDSS)
area operated through collaboration between the Kenya
Medical Research Institute and US Centers for Disease
Control and Prevention (KEMRI/CDC). The baseline com-
prehensive HUAS was designed to estimate diarrhea preva-
lence and examine caretakers’ knowledge, attitudes, and
healthcare-seeking behaviors for children with diarrhea
before the GEMS case-control study. The abbreviated sur-
veys were carried out to provide additional information from
different seasons and over time.8 The HUAS-lite informa-
tion allows adjusted attributable fraction data for individual
pathogens and moderate-to-severe diarrhea (MSD) incidence
rates from sentinel health facilities to be extrapolated to the
entire HDSS population.9
METHODS ANDMATERIALS
Study area and study population. The KEMRI/CDC began
implementing the HDSS in western Kenya in 2001.10,11
The HUAS and the five abbreviated surveys (called HUAS-
lite surveys) were conducted in Asembo and Gem areas,
which are part of the HDSS study area, representing an area
of ~500 km2 and a population of ~135,000 persons (popu-
lation density ~300 persons/km2), about 50–65 km west of
Kisumu city (Figure 1). The altitude is about 1,100 m, aver-
age monthly temperature is 24.5°C, and annual rainfall is
1,358 mm.12 Rainy seasons generally occur in March to May
and October to November.10,11,13 Residents, predominantly
of the Luo ethnic group,14 earn their living through small-
scale business, farming, and fishing.15 The main source of
cooking fuel is firewood,12 and the main source for drink-
ing water is Lake Victoria, streams, and rivers.14 This region
reports the highest adult human immunodeficiency virus (HIV)
prevalence rates (approximately 15%) in Kenya.16,17 Malaria
transmission is high and holoendemic.10,18 In 2007, 20,853 chil-
dren < 5 years old (53% female) resided in 217 villages within
the Asembo and Gem HDSS areas.
Definitions. A resident of the HDSS area was defined as
a person who has lived in the HDSS area for at least 4 con-
secutive months or a newborn child of such a person.
Diarrhea was defined as more than or equal to three loose
stools within the previous 24 hours.
MSD was defined as diarrhea with one or more of the
following characteristics: sunken eyes, loss of skin turgor,
dysentery (blood in stool), receipt of intravenous rehydration,
or required hospitalization.
Less severe diarrhea (LSD) was defined as diarrhea with
absence of any characteristic of MSD (above).
*Address correspondence to Robert F. Breiman, Emory Global Health
Institute, Emory University, Atlanta, GA 30322. E-mail: rfbreiman@
emory.edu
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Other definitions for this study have been detailed elsewhere.8
Sample size considerations. HUAS. The sample size con-
siderations for the HUAS have been described elsewhere.8
HUAS-lite. The HUAS-lite aimed at enrolling the entire
population of caretakers of children < 5 years old regis-
tered as residents in the HDSS area during every round
(N ~20,000–22,000).
Sampling procedure. HUAS. From a sampling frame of
~20,853 children < 5 years old registered in HDSS at the
time of the survey, we sought to complete interviews with
a minimum of 333 caretakers of children in each of three
age strata: 0–11, 12–23, and 24–59 months old.
In total, 1,425 children were randomly selected to par-
ticipate in the HUAS. To ensure that sufficient numbers of
neonates < 1 month and children 1–4 months were repre-
sented, using the most updated census data collected
through the HDSS, we supplemented the sample with a list
of 100 pregnant mothers (collected from HDSS data from
the most recent round; i.e., January to April of 2007) and
130 randomly selected children 1–4 months old from the
most recently completed HDSS census round (January to
April of 2007). All other children were randomly selected
from the previous census round (September to December of
2006), including 230 children 5–11 months old, 370 children
12–23 months old, and 370 children 24–59 months old. To
account for an estimated 20% loss in enrollment because
of outmigration, death, and children being over age, we ran-
domly selected an additional 75 children per age stratum.
Among 1,425 children randomly selected, 553 children were
ages 0–11 months (125 neonates, 155 1- to 4-month old
children, and 255 5- to 11-month-old children), 445 chil-
dren were ages 12–23 months, and 445 children were ages
24–59 months. Children who had moved from their residence,
could not be traced, died, or were over age were replaced with
a child in the appropriate age group. There was no replace-
ment of children who had traveled (but still resided within
the HDSS), refused to participate, or were not available after
three attempts were made to contact their caretakers. In total,
1,298 caretakers were approached for interview (Figure 2A).
HUAS-lite. The KEMRI/CDC HDSS collects census and
surveillance data through house-to-house interviews by trained
staff on a regular basis through three rounds in each calen-
dar year (January to April, May to August, and September to
December).10 The HUAS-lites were conducted from May of
2009 to December 31, 2010 in conjunction with each of these
data collection rounds (Figure 2B).
Data collection. HUAS. The baseline survey was carried
out from April 25 to May 9, 2007 (the HUAS study period).
Trained community interviewers located the households and
interviewed the primary caretakers of the randomly selected
children. Reinterviews were carried out in 10% of households.
After obtaining caretaker’s written consent, community
interviewers administered to the caretakers of all selected
children a pre-tested questionnaire written in English and
translated into the local dialect (Dholuo). Through 65 ques-
tions (administered over 30 minutes if the child had diarrhea),
we collected information on demographics, child morbidity,
parents’ perception of illness and use of healthcare facilities,
diarrhea history during the past 2 weeks (including signs and
symptoms), home and health facility management of the
child’s diarrheal illness (including use of ORS), healthcare
use, healthcare expenses, attitudes to healthcare and diarrhea,
Figure 1. Location of the Asembo and Gem HDSS areas in western Kenya. The stars located in Asembo and Gem designate the locations
of the GEMS sentinel health facilities.
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Figure 2. (A) Study enrollment procedures for the cross-sectional HUAS of caretakers of children < 5 years old in western Kenya in 2007.
(B) Study enrollment procedures for the HUAS-lite among children < 5 years old in western Kenya from May 22, 2009 to December 31, 2010.
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and hypothetical use of enteric vaccines should they become
available. For children without diarrhea, the HUAS survey
took, on average, 10 minutes.
HUAS-lite. The HUAS-lite used a condensed version of
the HUAS questionnaire with 21 questions; the child’s pri-
mary caretaker was interviewed about information on demo-
graphics, the child’s diarrhea history, and healthcare use. The
first two questions screened caretakers to determine if that
person was the child’s primary caretaker and if the child
had an illness with diarrhea during the last 14 days. If the
child had diarrhea, then the additional HUAS-lite questions
were asked; if not, the HUAS-lite interview was complete.
For children with diarrhea, the HUAS-lite survey took, on
average, 10 minutes to administer.
Data management. HUAS. Data were recorded on opti-
cal character recognition-enabled forms. After manual accu-
racy checks, the forms were electronically transmitted from
KEMRI/CDC to the GEMSData Coordinating Center (DCC)
at the Perry Point Veterans Administration Hospital in
Maryland, where data were captured by DataFax software
(Clinical DataFax Systems Inc., Ontario, Canada). Cleaned
data were exported to an SAS dataset (SAS Institute Inc.,
Cary, NC).
HUAS-lite. The HUAS-lite survey form was developed
and deployed to a handheld device (Personal Digital Assis-
tant [PDA]; HTC Advantage X7500, HTC Corporation,
Taoyuan City, Taiwan) running on Windows mobile 6.5 plat-
form. The HUAS-lite questionnaire was developed and
deployed to the PDA using Visual Studio.net 2005 and
Microsoft SQL server 2005. For data quality, validation rules
were programmed to avoid inconsistent or out of range values;
repeat interviews were conducted in 3% of compounds per
village, and supervisory oversight was conducted on at least
2% of weekly interviews. Weekly data were downloaded in
the field to programmed netbooks, from which data inconsis-
tency checks were undertaken. Data cleaning was performed
using SAS version 9.2 (SAS Institute Inc., Cary, NC) on down-
load at the KEMRI/CDC HDSS data section. Data were
transmitted weekly to DCC through a web-based secure file
transfer protocol server, where additional data cleaning and
data validation were completed. Databases for each of the five
HUAS-lite surveys were exported to SAS datasets.
Statistical analysis. HUAS. We used c2 tests to examine
the association between the characteristics of the child and the
caretakers’ knowledge, attitude, and health-seeking behavior
(predictor factors) and any diarrhea, seeking care outside the
home, use of ORS at home, and seeking care from a health
facility (outcomes of interest). For all statistical tests, a two-
sided P < 0.05 was considered statistically significant. Unad-
justed odds ratios (ORs) and accompanying 95% confidence
intervals (CIs) were used to assess the strength of the asso-
ciations between categorical predictor factors and outcomes
of interest.
Logistic regression was used to model separately for each
outcome to evaluate the effect of specific variables and con-
trol for confounding. Variables with P £ 0.1 from the bivariate
c2 tests level were initially entered into the multivariable
models. We used a backward stepwise regression method to
arrive at our final models. All variables that were significant
at P < 0.05 remained in the models. Adjusted odds ratios
(aORs) for each variable are reported from the logistic
regression model, controlling for the other variables in the
model. The analyses were conducted taking stratification
and sample weighting into account. The weighting accounted
for child sex and age.
HUAS-lite. For each survey, we estimated the 2-week period
prevalence of any diarrhea, MSD, proportion of the diarrhea
group seeking care outside the home, and proportion of the
MSD group seeking care outside the home to one of the
designated GEMS case-control study sentinel health facili-
ties. Proportions and 95% CIs were calculated, controlling
for correlation at the compound level, because more than one
child may have been surveyed from the same compound. The
Cochran–Armitage test for trend was used to examine differ-
ences across rounds.19 Analyses were performed using SAS
statistical software version 9.2 (SAS Institute Inc, Cary, NC).
Scientific ethics. For the HUAS, written informed consent
was obtained in the local dialect from all participating care-
takers before interview. For the HUAS-lite, verbal consent
was sought as consent for data collection, because data col-
lection elements for the HUAS-lite were already approved
under the existing HDSS protocol (KEMRI Protocol #1801/
CDC Protocol #3308).
The study protocols for the HUAS and HUAS-lite were
reviewed and approved by the Scientific and Ethical Review
Committees of the KEMRI (KEMRI Protocol #1155) and
the Institutional Review Board (IRB) of the University of
Maryland, School of Medicine, Baltimore, MD (UMD Proto-
col #H-28327). The IRB for the CDC, Atlanta, GA, deferred
its review to the UMD IRB (CDC Protocol #5038).
RESULTS
Estimated prevalence for diarrhea in the HDSS from
the HUAS. Based on the weighted analysis, the estimated
prevalence of any diarrheal episode during the past 2 weeks
at baseline was 22.3% (CI = 19.5–25.0) among 20,853 children
living in the HDSS area at the time of the HUAS survey.
Diarrhea prevalence in the HDSS from the HUAS-lite.
The prevalence of reported diarrhea in the past 2 weeks
among children < 5 years old in the HDSS ranged from the
highest rate of 10.8% (May 22 to August 31, 2009) to the
lowest rate of 3.9% (September 14 to December 31, 2010)
(Table 1). Among children with diarrhea in the past 2 weeks
in the five rounds of the HUAS-lite, the proportion with
MSD ranged from 53% (September 15 to December 3, 2009)
to 58% (September 14 to December 31, 2010) (Figure 3).
HUAS study enrollment and background characteristics.
During the baseline HUAS, we successfully interviewed care-
takers of 1,043 children 0–59 months of age; 275 (26%) chil-
dren were reported to have had diarrhea during the 2 weeks
preceding the interview (Figure 2A). The children with
diarrhea included 112 (41%) infants, 108 (39%) toddlers
(12–23 months), and 55 (20%) children (24–59 months).
We used data on household asset ownership to rank
household wealth from poorest to wealthiest using five
quintiles. Overall, 34.3% of 1,043 respondents surveyed
lived in households within the two lowest wealth quintiles;
the highest proportion of children with diarrhea (33%) fell
within the poorest wealth quintile (Figure 4). Other char-
acteristics of the households of children with diarrhea in the
2 weeks preceding the study were similar to the character-
istics of all households interviewed (Table 2). Among care-
takers interviewed, 922 (88.4%) caretakers were mothers,
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65 (6.2%) caretakers were fathers, 33 (3.2%) caretakers were
grandmothers, and 23 (2.2%) caretakers were other relatives.
Caretakers knowledge, attitudes, and perceptions of illness
and health seeking. We asked caretakers what they would
look for to determine if a child is dehydrated; 716 (68.6%)
caretakers indicated that they would look for lethargy,
481 (46.1%) caretakers answered sunken eyes, 369 (35.4%)
caretakers answered wrinkled skin, 297 (28.5%) caretakers
answered dry mouth, and 297 (28.5%) caretakers answered
thirst. In total, 206 (19.8%) caretakers said that they would look
for both thirst and dry mouth to see if a child is dehydrated.
According to caretakers, the majority (86.2%) of 275 chil-
dren who had an episode of any diarrhea in the preceding
2 weeks had three to six loose stools per day. Reported
accompanying symptoms included lethargy (N = 225, 81.8%),
fever (N = 201, 73.1%), being very thirsty (N = 193, 70.7%),
mucus or pus in stool (N = 194, 70.6%), dry mouth (N =
188, 68.4%), rice watery stool (N = 163, 59.7%), sunken eyes
(N = 162, 58.9%), decreased urination (N = 102, 40.2%),
wrinkled skin (N = 92, 33.7%), vomiting (N = 89, 32.7%),
coma or loss of consciousness (N = 67, 24.6%), and blood
in stool (N = 34, 12.4%). Caretakers reported overall that
6.7% of children with diarrhea were hospitalized and that
6.6% received administered intravenous (IV) fluids for
rehydration; 47% of the children hospitalized with diarrhea
received IV fluids.
We asked caretakers what they offered their child to drink
and eat during the child’s diarrheal illness. Of 275 children
with diarrhea, 41 (15%) caretakers said they offered the child
more drink than usual, 51 (19%) caretakers reported offer-
ing the child the same amount, and 183 (67%) caretakers
reported that they offered less than usual to drink during
the child’s diarrheal episode. Of those caretakers who offered
less than usual, 96 (52%) children were offered somewhat
less, 69 (38%) children were offered much less, and 18 (10%)
children were offered nothing to drink during their diarrheal
illness. Of 269 caretakers who reported what they offered their
child to eat during their diarrheal episode, 3 (1%) caretakers
offered more than usual, 43 (16%) caretakers offered the usual
amount, and 223 (83%) caretakers stated that they offered less
than usual to eat. Of those caretakers who offered less than
usual, 74 (33%) caretakers offered somewhat less, 67 (30%)
caretakers offered much less, and 82 (37%) caretakers offered
nothing during the diarrheal illness. According to their care-
takers, 66 (37%) of 180 and 77 (35%) of 220 children who
were offered less than usual to drink and eat, respectively,
had vomiting accompanying their diarrheal illness.
Healthcare was sought outside the home for 214 (77.8%)
of 275 children with diarrhea. For any episode of diarrhea,
the places visited as the first source of healthcare outside
the home included licensed (62%) and unlicensed (11%)
providers and pharmacies (27%). Seeking care outside the
home was similar among caretakers of children with bloody
compared with non-bloody diarrhea (27 [79%] of 34 versus
187 [78%] of 241, P > 0.05) and more common among
caretakers of children who were very thirsty and had a dry
mouth compared with children who did not have both con-
ditions (142 [77%] of 184 versus 17 [46%] of 37, P < 0.05).
Of 61 caretakers who did not seek care outside their home
for their children with diarrhea, the main reasons that they
gave were that the child did not seem to need care (44.3%),
the cost of treatment was too high (32.8%), the clinic was
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too far from home (9.8%), and they were unable to find trans-
portation (8.2%).
The most common means of transportation to the nearest
health facility of choice was walking (74%) followed by
commercial transportation (which included riding on the
back of a bicycle; 13%) and personal transport (generally
a bicycle; 4%).
We asked caretakers how long it would usually take to
reach the health facility of choice; 770 (74%) of 1,035 respon-
dents estimated that it would usually take less than 1 hour.
The main circumstances that make it difficult for caretakers
to reach their nearest health facility of choice were that it
cost too much money (49%) followed by heavy rainfall or
flooding (45%) and lack of transportation (24%).
We asked caretakers about who makes the decision to
take the child to a health facility when sick; 809 (78%) of
1,041 respondents said that the child’s mother makes the
decision, whereas 232 (22%) said other relatives, including
the child’s father, make this decision. We asked all 1,043 care-
takers who participated in this survey if they think that vac-
cines are important to their child’s health; 99% said they think
that vaccines are important.
Risk factors for diarrheal illness. The weighted multivari-
ate analysis of risk factors for any diarrheal illness showed
that children ages < 12 months (30.5%, aOR = 2.19, CI =
1.50–3.21) and 12–23 months (31.4%, aOR = 2.24, CI =
1.53–3.30) compared with children ages 24–59 months (16.2%)
were at increased risk of having an episode of diarrhea
(regardless of severity) during the 2 weeks preceding the
survey (Table 3). Also, caretakers who knew of a child who
had died of bloody diarrhea (aOR = 2.30, CI = 1.50–3.54)
and who knew that bloody diarrhea is more dangerous than
other forms of diarrhea (aOR = 1.68, CI = 1.20–2.35) were
associated with the caretaker reporting that their child had
diarrhea in the 2 weeks preceding the survey (Table 3). The
latter findings may indicate that mothers who understand
how serious diarrhea can be may be more alert for it in their
children and thus, more likely to report it during a survey.
Predictors of seeking healthcare outside the home for any
diarrheal illness. On weighted multivariate analysis, seeking
healthcare outside the home for diarrheal illness was less
common for infants than children ages 24–59 months (aOR =
0.33, CI = 0.12–0.87) (Table 4). Caretakers who said lack
of transportation was the main factor preventing them from
reaching the health facility of their first choice were more
likely to seek care outside the home for any diarrhea com-
pared with caretakers who did not answer in this way (90.5%
versus 78.9%; aOR = 3.18, CI = 1.13–8.89). This result may
indicate that caretakers who have an expressed preference
for certain health facilities may be more willing to seek care,
perhaps because they are generally more informed. Care-
takers of children who had sunken eyes during their diarrheal
illness compared with caretakers of children who did not
have sunken eyes (92.2% versus 64.9%) sought care more
frequently outside the home (aOR = 4.76, CI = 2.12–10.70)
(Table 4).
Predictors of seeking healthcare from a health facility among
caretakers who sought care outside the home for any diarrheal
illness. On weighted multivariate analysis, seeking care from a
licensed health facility (versus a non-licensed health facility)
among those caretakers who sought care outside the home
for any diarrheal illness was significantly more common for
infants versus older children (aOR = 5.06, CI = 1.88–13.61),
Figure 3. Prevalence of MSD and LSD in the last 2 weeks among children < 5 years old by the HUAS-lite round from May 22, 2009 to
December 31, 2010, in western Kenya.
Figure 4. Wealth quintile ranking of caretakers of children < 5 years
old participating in the HUAS in western Kenya in 2007.
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when the caretaker had some formal education versus none
(aOR = 3.32, CI = 1.56–7.07), when caretakers thought that
bloody diarrhea could cause harm or death (aOR = 3.25,
CI = 1.16–9.09), when caretakers did not report circum-
stances that make it difficult to reach their preferred health
facility (aOR = 3.90, CI = 1.47–10.35), when the child was
lethargic during the diarrheal episode (aOR = 5.73, CI =
1.79–18.42), when the child had been offered ORS at home
(aOR = 6.99, CI = 3.01–16.22), and when the child was
offered no special (i.e., alternative) remedies at home (aOR =
10.17, CI = 2.84–36.37). The latter may possibly be indicative
of caretakers’ higher education, which was also a predictor of
seeking care at a health facility (aOR = 3.32, CI = 1.56–7.07).
Caretakers who did not report looking for thirst as a sign of
dehydration were less likely to seek care from a health facility
for their child’s diarrheal illness (aOR = 0.21, CI = 0.09–0.47)
(Table 5).
Factors associated with ORS use among children with any
diarrhea. Most (89.5%) caretakers indicated that ORSs
works well to treat diarrhea. However, only 63 (22.9%) of
275 children with any diarrhea, regardless of severity, were
offered ORS at home according to their caretakers. A higher
proportion of children with MSD (46 of 182, 25.3%) com-
pared with LSD (17 of 93, 18.3%) were offered ORS at home
(P > 0.05).
We examined factors associated with the use of ORSs at
home for the child’s diarrheal illness (Table 6). In the multi-
variate weighted analysis, caretakers were less likely to use
ORSs at home for infants versus older children (aOR = 0.35,
CI = 0.14–0.89). They were more likely to use ORSs at home
if the primary caretaker had some formal education versus
none (aOR = 3.01, CI = 1.41–6.42), if the caretaker perceived
that dehydration could result in harm or death (aOR = 5.54,
CI = 2.23–13.73), if the child had vomiting three or more
times per day during the diarrheal episode (aOR = 3.33,
CI = 1.56–7.11), if the caretaker knew of a child who died
of bloody diarrhea (aOR = 2.73, CI = 1.20–6.20), if the
child was offered the usual amount to eat or less than usual
during their diarrheal episode (aOR = 8.24, CI = 1.80–37.73),
and if the caretaker believed that breastfeeding prevents
diarrheal illness (aOR = 16.19, CI = 1.32–199.21).
Estimated care seeking for diarrhea in the HDSS from the
HUAS and HUAS-lite. Our weighted analysis estimated that
caretakers of 81.5% (CI = 76.5–86.4) of children in the HDSS
with any diarrheal episode in the past 2 weeks sought care
outside the home. In general, care was sought from licensed
Table 2
Description of the population surveyed in the HUAS study population in western Kenya in 2007 (unweighted analysis; N = 1,043)
Characteristic
Interviewed
caretakers (N = 1,043)
Interviewed caretakers of children
with diarrhea in preceding 2 weeks (N = 275)
n/N Percent n/N Percent
Child’s age stratum (months)
0–11 366 35 112 41
12–23 340 33 108 39
24–59 337 32 55 20
Child’s sex: female 501 48 118 43
Primary caretaker of the child interviewed was a parent 987 95 266 97
Child’s mother lives in household 1,016 97 271 99
Child’s father lives in household 731 70 194 71
Child’s primary caretaker completed primary school or above 549 53 131 48
Median no. (IQR) of people living in house for past 6 months 5 (4–7) 5 (4–7)
Median no. (IQR) of rooms in house for sleeping 2 (1–2) 2 (1–2)
Median no. (IQR) of children ages < 60 months living in house 2 (1–2) 2 (1–2)
IQR = interquartile range.
Table 3
Independent predictors of any diarrheal illness among children < 5 years old in the HUAS in western Kenya in 2007 (weighted analysis; N = 1,043)
Variable*
Any diarrhea
Unadjusted OR
(95% CI) aOR† (95% CI)n/N Weighted (%)
Child’s age group (months)
0–11 112/366 30.5 2.27 (1.57–3.27) 2.19 (1.50–3.21)
12–23 108/340 31.4 2.37 (1.63–3.46) 2.24 (1.53–3.30)
24–59 55/337 16.2 Reference Reference
Child’s sex
Male 157/542 24.7 1.32 (0.96–1.83) 1.24 (0.88–1.75)
Female 118/501 19.8
Caretaker knows a child who died of bloody diarrhea
Yes 63/185 33.0 1.99 (1.34–2.97) 2.30 (1.50–3.54)
No 207/843 19.8
Caretaker thinks bloody diarrhea is more dangerous than
simple loose watery and cholera-like diarrhea
Yes 159/526 26.7 1.67 (1.21–2.31) 1.68 (1.20–2.35)
No 114/514 17.9
Caretaker knows ways to prevent bloody diarrhea
Yes 102/458 17.6 0.60 (0.43–0.83) 0.57 (0.41–0.81)
No 173/585 26.4
*Based on the inclusion criteria, 22 variables were initially included in the model; results are shown for the significant variables controlling for age and sex.
†aORs, where all ORs control for other factors in the model.
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providers (57.6%, CI = 49.9–65.5), unlicensed providers (12.5%,
CI = 7.2–17.7), and pharmacies (29.9%, CI = 22.5–37.3).
Among children with reported diarrhea specifically in the
HUAS-lite, 82.0% of those children with MSD (95% CI =
80.6–83.4) received care outside the home versus 67.3%
(95% CI = 65.4–69.2) of children with LSD (when averaged
over the five surveys) (Table 1).
Care seeking for moderate-to-severe diarrhea in the HDSS
from the HUAS-lite. Among those caretakers seeking care
for MSD in the HUAS-lite, 61.9% (95% CI = 59.9–63.9)
sought care from a health facility; 35.4% (95% CI = 32.8–37.9)
of MSD cases seeking care at a health facility specifically vis-
ited one of the GEMS case-control study sentinel healthcare
facilities (Table 1). Of note, there were no significant differ-
ences in the proportions of caretakers who sought care at
GEMS case-control study sentinel health facilities for MSD
(586/1657, 35.4%) or LSD (293/929, 31.5%) over the course
of the five rounds (P = 0.496 for MSD; P = 0.369 for LSD).
DISCUSSION
Our study found that the 2-week period prevalence of
diarrhea was 26% at the baseline HUAS and decreased over
the five HUAS-lite surveys of caretakers of all children in
the HDSS from 11% to 4% between 2009 and 2010. The
key findings of our surveys were that less than one-half of
children with diarrheal disease receive care at a licensed
healthcare facility and that substantial proportions of chil-
dren with diarrhea are given less food and drink than normal
and are not offered ORS. Health use surveys can be helpful
in extrapolating burden data from surveillance studies, like
GEMS, which use sentinel hospitals to capture patients.
Because GEMS calculates population-based incidence of diar-
rheal disease and its specific attributed etiologies, having reli-
able estimates on the proportion of children with diarrheal
disease who are seen at the sentinel study clinics provides a
basis for using a multiplier to adjust incidence rates to account
for what was missed because of the surveillance methodology.9
These surveys also provide guides to direct interventions
to reduce the public health impact of diarrheal disease. For
example, our survey documents that ORSs are underused
in Kenya,20–23 similar to other locations in Africa.21,24 Find-
ings from this study and others20–24 can provide an impetus
for raising community and clinician awareness and parental
demand for ORSs, an inexpensive remedy that has been esti-
mated to save over 1.5 million children’s lives per year.3,25
Community education is also needed to ensure that parents
continue to feed and provide increased drink to children,
particularly infants, with diarrhea. Failure to do so may hasten
severe dehydration and death from diarrheal disease.
In developing countries, diarrhea is often inadequately man-
aged at home,24 and delays in seeking care for moderate to
severe pediatric diarrheal illness are common in Kenya,
leading to poor outcomes.26 Strategies, policies, and inter-
ventions to reduce childhood diarrheal disease should take
into consideration that the caretakers in Kenya (and pos-
sibly, in similar settings) are not familiar with the critical
importance of appropriate home management of diarrhea,
especially for infants who may be at highest risk of poor out-
comes. A concerning observation from the HUAS is that
85.5% of caretakers of children with diarrhea, regardless of
severity, knew that ORSs work well to treat diarrhea but only
Table 4
Independent predictors of seeking care outside the home for children < 5 years old with any diarrhea in the HUAS in western Kenya in 2007
(weighted analysis; N = 275)
Variable*
Sought care outside home for
any diarrhea
Unadjusted OR
(95% CI) aOR† (95% CI)n/N Weighted (%)
Child’s age group (months)
0–11 76/112 67.7 0.31 (0.13–0.76) 0.33 (0.12–0.87)
12–23 90/108 84.3 0.80 (0.31–2.07) 0.72 (0.26–1.97)
24–59 48/55 87.1 Reference Reference
Child’s sex
Male 123/157 81.9 1.06 (0.54–2.09) 1.27 (0.57–2.81)
Female 91/118 80.9
Lack of transportation makes it difficult for
caretakers to reach their health center of first choice
Yes 51/59 90.5 2.55 (1.09–5.99) 3.18 (1.13–8.89)
No 163/216 78.9
Sunken eyes as a symptom that the child presented
with during the diarrheal illness
Yes 145/162 92.2 6.38 (3.10–13.16) 4.76 (2.12–10.70)
No 69/113 64.9
Antibiotic offered to the child at home during
diarrheal illness
Yes 38/43 93.3 3.65 (1.34–9.97) 3.41 (1.07–10.82)
No 176/232 79.2
Feeding practices at home during diarrheal illness
Offered less than usual to eat 189/223 86.5 4.57 (2.06–10.13) 3.42 (1.37–8.53)
Offered usual or more than usual to eat 23/46 58.3
Caretaker thinks that medication is the best way
to prevent any diarrheal illness
Yes 41/48 90.5 2.44 (0.99–6.00) 3.51 (1.27–9.72)
No 173/227 79.6
*Based on the inclusion criteria, 16 variables were initially included in the model; results are shown for the significant variables controlling for age and sex.
†aORs, where all ORs control for other factors in the model.
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22.9% of caretakers in practice offered their child ORSs at
home during an episode. This finding, coupled with the find-
ing that caretakers in the study population substantially
decrease both fluid and food intake for their children during
diarrheal illness, is worrisome and contrary to World Health
Organization recommendations.3 Such findings have also been
reported recently in a number of studies in rural and urban
Kenya, and they are consistent with global trends in reduc-
tions in ORS use and the practice of decreasing the amount
of fluid given to children during their diarrheal illness.21,24
Such inappropriate home management may have been a
factor in the finding that caretakers were less likely to seek
healthcare outside the home for infants with diarrhea, but
among those caretakers who did seek healthcare, the loca-
tion was most commonly a health facility. Furthermore, the
finding that caretakers were significantly more likely to seek
care when their ill child had lethargy, may represent inade-
quate home management of diarrheal illness as lethargy may
have been a proxy for late presentation of infants to health
facilities in a critical life threatening condition. Early home
management may have avoided such situations.
Almost three-quarters of caretakers said that they usually
walk the health facility of choice, and 74% of caretakers
reported that it takes less than 1 hour to get to their health
facility of choice. Moreover, the main reason that caretakers
gave for not seeking care outside the home was that children
did not seem to need care, which corroborates poor recog-
nition of disease severity in children. Overprescription of
antibiotics by clinicians and inappropriate use of antibiotics
at home before seeking care have previously been reported
in the study area and are responsible for the emergence of
antimicrobial-resistant strains of enteric bacteria.26–28 In the
HUAS, we found that 14% of children who reached a health
facility had already been offered unprescribed antibiotics
administered by the caretaker, which is consistent with pre-
vious observations.27 In recent qualitative studies in the area,
caretakers reported a preference to using Western antimicro-
bial and antimotility drugs over fluid-based medicines, which
are not as effective in stopping diarrhea.20 Empowering care-
givers to be comfortable giving ORSs and know to continue
feeding by educational messages and campaigns and increas-
ing community ORS availability are essential to improving
diarrhea management.22 Caretakers’ knowledge of a child
who had died of bloody diarrhea and their awareness that
bloody diarrhea may be more dangerous than other forms
of diarrhea were associated with the caretaker reporting that
the child had diarrhea in the 2 weeks preceding the HUAS
survey. This result could suggest that caretakers who are
better informed on the potentially serious nature of diarrhea
may be more astute in recognizing an episode of diarrhea
among their young children. Caretakers were more likely
to seek care in the HUAS if they reported that they never
endure circumstances that make it difficult to reach their health
facility of choice. This result may suggest that these particular
Table 5
Independent predictors of seeking care from a health facility among children < 5 years old with any diarrhea in the HUAS in western Kenya
in 2007 (weighted analysis; N = 214)
Variable*
Sought care for any diarrhea
at a health facility
Unadjusted OR
(95% CI) aOR† (95% CI)n/N Weighted (%)
Child’s age group (months)
0–11 53/76 69.7 2.30 (1.08–4.93) 5.06 (1.88–13.61)
12–23 46/90 51.8 1.08 (0.52–2.22) 1.35 (0.57–3.21)
24–59 24/48 49.98 Reference Reference
Child’s sex
Male 77/123 54.7 1.03 (0.59–1.80) 0.65 (0.32–1.34)
Female 46/91 54.5
Caretaker’s education
More than primary school (some formal education) 67/104 65.1 2.35 (1.25–4.44) 3.32 (1.56–7.07)
Less than primary school (no formal education) 56/110 44.2
Caretaker looks to see if the child is thirsty to
assess dehydration
Yes 34/65 43.3 0.52 (0.27–1.03) 0.21 (0.09–0.47)
No 89/149 59.4
Caretaker perceives that blood in stool can cause harm
or death to the child
Yes 112/186 57.9 2.95 (1.15–7.60) 3.25 (1.16–9.09)
No 11/28 31.8
Caretaker never endures circumstances that make it
difficult to reach the health facility of choice
Yes 32/42 69.7 2.25 (0.93–5.44) 3.90 (1.47–10.35)
No 91/172 50.6
Lethargy as a symptom during diarrheal illness
Yes 112/185 57.6 2.41 (0.92–6.30) 5.73 (1.79–18.42)
No 11/29 36.1
Child was offered ORSs at home for diarrheal illness
Yes 43/56 75.5 3.50 (1.57–7.84) 6.99 (3.01–16.22)
No 80/158 46.8
Child was offered no special remedies at home for
diarrheal illness
Yes 22/27 79.1 3.73 (1.17–11.86) 10.17 (2.84–36.37)
No 101/187 50.4
*Based on the inclusion criteria, 14 variables were initially included in the model; results are shown for the significant variables controlling for age and sex.
†aORs, where all ORs control for other factors in the model.
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caretakers have little or no circumstantial barriers (such as cost,
flooding, or lack of transportation) to seeking care for their
child’s diarrhea.
Our study is subject to biases, because we depended on
caretakers’ recall of the occurrence of the child’s diarrheal
episode over the previous 2 weeks; also, we assumed that
caretakers were familiar with signs and symptoms of diarrhea,
such as sunken eyes, wrinkled skin, and dehydration, to clas-
sify diarrhea as MSD or LSD. Qualitative behavioral research
among caretakers of young children coupled with the HUAS
and HUAS-lite surveys would have aided in interpretation of
the reasons for the lack of appropriate home management and
beliefs related to seeking care. Although diarrhea among young
children occurred frequently, it seemed to differ in this com-
munity at the time of the one-time cross-sectional HUAS sur-
vey (26%) compared with the five HUAS-lite surveys (4–11%).
Data were collected from a sample of 1,425 children in the
HDSS population in 2007 and the entire population of
approximately 21,000 children during five census rounds
from May of 2009 to December of 2010; thus, the HUAS-lite
estimates are likely more precise estimates of diarrhea preva-
lence, because we captured the whole HDSS population and
not just a random sample as in the HUAS cross-sectional
survey. The difference in prevalence between the baseline and
census rounds may also be a consequence of the differences
in methods used between the baseline HUAS and the sub-
sequent five surveys. The baseline survey was a cross-sectional
survey conducted at a single point in time (during a rainy
season) among a randomly selected subset of children in the
HDSS; in contrast, in the HUAS-lite, which was conducted
in the entire HDSS population, we approached all children in
the HDSS for interview over a much longer period for each
of the five surveys. In addition, there may have been differ-
ences in caregivers recall between the two surveys or inter-
viewer bias, because different teams administered the HUAS
and HUAS-lite. However, declines in diarrhea have also
been noted in HDSS surveillance over the last few years
(KEMRI/CDC, unpublished data) as coincident with hygiene
and in-home water treatment promotion, increased use of
ORSs, and seeking treatment of diarrhea at a health facility
among HDSS residents.29 The proportion of childhood diarrhea
episodes classified as MSD remained consistently between
50% and 60% when captured over the course of the five
rounds of the HUAS-lite surveys. Given the findings from the
HUAS-lite surveys that were carried out to assess seasonal
trends in diarrhea prevalence and healthcare seeking, it is
important that future studies calculating diarrheal incidence
account for seasonality. The data collected onMSD prevalence
and healthcare seeking from GEMS sentinel health facilities in
the five HUAS-lite surveys will be used to extrapolate incidence
Table 6
Independent factors associated with use of ORSs at home among children < 5 years old with any diarrhea in the HUAS in western Kenya in 2007
(weighted analysis; N = 275)
Variable*
Reported ORS use at home
for child’s diarrheal illness
Unadjusted OR
(95% CI) aOR† (95% CI)n/N Weighted (%)
Child’s age group (months)
0–11 20/112 17.7 0.53 (0.25–1.14) 0.35 (0.14–0.89)
12–23 27/108 23.7 0.77 (0.37–1.61) 0.85 (0.35–2.06)
24–59 16/55 28.9 Reference Reference
Child’s sex
Male 41/157 29.0 1.78 (0.90–3.53) 1.64 (0.78–3.48)
Female 22/118 18.7
Caretaker’s education
More than primary school (some formal education) 36/131 30.6 1.92 (0.99–3.70) 3.01 (1.41–6.42)
Less than primary school (no formal education) 27/144 18.7
Caretaker perceives that diarrhea with vomiting can
result in harm to or death of child
Yes 48/218 21.8 0.48 (0.22–1.01) 0.10 (0.03–0.32)
No 15/57 36.9
Caretaker perceives that presence of dehydration can
result in harm to or death of child
Yes 43/160 29.0 1.86 (0.94–3.71) 5.54 (2.23–13.73)
No 20/115 18.0
Child has vomiting three or more times per day during
diarrheal episode
Yes 32/89 35.2 2.19 (1.12–4.32) 3.33 (1.56–7.11)
No 31/183 19.9
Caretaker knows a child who died of bloody diarrhea
Yes 21/63 32.6 1.86 (0.89–3.88) 2.73 (1.20–6.20)
No 40/207 20.7
Feeding practices at home during diarrheal illness
Offered usual/less than usual to eat 59/223 28.1 5.10 (1.70–15.31)‡ 8.24 (1.80–37.73)
Offered more than usual to eat 4/46 7.1
Caretaker believes that breastfeeding prevents childhood
diarrheal illness
Yes 3/5 69.6 7.38§ 16.19 (1.32–199.21)
No 60/270 23.7
*Based on the inclusion criteria, 17 variables were initially included in the model; results are shown for the significant variables controlling for age and sex.
†aORs, where all ORs control for other factors in the model.
‡Exact Pearson c2 P value is 0.0076.
§Exact Pearson c2 P value is 0.081. CI for OR is not presented because of small cell sizes.
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rates from GEMS surveillance for MSD in Kenya, which was
conducted during the same time period in sentinel health facil-
ities within the same geographic area.
Received December 13, 2012. Accepted for publication March 3, 2013.
Published online April 29, 2013.
Acknowledgments: This study includes data generated by the Kenya
Medical Research Institute/Centers for Disease Control and Preven-
tion (KEMRI/CDC) Health and Demographic Surveillance System
(HDSS), which is a member of the International Network for the
Demographic Evaluation of Populations and their Health (INDEPTH).
We acknowledge the contributions of and thank the KEMRI/CDC
HDSS team, especially the late Dr. Kubaje Adazu (1961–2009); the
Global Enteric Multicenter Study (GEMS) Kenya staff for support-
ing the data collection and processing; Salome Omondi, Caleb Okonji,
Alex Ondeng, Peter Jaron, Maquins Sewe, Onyango Emmanuel, and
Gordon Orwa at the KEMRI/CDC, Kisumu, Kenya; John Crump,
Elizabeth Blanton, and Kavita Trivedi at the CDC, Atlanta, GA;
Daniel Feikin at the Johns Hopkins Bloomberg School of Public
Health and Centers for Disease Control and Prevention, Baltimore,
MD; the GEMS Data Coordinating Center, Perry Point Veterans
Administration Medical Center, Perry Point, MD; and Dilruba Nasrin,
University of Maryland, School of Medicine, Center for Vaccine
Development, Baltimore, MD. We are grateful to the caretakers in
the Asembo and Gem community who participated in this work. This
manuscript is published with the approval of the director of KEMRI.
Financial support: This study was funded by the Bill and Melinda
Gates Foundation through the University of Maryland, School of
Medicine, Center for Vaccine Development, Baltimore, MD (M.M.L.,
Principle Investigator).
Disclaimer: The findings and conclusions in this report are the findings
and conclusions of the authors and do not necessarily represent the
official position of the US Centers for Disease Control and Prevention.
Authors’ addresses: Richard Omore, John Williamson, Fenny Moke,
Vincent Were, David Obor, Frank Odhiambo, and Kayla F. Laserson,
Kenya Medical Research Institute/Centers for Disease Control and
Prevention Research and Public Health Collaboration, Kisian Campus,
Kisumu, Kenya, E-mails: romore@kemricdc.org, jwilliamson@ke.cdc
.gov, fmoke@kemricdc.org, vwere@kemricdc.org, dobor@kemricdc.org,
fodhiambo@ke.cdc.gov, and Klaserson@ke.cdc.gov. Ciara E. O’Reilly
and Eric D. Mintz, Division of Foodborne, Waterborne, and Environ-
mental Diseases, Centers for Disease Control and Prevention, Atlanta,
GA, E-mails: bwf1@cdc.gov and edm1@cdc.gov. Tamer H. Farag,
Karen L. Kotloff, and Myron M. Levine, Center for Vaccine Devel-
opment, University of Maryland School of Medicine, Baltimore,
MD, E-mails: tfarag@medicine.umaryland.edu, Kkotloff@medicine
.umaryland.edu, and mlevine@medicine.umaryland.edu. Anna Maria
van Eijk, Liverpool School of Tropical Medicine, Liverpool, Merseyside,
United Kingdom, E-mail: amvaneijk@yahoo.com. John Vulule,
Centre for Global Health Research, Kenya Medical Research Insti-
tute, Kisumu, Kenya, E-mail: jvulule@kisian.mimcom.net. Robert
F. Breiman, Emory Global Health Institute, Emory University,
Atlanta, GA, E-mail: rfbreiman@emory.edu.
REFERENCES
1. Boschi-Pinto C, Velebit L, Shibuya K, 2008. Estimating child
mortality due to diarrhoea in developing countries. Bull World
Health Organ 86: 710–717.
2. Nalin DR, Levine MM, Hornick RB, Bergquist EJ, Hoover D,
Holley HP, Waterman D, VanBlerk J, Matheny S, Sotman S,
Rennels M, 1979. The problem of emesis during oral glucose-
electrolytes therapy given from the onset of severe cholera.
Trans R Soc Trop Med Hyg 73: 10–14.
3. World Health Organization (WHO), 2006. Implementing the New
Recommendations on the Clinical Management of Diarrhoea.
Geneva: World Health Organization.
4. Burton DC, Flannery B, Onyango B, Larson C, Alaii J, Zhang X,
Hamel MJ, Breiman RF, Feikin DR, 2011. Healthcare-seeking
behaviour for common infectious disease-related illnesses in
rural Kenya: a community-based house-to-house survey. J Health
Popul Nutr 29: 61–70.
5. Bigogo G, Audi A, Aura B, Aol G, Breiman RF, Feikin DR, 2011.
Health-seeking patterns among participants of population-
based morbidity surveillance in rural western Kenya: implica-
tions for calculating disease rates. Int J Infect Dis 14: e967–e973.
6. Breiman RF, Olack B, Shultz A, Roder S, Kimani K, Feikin DR,
Burke H, 2011. Healthcare-use for major infectious disease syn-
dromes in an informal settlement in Nairobi, Kenya. J Health
Popul Nutr 29: 123–133.
7. Levine MM, Kotloff KL, Nataro JP, Muhsen K, 2012. The
Global Enteric Multicenter Study (GEMS): impetus, ratio-
nale, and genesis. Clin Infect Dis 55 (Suppl 4): S215–S224.
8. Nasrin D, Wu Y, Blackwelder WC, Farag TH, Saha D, Sow
SO, Alfonso PL, Breiman RF, Sur D, Faruque ASG, Zaidi
AKM, Biswas K, van Eijk AM, Walker DG, Levine MM,
Kotlof KL, 2013. Health care-seeking for childhood diarrhea
in developing countries: evidence from seven sites in Africa
and Asia. Am J Trop Med Hyg 89 (Suppl): 3–12.
9. Blackwelder WC, Biswas K, Wu Y, Kotloff KL, Farag TH,
Nasrin D, Graubard BI, Sommerfelt H, Levine MM, 2012.
Statistical methods in the Global Enteric Multicenter Study
(GEMS). Clin Infect Dis 55 (Suppl 4): S246–S253.
10. Adazu K, Lindblade KA, Rosen DH, Odhiambo F, Ofware P,
Kwach J, Van Eijk AM, Decock KM, Amornkul P, Karanja D,
Vulule JM, Slutsker L, 2005. Health and demographic surveil-
lance in rural western Kenya: a platform for evaluating inter-
ventions to reduce morbidity and mortality from infectious
diseases. Am J Trop Med Hyg 73: 1151–1158.
11. Odhiambo FO, Laserson KF, Sewe M, Hamel MJ, Feikin DR,
Adazu K, Ogwang S, Obor D, Amek N, Bayoh N, Ombok
M, Lindblade K, Desai M, Ter Kuile F, Phillips-Howard P,
van Eijk AM, Rosen D, Hightower A, Ofware P, Muttai H,
Nahlen B, Decock K, Slutsker L, Breiman RF, Vulule JM, 2012.
Profile: the KEMRI/CDC Health and Demographic Surveil-
lance System–western Kenya. Int J Epidemiol 41: 977–987.
12. Feikin DR, Nguyen LM, Adazu K, Ombok M, Audi A, Slutsker
L, Lindblade KA, 2009. The impact of distance of residence
from a peripheral health facility on pediatric health utilisation
in rural western Kenya. Trop Med Int Health 14: 54–61.
13. Feikin DR, Olack B, Bigogo GM, Audi A, Cosmas L, Aura B,
Burke H, Njenga MK, Williamson J, Breiman RF, 2011. The
burden of common infectious disease syndromes at the clinic
and household level from population-based surveillance in
rural and urban Kenya. PLoS One 6: e16085.
14. Hawley WA, ter Kuile FO, Steketee RS, Nahlen BL, Terlouw DJ,
Gimnig JE, Shi YP, Vulule JM, Alaii JA, Hightower AW,
Kolczak MS, Kariuki SK, Phillips-Howard PA, 2003. Implica-
tions of the western Kenya permethrin-treated bed net study
for policy, program implementation, and future research. Am J
Trop Med Hyg 68: 168–173.
15. Lindblade KA, Eisele TP, Gimnig JE, Alaii JA, Odhiambo F,
ter Kuile FO, Hawley WA, Wannemuehler KA, Phillips-
Howard PA, Rosen DH, Nahlen BL, Terlouw DJ, Adazu K,
Vulule JM, Slutsker L, 2004. Sustainability of reductions in
malaria transmission and infant mortality in western Kenya
with use of insecticide-treated bednets: 4 to 6 years of follow-up.
JAMA 291: 2571–2580.
16. Amornkul PN, Vandenhoudt H, Nasokho P, Odhiambo F,
Mwaengo D, Hightower A, Buve A, Misore A, Vulule J,
Vitek C, Glynn J, Greenberg A, Slutsker L, De Cock KM, 2009.
HIV prevalence and associated risk factors among individuals
aged 13–34 years in rural western Kenya. PLoS One 4: e6470.
17. National AIDS and STI Control Program (NASCOP), 2007.Kenya
AIDS Indicator Survey, 2007. Nairobi, Kenya: Ministry of Medi-
cal Services and Ministry of Public Health and Sanitation.
18. Gatei W, Kariuki S, Hawley W, ter Kuile F, Terlouw D, Phillips-
Howard P, Nahlen B, Gimnig J, Lindblade K, Walker E,
Hamel M, Crawford S, Williamson J, Slutsker L, Shi YP, 2010.
Effects of transmission reduction by insecticide-treated bed
nets (ITNs) on parasite genetics population structure: I. The
genetic diversity of Plasmodium falciparum parasites by micro-
satellite markers in western Kenya.Malar J 9: 353.
19. Armitage P, 1955. Tests for linear trends in proportions and
frequencies. Biometrics 11: 375–386.
HEALTH SEEKING FOR CHILDHOOD DIARRHEA IN KENYA 39
20. Blum LS, Oria PA, Olson CK, Breiman RF, Ram PK, 2011.
Examining the use of oral rehydration salts and other oral
rehydration therapy for childhood diarrhea in Kenya. Am J
Trop Med Hyg 85: 1126–1133.
21. Ram PK, Choi M, Blum LS, Wamae AW, Mintz ED, Bartlett
AV, 2008. Declines in case management of diarrhoea among
children less than five years old. Bull World Health Organ
86: E–F.
22. Olson CK, Blum LS, Patel KN, Oria PA, Feikin DR, Laserson
KF, Wamae AW, Bartlett AV, Breiman RF, Ram PK, 2011.
Community case management of childhood diarrhea in a set-
ting with declining use of oral rehydration therapy: findings
from cross-sectional studies among primary household care-
givers, Kenya, 2007. Am J Trop Med Hyg 85: 1134–1140.
23. Othero DM, Orago AS, Groenewegen T, Kaseje DO, Otengah
PA, 2008. Home management of diarrhea among underfives
in a rural community in Kenya: household perceptions and
practices. East Afr J Public Health 5: 142–146.
24. Forsberg BC, Petzold MG, Tomson G, Allebeck P, 2007. Diar-
rhoea case management in low- and middle-income countries—
an unfinished agenda. Bull World Health Organ 85: 42–48.
25. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS,
2003. How many child deaths can we prevent this year? Lancet
362: 65–71.
26. Kenya National Bureau of Statistics, Ministry of Public Health
and Sanitation, National Coordinating Agency for Population
and Development, 2009. Kenya Demographic and Health Survey
2008–09. Nairobi, Kenya: Kenya National Bureau of Statistics.
27. Shapiro RL, Kumar L, Phillips-Howard P, Wells JG, Adcock
P, Brooks J, Ackers ML, Ochieng JB, Mintz E, Wahlquist
S, Waiyaki P, Slutsker L, 2001. Antimicrobial-resistant bac-
terial diarrhea in rural western Kenya. J Infect Dis 183:
1701–1704.
28. Brooks JT, Ochieng JB, Kumar L, Okoth G, Shapiro RL,
Wells JG, Bird M, Bopp C, Chege W, Beatty ME, Chiller T,
Vulule JM, Mintz E, Slutsker L, 2006. Surveillance for bac-
terial diarrhea and antimicrobial resistance in rural western
Kenya, 1997–2003. Clin Infect Dis 43: 393–401.
29. Hamel MJ, Adazu K, Obor D, Sewe M, Vulule J, Williamson
JM, Slutsker L, Feikin DR, Laserson KF, 2011. A reversal in
reductions of child mortality in western Kenya, 2003–2009.
Am J Trop Med Hyg 85: 597–605.
40 OMORE AND OTHERS
PUBLICATION 
II 
Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis 
before rotavirus vaccine introduction in Kenya, 2010-2013 
Omore R, Khagayi S, Onkoba R, Ochieng JB, Juma J, Munga S, Kibet S, Nuorti 
JP, Odhiambo F, Mwenda J, Breiman RF, Parashar DU and Tate EJ  
BMC Infectious Diseases volume 19, Article number: 47 (2019). 
doi: 10.1186/s12879-018-3615-6 
Publication reprinted with the permission of the copyright holders. 

RESEARCH ARTICLE Open Access
Rates of hospitalization and death for
all-cause and rotavirus acute gastroenteritis
before rotavirus vaccine introduction in
Kenya, 2010–2013
Richard Omore1,2* , Sammy Khagayi1, Billy Ogwel1, Reuben Onkoba1, John B. Ochieng1, Jane Juma1,
Stephen Munga1, Collins Tabu3, Sergon Kibet4, J. Pekka Nuorti2, Frank Odhiambo1, Jason M. Mwenda5,
Robert F. Breiman7, Umesh D. Parashar6 and Jacqueline E. Tate6
Abstract
Background: Rotavirus vaccine was introduced in Kenya immunization program in July 2014. Pre-vaccine disease
burden estimates are important for assessing vaccine impact.
Methods: Children with acute gastroenteritis (AGE) (≥3 loose stools and/or ≥ 1 episode of unexplained vomiting
followed by loose stool within a 24-h period), hospitalized in Siaya County Referral Hospital (SCRH) from January
2010 through December 2013 were enrolled. Stool specimens were tested for rotavirus (RV) using an enzyme
immunoassay (EIA). Hospitalization rates were calculated using person-years of observation (PYO) from the Health
Demographic Surveillance System (HDSS) as a denominator, while adjusting for healthcare utilization at household
level and proportion of stool specimen collected from patients who met the case definition at the surveillance
hospital. Mortality rates were calculated using PYO as the denominator and number of deaths estimated using total
deaths in the HDSS, proportion of deaths attributed to diarrhoea by verbal autopsy (VA) and percent positive for
rotavirus AGE (RVAGE) hospitalizations.
Results: Of 7760 all-cause hospitalizations among children < 5 years of age, 3793 (49%) were included in the
analysis. Of these, 21% (805) had AGE; RV was detected in 143 (26%) of 541 stools tested. Among children < 5 years,
the estimated hospitalization rates per 100,000 PYO for AGE and RVAGE were 2413 and 429, respectively. Mortality
rate associated with AGE and RVAGE were 176 and 45 per 100,000 PYO, respectively.
Conclusion: AGE and RVAGE caused substantial health care burden (hospitalizations and deaths) before rotavirus
vaccine introduction in Kenya.
Keywords: Rotavirus, Morbidity, Mortality, Children, Kenyan
Background
Rotavirus is the most common cause of vaccine-preventable
severe acute gastroenteritis (AGE) among infants and young
children worldwide [1, 2]. In 2013, RVAGE was estimated to
cause 215,000 global deaths among children < 5 years of
whom 2% (~ 4000) were from Kenya [3] alone. In Kenya,
RVAGE accounts for 19% (~ 9000) of annual hospitaliza-
tions among children < 5 years [4]. Two RV vaccines
Rotarix® (GlaxoSmithKline), and RotaTeq® (Merck & Co.),
are approved and recommended by the World Health
Organization (WHO) for global use [5]. Efficacy and effect-
iveness studies of these vaccines have shown significant re-
duction in AGE and RVAGE associated hospitalizations and
deaths among children < 5 years in both clinical trials and in
settings where they have been incorporated into the national
immunization programs [1, 6–10]. Consistent with data
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from Mexico [6] and Brazil [7, 11], African countries that
were early introducers of RV vaccines including Malawi
[10], Ghana [12], and Rwanda [13], have shown remarkable
declines in childhood morbidity and mortality associated
with AGE and RVAGE. Furthermore, the cost benefit of
these vaccines has equally been demonstrated [4, 7, 14]
.RV vaccine (Rotarix®) was introduced into the Kenya na-
tional immunization program in July 2014. Recent
population-based data on pre-vaccine disease rates are not
available in Kenya. However, such data are needed to
evaluate the impact of vaccination program and may help
county and national level governments, regional and glo-
bal decision makers with evidence needed to support in-
vestment in these vaccines.
We examined baseline rates of AGE and RVAGE specific
hospitalizations and deaths among children < 5 years in rural
western Kenya from January 1, 2010 to December 31, 2013
before RV vaccine introduction in Kenya.
Methods
Study site
Rotavirus surveillance and the Health Demographic Sur-
veillance System (HDSS) platform in our study setting
has been detailed elsewhere [15, 16]. In brief, the HDSS
site is located in Siaya County in rural western Kenya.
The HDSS is a longitudinal study that monitors births,
deaths, out and in-migrations and other demographics
of a defined population [16]. Our study was conducted
in Karemo HDSS area within Siaya county referral hos-
pital (SCRH) — the main regional referral hospital in
this setting.
Rotavirus surveillance and laboratory methods
As part of the African-based, World Health Organization
(WHO) coordinated RV rotavirus disease surveillance net-
work [17], we conducted hospital-based prospective sur-
veillance for RVAGE within the Kenya Medical Research
Institute (KEMRI) operated HDSS area in Karemo [15].
Children aged 0–59months residents of Karemo HDSS,
hospitalized at the in-patient department of SCRH with
AGE; defined as ≥3 looser than normal stools and/or ≥ 1
episode of unexplained vomiting followed by loose stool
within a 24-h period beginning within the 7 days before
seeking healthcare from January 1, 2010 to December 31,
2013 were eligible for enrolment. Trained health facility
recorders approached all eligible patient children, ex-
plained the study and administered a questionnaire on
demographics to their caretakers after obtaining informed
consent. A study clinician then examined these patients
and administered the standardized questionnaire to their
parent/caretaker to gather information about symptoms,
medical history, laboratory investigations, diagnosis, treat-
ment and outcome of hospitalization. A whole stool speci-
men was collected from each participant in a plastic
diaper from which at least 2ml of stool was scooped into
a specimen container using a sterile spatula within 48 h of
admission, transported on the same day to the enteric la-
boratory based at the KEMRI-CGHR, and finally tested
for rotavirus using a commercial enzyme immunoassay
(EIA) (Rotaclone Kit, Meridian Bioscience). A case of
RVAGE was defined as an AGE patient with a RV positive
stool specimen.
Data management
Details of the enrolment, testing and data management
have been described previously [15]. In brief, we linked
clinic data to laboratory results and to the longitudinal
data including cause of death from verbal autopsy (VA)
from the HDSS. During data collection, built-in software
in the electronic questionnaire with built-in checks and
controls ensured quality control. The linked data were
then uploaded and managed using a Microsoft SQL Ser-
ver 2008 database. Data were analysed using SAS version
9.4 (SAS Institute, Inc. Cary, North Carolina, USA).
Statistical analysis
Descriptive analysis for AGE and RVAGE
Proportion of admissions due to AGE was calculated by
dividing the number of AGE cases by the number of
all-cause admissions at SCRH who were residents of
Karemo HDSS during the study period. The proportion
of admissions that were associated with RVAGE was cal-
culated by dividing the number of RV positive stool
samples with the total samples collected and tested.
Positivity rates by month and patient characteristics
(age, gender, clinical features and illness outcome) were
calculated. These proportions were plotted by month to
show seasonality.
Analysis of RVAGE, disease severity and risk factors
The severity of RVAGE was assessed by using the 20-point
Vesikari score [18].A score of less than 11 was categorized
as mild while a score of 11 or more was classified as severe.
Bivariate comparison of the laboratory-confirmed RV posi-
tivity and patient characteristics and treatment outcomes
were evaluated using chi-square tests.
Incidence rates of hospitalization and mortality due to AGE
and RVAGE
We used person-years of observation (PYO) contributed
by all children aged less than 5 years residents of Karemo
region during the study period as the denominator. As de-
scribed previously [15], we calculated PYO by totaling
person-time for all children aged 0–59months who met
HDSS residency requirement during the 4-year study
period from 1st January 2010 or date of enrolment (if
after) until they exited or lost their HDSS residency status
through out-migration or death.
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The crude hospitalization rates were calculated by divid-
ing the total number of AGE and RVAGE hospitalizations
by the PYO contributed by children aged 0–59months for
the period that they met residency criteria for the HDSS.
We used two adjustments for the hospitalization rates.
First, to account for possible missed AGE cases, we di-
vided the crude rate of AGE and RVAGE by the propor-
tion of all in-patients who met the stool collection criteria,
whether a sample was collected or not.
The second adjustment accounted for children with AGE
or possibly RVAGE who did not reach or attend a sentinel
health care facility as reported from a population-based,
healthcare utilization and attitude surveys (HUAS) for diar-
rhoea—a separate household survey conducted within the
HDSS during the current RVAGE surveillance period
[19].The HUAS revealed that the frequencies of seeking
care for moderate-to-severe diarrhoea (MSD) from a hos-
pital were 69, 70, 67, 57 and 64% for children aged 0–5, 6–
11, 12–23, 24–59 and 0–59months, respectively (GEMS--
Kenya unpublished data). The 95% confidence intervals
(CI) were calculated around crude rates by using the PEPI
method [20]. Crude rates were then adjusted using Delta
method [21, 22]. The adjusted hospitalization rates were fi-
nally stratified and reported by age groups that included;
0–5, 6–11, 12–23, 24–59, 0–11 and 0–59months.
AGE and RVAGE mortality rates
Deaths were recorded at household level through regular in-
terviews of HDSS residents. Diarrhoea as a cause of death
was derived from Verbal autopsy (VA). The VA methodolo-
gies, coding and interpretation are described elsewhere [23,
24]. Upon the death of an HDSS resident, a trained
village-based reporter sent a notification to HDSS data team.
After a mourning period of at least 3 weeks, the interviewer
from the HDSS approached the most appropriate inter-
viewee who was closest to the deceased to administer a de-
tailed questionnaire focusing on the signs, symptoms and
medical history of the deceased. The VA data were collected
electronically, validated and processed using an InterVA pro-
gram, which is a probabilistic computer-based expert opinion
algorithm that determines the most probable cause of death
as described elsewhere [24]. We calculated the number of
deaths attributed to RV by multiplying the total under-five
deaths among HDSS residents in the study area by the pro-
portion of deaths attributable to diarrhoea by VA, and the
proportion of hospitalized AGE episodes attributable to RV
in each of the various age groups as described below.
Mortality rates associated with rotavirus gastroenteritis
were obtained by dividing the number of deaths attrib-
uted to rotavirus by the total PYO in each of the specific
age groups as described above.
Results
Enrolment profile and patient characteristics
During the study period, a total of 7760 all-cause hospitaliza-
tions among children < 5 years of age were recorded at the
SCRH paediatric ward, out of which 3793 were Karemo
HDSS resident population. Among the 3793 Karemo HDSS
resident children, 805 (21, 95%CI: 20–23) children were hos-
pitalized due to AGE (Fig. 1). RV-positivity among hospital-
ized children from Karemo with AGE was more pronounced
in infants (< 12months of age), then toddlers (12–23months
of age), and was least in school-age children (24–59months
of age) (Table 1). Characteristics of patients who had stool
specimens collected and those who did not have specimens
collected are shown in Table 2.
Of the 541 stool samples collected, 204 (38%) were
from infants aged 6–11months. There was no difference
in stool collection by gender. Furthermore, we did not
observe any statistical difference in rotavirus positivity in
male versus female patients among infants aged < 12
months ((69/211 [32.7%]) vs. (42/165 [25.4%]), OR =
1.42, p = 0.13),toddlers aged 12–23months ((9/61
[14.7%]) vs. (12/46 [26.1%]), OR = 0.49, p = 0.15), or in
children aged 24–59 months ((9/37 [24.3%]) vs. (2/21
[9.5%]), OR = 3.05, p = 0.18), respectively.
The overall annual proportion of rotavirus detection
ranged from 43/147 (29.3%) in 2010 to 21/95 (22.1%) in
2013 and the annual proportion of samples detected with
rotavirus did not differ significantly over the 4-year study
period. Rotavirus hospitalizations were seen throughout
the year over the surveillance period, but peaked from
January through March and around August–September
each year during study period (Fig. 2).
Compared with non-RVAGE cases, RVAGE cases were
younger ((median age = 8 Interquartile range [IQR] 5–
12) vs. 9 [IQR: 6–15] months; p < 0.032)), more likely to
present with vomiting ((126/143 (88.1%) vs. 297/397
(74.8%)), and more likely to be classified as severe by
Vesikari score (88/143 (61.5%) vs. 179/398 (44.9%),
p-value = 0.0007).(Table 3).The length of hospitalization
was similar for RVAGE compared to non-RVAGE (num-
ber of hospitalization days 4 [IQR] 3–6 vs. 4 [IQR] 3–6,
p-value = 0.564).
No of deaths attributable to RV ¼
Total under−five deaths among HDSS residents in study areað Þ
 proportion of deaths attributable to diarrheað Þ
 proportion of hospitalized AGE episodes attributable to RVð Þ
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Fig. 1 Flow diagram of Karemo DSS residents < 5 yrs. who were hospitalized and enrolled in the study from Siaya county referral hospital,
western Kenya 2010–2013
Table 1 Characteristics of children< 5 years hospitalized at SCRH with all cause morbidity, AGE and RVAGE, 2010—2013
Characteristics All Cause Hospitalizations
from Karemo DSS (N = 3793)
AGE Hospitalizations
(N = 805)
AGE specimen collected and tested
for RV ҂ (N = 541)
Proportion tested RV Positive
(N = 143)
n n (row %) n (row %) n (row %)
Sex
Male 2066 461 (22%) 309 (67%) 87 (28%)
Female 3793 344 (20%) 232 (67%) 56 (24%)
Year
2010 920 224 (24%) 147 (66%) 43 (29%)
2011 1335 313 (23%) 206 (66%) 53 (26%)
2012 822 147 (18%) 93 (63%) 26 (28%)
2013 716 121 (17%) 95 (79%) 21 (22%)
Age (Months)
0–5 536 205 (38%) 141 (69%) 45 (32%)
6–11 781 285 (36%) 204(72%) 57 (28%)
12–23 1110 205 (18%) 138 (67%) 30 (22%)
24–36 687 70 (10%) 40 (57%) 9 (23%)
37–59 679 40 (6%) 18 (45%) 2 (11%)
҂ 3 samples collected were not tested
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Hospitalization attributed to AGE in Karemo HDSS
The highest annual hospitalization rate (per 100,000
PYO) associated with AGE was observed in 2011
followed by 2010, 2012 and 2013 in descending order.
The annual incidence (per 100,000) of hospitalizations
due to all cause AGE was highest among infants and
children aged 6–11months remained most affected.
Hospitalization attributed to RVAGE among children < 5
years from Karemo HDSS
Incidence rates of RVAGE associated hospitalization was
highest among infants, particularly among those aged 6–11
months. We observed the highest RVAGE hospitalization
rate in 2011 followed by 2010, 2012 and 2013 in decreasing
order. Hospitalization rates for AGE and RVAGE are shown
in Table 4.
Mortality attributed to AGE and RVAGE
Discharge information was available for 531 (98%) of the
hospitalizations due to AGE of whom 33 (6.2%) died dur-
ing hospitalization. The case-fatality proportion among
RVAGE ((4.2%), [6/142]) compared to that observed from
non-RVAGE ((6.9%), [27/389]) cases was similar, p = 0.26.
The highest mortality rates of AGE and RVAGE were
observed among infants (< 12 months of age), and
remained most elevated among infants aged 6–11
months. Annual mortality rates associated with RVAGE
were stable between 2010 and 2011, but increased before
Table 2 Characteristics of Karemo resident children < 5 years hospitalized with AGE who had stool collected and those without
stool collected, Siaya County Referral Hospital, Western Kenya, 2010–2013
Characteristic Stool Sample Collected
(N = 544)
Stool Sample Not collected
(N = 261)
P-value
n (%) n (%)
Age
0–5 months 143 (26) 62 (24) 0.0034
6–11 months 204 (38) 81 (31)
12–23months 139 (26) 66 (25)
24–59months 58 (11) 52 (20)
Gender
Male 312 (57) 149 (57) 0.9
Female 232 (43) 112 (43)
Vesikari Score
Severe 268 (49) 93 (36) < 0.0001
Mild 276 (51) 168 (64)
Fig. 2 Rotavirus infection trends among hospitalized children < 5 years from Karemo DSS resident population seeking Care from Siaya County
Referral Hospital, western Kenya 2010–2013
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RV vaccine introduction, especially among children aged
6–11 months. Mortality rates attributed to AGE and
RVAGE are shown in Table 5.
Discussion
This study documents comprehensive, age-stratified
population-based hospitalization and mortality rates as-
sociated with AGE and RVAGE before introduction of
RV vaccines among Kenyan children < 5 years in a rural
community whose demographic and healthcare seeking
characteristics are well described [16, 19]. Unlike other
WHO rotavirus surveillance study sites in Africa, our
hospital-based surveillance site for rotavirus is unique
for a few reasons. First, it is supported by an ongoing
HDSS which monitors population denominators and
conducts verbal autopsy [16]. Second, our surveillance
hospital is the only regional public referral hospital for
the local HDSS and the only in-patient facility within
the HDSS, making our surveillance data representative
of the population as shown from our current data and as
previously observed [15]. Furthermore, the advantages of
a population-based incidence rate are two-fold. First, they
provide an opportunity to estimate number of people af-
fected by a disease. Second, they can help to project the
number of illness episodes that can be prevented with ef-
fectively known interventions such as vaccines [25].
Our 4-year study’s most important findings are that
before RV vaccine introduction in Kenya; approximately
90 and 60% of RVAGE hospitalized children were aged
< 2 years and < 1 year, respectively, and that hospitaliza-
tions and mortality associated with AGE and RVAGE
were highest among infants. Furthermore our data sug-
gests that children bearing the greatest burden of morbid-
ity and mortality associated with AGE and RVAGE were
infants aged 6–11months. This finding is similar to obser-
vations from neighboring Sudan where pre-RV vaccine
data indicates that 91 and 61% of rotavirus hospitaliza-
tions occurred before 2 years and 1 year respectively [26].
Table 3 The Vesikari scores for severity of illness among RVAGE and non- RVAGE hospitalized children <5 yrs. in Siaya County
Referral Hospital, western Kenya, 2010–2013
Variable Points assigned Rotavirus-positive Rotavirus-negative P-value
N = 143 N = 398
Duration of diarrhea (days)
1–4 1 119 (83) 281 (70%) 0.0089
5 2 4 (3%) 31 (8%)
> =6 3 20 (14%) 86 (22%)
Max no. diarrhea/24 h
1–3 1 41 (29%) 153 (38%) 0.1091
4–5 2 75 (52%) 177 (45%)
> =6 3 27 (19) 68 (17%)
Duration of vomiting (days) N = 126 N = 296
1 1 22 (15.4) 77 (19.4) 0.165
2 2 27 (18.9) 57 (14.4)
> =3 3 77 (53.8) 162 (40.9)
Max no. vomiting/24 h
1 1 8 (7%) 39 (13%) 0.1003
2–4 2 95 (75%) 214 (72%)
> =5 3 23 (18%) 43 (15%)
Fever
< 37.0 0 74 (52%) 196 (49%) 0.0435
37.1–38.4 1 58 (40%) 157 (40%)
38.5–38.9 2 8 (6%) 12 (3%)
> =39 3 3 (2%) 33 (8%)
Dehydration N = 55 N = 139
1–5% 2 48 (87%) 117 (84%) 0.5852
> =6% 3 7 (13%) 22 (16%)
Treatment* 2 143 (100%) 398 (100%) –
*All cases were treated in the ward
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Furthermore, our finding is consistent with observations
from the first 2 years of the current study [15], a study
conducted at the coastal region of Kenya [27], Global En-
teric Multicenter Study (GEMS) [2] and other studies con-
ducted in Europe [28] before introduction of RV vaccines.
Our observation that 21% of hospitalizations among chil-
dren < 5 years in the HDSS were due to AGE is similar to
23% reported previously from mid-term analysis of our
current study [15], 22% reported from Kilifi HDSS in
coastal region of Kenya [27], 21% from neighboring
Mwanza region in Tanzania [29], and 21% from Ethiopia
[30]. In addition, our finding that 26% of hospitalized
AGE case patients were infected with RV remains similar
to the rate of 27% reported from mid-term analysis of our
current surveillance data [15] and to 29% from Kilifi
HDSS at the Kenyan coast [27]. These observations sug-
gest that AGE and RVAGE burden in our setting is com-
parable to those from other settings in Kenya and
neighboring countries before RV vaccine introduction.
Our observation that rates of hospitalization due AGE
and RVAGE declined over the study period before vaccine
introduction may be associated with unknown non-RV
vaccine intervention factors. However, the proportion of
all deaths that were associated with AGE and RVAGE did
not follow the same pattern. Thus, these observed trends
are difficult to explain, though in part may reflect the ef-
fects of other interventions. Although widespread distri-
bution and use of zinc and ORS as part of devolved
government development efforts in Kenya has been de-
scribed [31] and may be a contributing factor to the ob-
served decline in diarrhea burden in this setting, such
argument remains speculative and prompts further inves-
tigation. This trend however is consistent with other ob-
servations from a recent community-based survey
conducted in this setting [19], and is not dissimilar to the
global trend of diarrhoea and rotavirus disease [3, 32].
Our data show that rotavirus was more commonly de-
tected among infants. Moreover, RVAGE presented with
more severe episodes than non-RVAGE as characterized
by severe dehydration, vomiting and low grade fever
—an observation similar to other previous studies [30,
33–35]. Rotavirus is the most common cause of severe
dehydrating diarrhoea and is the leading pathogen asso-
ciated with moderate-to-severe diarrhoea (MSD) [35], as
further reaffirmed by GEMS — the largest diarrhoea eti-
ology case-control study ever conducted in countries
representing the highest disease burden regions located
in Africa and Asia [2]. Severe dehydration caused by
diarrhoea in children is a major cause of preventable
morbidity and mortality in Kenya [31]. As commonly
observed in our setting and consistent with the care-
takers healthcare seeking trends in Kenya [19, 31], delay
in seeking care for childhood diarrhoea and reducing
amount of fluid and food intake during childhood AGE
illness can lead to severe disease. Our current study
found that case-fatality among RVAGE was not signifi-
cantly different from non-RVAGE cases, suggesting that
rotavirus may not be associated with mortality in hos-
pital based studies as shown from other studies [33, 36].
This finding supports the assumption that seeking care
for RVAGE from a health care facility enables access to
appropriate rehydration, which would then reduce the
risk of death from the disease.
Understanding seasonality of rotavirus can help for-
mulate hypothesis for assessing potential factors influen-
cing transmission and guide policy makers in deciding
on appropriate interventions and approaches that can
work in local settings for improving case management
during peak seasons [37]. For example, in settings such
as USA, rotavirus seasons have been observed to be de-
layed, shortened, and diminished [4, 38] after vaccine
introduction. In our current analysis, rotavirus detection
peaked in months which are locally known to be usually
warm and dry. Our current findings are consistent with
recent observations from Kenya [15, 33], and remains
similar to findings from other studies conducted in Bur-
kina Faso [37], Peru and Bangladesh [39] before rota-
virus vaccine introduction in those settings. Although
there is no unifying rotavirus seasonality pattern globally
[40], it’s spread by the faecal-oral route remains agree-
able [35], and even airborne or droplet transmission has
been postulated [41]. The later attribute potentially
makes the virus transmission route also to resemble that
of other non-enteric respiratory infectious diseases such
as measles [42].These observations suggests that a drop
in humidity and rainfall combined with dry soil could
potentially increase additional chance for transmission
through aerial contaminated faecal materials since sur-
vival of rotavirus may still be favored in such conditions
as described elsewhere [41, 43].
Treating RVAGE is expensive. In Kenya, it has been
estimated that rotavirus disease cost the national health-
care system $10.8 million each year, and that a 2-dose
rotavirus vaccine (RVV) series can avert ~ 2500 deaths,
~ 6000 hospitalizations and ~ 860,000 clinic visits with a
cost saving of $2.1 million annually [4].RV vaccines have
been shown to be effective in reducing the hospitaliza-
tions and death due to diarrhoea in children and the
protective effect potentially lasts through 2nd year of life
[1, 44].While the benefit of these vaccines has been doc-
umented in other African countries where they were in-
troduced ahead of Kenya, such as in South Africa [45],
Rwanda [3], Ghana [12],and Togo [46], population-level
benefits of RVV are yet to be demonstrated from Kenya.
A possible limitation of our current study is that many
rotavirus-associated fatalities are likely associated with
delay in healthcare seeking [5]. Furthermore, VA relies
on signs, symptoms and circumstances prior to death to
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assign cause of death which is subject to misclassifica-
tion error, and therefore the method as applied in our
current study may lead to over or under-estimation of
mortality [36]. Our methodology for estimating diar-
rhoea deaths attributable to rotavirus was based on the
following 3 assumptions: (i) that in the absence of treat-
ment, the hospitalized severe cases would not have sur-
vived; (ii) the treatment effect on survival of severe
diarrhoea is equal for rotavirus and non-rotavirus diar-
rhoea; and that (iii) the rotavirus attributable fraction of
severe diarrhoea observed in the sentinel hospital are
generalizable to the source population within each age
stratum as already described elsewhere [36]. Maintaining
caution when interpreting these estimates is important
since we recognize that such assumptions may affect the
validity and generalizability of the estimates to the gen-
eral population. However, since there are currently no
reliable data for the direct measurement of the propor-
tion of diarrhoea deaths that are attributable to rotavirus
[22, 36] especially in the high disease burden regions lo-
cated mostly in low-and middle income countries such
as in our setting [3], we believe our methodology re-
mains more reasonable, robust and applicable as recom-
mended by WHO [22, 36]. Moreover, our current
hospital surveillance data suggests agreeable representa-
tion of the source population consistent with previous
observations [15].
Conclusions
This study shows that AGE and RVAGE associated
hospitalization and deaths are high in this setting with
children aged 6–11 months bearing the greatest burden.
These findings support the introduction of a vaccine that
would potentially provide protection to young children
before the disease peaks at 6–11months of age in this
setting. While improvements in drinking water, sanita-
tion and hygiene can effectively prevent other forms of
diarrhoea, such interventions do not adequately prevent
the spread of rotavirus, thus leaving vaccines as the best
alternative in preventing AGE and RVAGE in settings
such as ours [5]. Continued surveillance will be import-
ant for measuring the impact of rotavirus vaccine intro-
duction in Kenya.
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Abstract
Objective
To evaluate factors associated with rotavirus diarrhea and to describe severity of illness
among children <5 years old with non-dysenteric, moderate-to-severe diarrhea (MSD) in
rural western Kenya.
Methods
We analyzed data from children <5 years old with non-dysenteric MSD enrolled as cases in
the Global Enteric Multicenter Study (GEMS) in Kenya. A non-dysenteric MSD case was
defined as a child with3 loose stools in 24 hrs. and one or more of the following: sunken
eyes, skin tenting, intravenous rehydration, or hospitalization, who sought care at a sentinel
health center within 7 days of illness onset. Rotavirus antigens in stool samples were
detected by ELISA. Demographic and clinical information was collected at enrollment and
during a single follow-up home visit at approximately 60 days. We analyzed diarrhea
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severity using a GEMS 17 point numerical scoring system adapted from the Vesikari score.
We used logistic regression to evaluate factors associated with rotavirus infection.
Results
From January 31, 2008 to September 30, 2012, among 1,637 (92%) non-dysenteric MSD
cases, rotavirus was detected in stools of 245 (15.0%). Rotavirus-positive compared with
negative cases were: younger (median age, 8 vs. 13 months; p<0.0001), had more severe
illness (median severity score, 9 vs 8; p<0.0001) and had to be hospitalized more frequently
(37/245 [15.1%] vs. 134/1,392 [9.6%]), p <0.013). Independent factors associated with rota-
virus infection included age 0–11 months old (aOR = 5.29, 95% CI 3.14–8.89) and present-
ing with vomiting3 times/24hrs (aOR = 2.58, 95% CI [1.91–3.48]). Rotavirus was detected
more commonly in warm and dry months than in the cool and rainy months (142/691 [20%]
vs 70/673 [10%]) p<0.0001).
Conclusions
Diarrhea caused by rotavirus is associated with severe symptoms leading to hospitalization.
Consistent with other settings, infants had the greatest burden of disease.
Introduction
Diarrhea continues to be the second leading cause of death among children under 5 years
worldwide and was responsible for approximately 800,000 (~10.5%) of global deaths in this age
group in 2015 [1]. Of the 7.6 million global deaths reported among children<5 years in 2010,
9.9% were attributed to diarrheal diseases [2]. This was a remarkable decrease from the 8.9 mil-
lion reported deaths in 2008 when diarrheal diseases accounted for 15% of deaths [3]. Despite
these reductions rotavirus has remained as the most commonest cause of severe gastroenteritis
[4] and the estimated decrease in deaths associated with the disease has been reported to range
from ~500,000 deaths in 2008 among children<5 years of age, accounting for 5% of total
global deaths [5] to ~200,000 in 2015 among the same age group [6], consistent with the WHO
Child Health Epidemiology Reference Group (CHERG) estimates [1]. Approximately two-
thirds or more of these deaths continue to occur in South Asia and sub-Saharan Africa [1, 2, 4].
In Kenya, rotavirus diarrhea is estimated to cause over 19% (~9,000) of diarrhea hospitaliza-
tions, 16% (~1.5 million) of clinic visits for diarrhea and more than 4,000 deaths among chil-
dren<5 years of age annually [5, 7, 8]. More severe diarrhea and vomiting leading to severe
dehydration are common classical symptoms associated with rotavirus disease [9–11].
Currently available rotavirus vaccines have been shown to be effective in reducing the dis-
ease burden [12–16]. In July 2014, Kenya introduced rotavirus vaccine as part of the National
Immunization Program. Understanding the epidemiology of rotavirus infections in the local
setting therefore remains essential for documenting the basis for rotavirus immunization. Fur-
thermore such information is useful in guiding implementation of other concurrent interven-
tions that are effective in the prevention and treatment of diarrhea such as oral rehydration
therapy (ORT) inclusive of continued and ideally increased fluid intake and feeding during
diarrheal episodes, zinc treatment, and improvements in water and sanitation [17]. In this
study, we describe the epidemiology, seasonality, clinical features and factors associated with
rotavirus infection among children<5 years of age with non-dysenteric MSD in rural western
Kenya prior to rotavirus vaccine introduction.
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Materials and Methods
Study design
We evaluated data collected from cases enrolled in the Global Enteric Multicenter Study
(GEMS), a 4-year; prospective, age-stratified, health center-based matched case-control study
of MSD among children aged 0–59 months old residing within a defined and enumerated pop-
ulation [18–20].
Study setting
The study was conducted in the Asembo, Gem and Karemo communities in Siaya County,
(formerly Nyanza province) in rural western Kenya. The Kenya Medical Research Institute
(KEMRI) in collaboration with the U.S. Centers for Disease Control and Prevention (CDC)
has been operating a health and demographic surveillance system (HDSS) in these communi-
ties since 2001, see Fig 1. The study setting has been described further elsewhere [19, 20].
Study case definition, recruitment and laboratory methods
A non-dysenteric MSD case was defined as a child with3 loose stools in 24 hrs. and one or
more of the following: sunken eyes, skin tenting, requiring intravenous rehydration, or hospi-
talization, who sought care from outpatient or in-patient department of a study sentinel health
center (SHC) within 7 days of illness onset. In this analysis, MSD cases with dysentery were
excluded.
Caretaker’s maximum education was classified as formal education (completed primary,
secondary or post-secondary) or non-formal (incomplete primary, religious education or no
education). We classified dehydration as either mild or moderate to severe as follows: a child
was considered mildly dehydrated if 2 or more of the following were present: restless or
Fig 1. KEMRI/CDC HDSS study area (Asembo, Gem and Karemo) where GEMS Kenya Study was conducted.
doi:10.1371/journal.pone.0160060.g001
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irritable on arrival or at admission to the SHC, sunken eyes, thirsty, drank eagerly; skin pinch
goes back slowly (1–2 seconds). A child was considered moderately to severely dehydrated if 2
or more of the following were present: lethargic or unconscious on arrival or at admission to
the SHC, sunken eyes, drank poorly or unable to drink, skin pinch goes back very slowly (>2
seconds). Fever was defined by the presence of an axillary body temperature greater than or
equal to 38°C or parental perception.
At enrollment, demographic, clinical, epidemiological information and stool samples were
collected. Rotavirus VP6 antigen was detected in the whole stool specimen by a well-validated
commercial enzyme-linked immunosorbent assay (ELISA) (ProSpecT rotavirus kit, Oxford,
Basingstoke, UK). Detailed laboratory methods are described elsewhere [21]. A single home
visit ~ 60 days (targeted range 50–90 days) following enrollment was carried out to assess each
child’s health outcome from the acute diarrheal illness [8, 18]. Mortality that occurred at any
time point between initial enrollment from the SHC and the follow-up visit was recorded.
Statistical analysis
Data collection and management procedures for GEMS have been described previously [22].
Data were analyzed using SAS version 9.4 (SAS Institute, Inc. Cary, North Carolina, USA).
To compare non-dysenteric MSD cases who tested positive vs. negative for rotavirus, we
report proportions and chi square p-values for categorical variables, including mortality
recorded at ~60 days follow-up. Medians for continuous variables were compared with Wil-
coxon rank sum test. We initially explored the association between each factor and rotavirus
positivity among non-dysentery MSD cases one at a time using univariable logistic regression
models. Since many of the factors of interest might be highly correlated, we assessed correlation
across variables and when present, only the variable with the strongest association with rotavi-
rus positivity was considered for the multivariable model. We then tested for two-way interac-
tions between each of the variables and age because risk factors are likely to be different for
infants. We conducted manual backwards stepwise elimination; the final multivariable model
included all variables and aimed to include interactions which retained statistical significance
at p<0.05. We report adjusted odds ratios (aOR) and 95% confidence intervals (CI) from the
final model as variables significantly associated with rotavirus. Collinearity was assessed in the
final model using condition index as described elsewhere [23, 24].
To assess bias, sensitivity analysis was performed by constructing additional models with
various subsets of the data. Children were eligible for re-enrollment as an MSD case after 90
days post enrollment. Therefore, it was possible for some children to be enrolled for more than
one episode of MSD. We constructed additional models excluding all observations for the 33
cases who were enrolled more than once, to ensure consistency of results and assess any poten-
tial bias. In addition, at enrollment, case stools were tested for a panel of enteric pathogens and
thus could have had more than one pathogen identified. We assessed models limited to the 86
cases who had rotavirus as a single pathogen and 159 cases who had rotavirus with other
enteric co-infections separately.
Additionally, to further evaluate clinical features’ associated with rotavirus, we applied a 17
point scoring system, referred to in this analysis as “GEMSmodified Vesikari score system” which
was adapted from the 20 point scale developed by Ruuska and Vesikari [25] to assess severity of
rotavirus diarrhea in a separate subgroup analysis which was different with the above models. The
score was calculated based on symptoms of diarrheal illness and the child’s characteristics at
enrollment. To compare clinical features and modified Vesikari scores we used chi square tests.
Assessment of seasonal patterns was limited to the first three years (36 months) of the study
where we had un-interrupted continuous and consistent monthly study enrollments that could
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support a seasonality analysis. We classified months for this period into cool and rainy (April,
May, June, September, October and November) and warm and dry (January, February, March,
July, August and December) based on the seasonal patterns in the study area. We compared
proportions of rotavirus positivity by season type and computed prevalence odds ratios and
confidence intervals using bivariate logistic regression. We further explored seasonality pattern
(probability of monthly stool samples testing positive for rotavirus) in a separate logistic regres-
sion model for the first three years of data where there was continuity using sine and cosine
functions of time [26].
Verbal cause of death (VA)
VA data collection and analysis methods used in this study has been described elsewhere in
detail [19, 27]. In brief, VA interviews were conducted by trained field workers using VA ques-
tionnaires. They interviewed the main caregiver of the deceased child on signs and symptoms
leading to the death and care seeking behavior during the illness. Information from these ques-
tionnaires were processed into Inter- VA -4 (version 4.02) program to obtain most probable/
underlying cause of death as further described elsewhere [28].
Ethics Statement
This evaluation is covered by the GEMS Kenya protocol which was approved by the scientific
and ethical review committees of KEMRI (KEMRI protocol # 1155) and the Institution Review
Board (IRB) of the University of Maryland, School of Medicine, Baltimore, MD USA (UMB
Protocol # H-28327). The IRB for the Centers for Disease Control and Prevention, Atlanta,
GA, USA formally deferred its review to the University of Maryland IRB (CDC Protocol #
5038). Written informed consent was obtained in the local dialect (i.e. Dholuo) from all partici-
pating caretakers before recruitment of their children into the study. Data were fully anon-
ymized at collection.
Results
Enrollment Profile
From January 31, 2008 to September 30, 2012, 1,778 MSD cases were enrolled in GEMS at the
Kenya site; 253 were positive for rotavirus. During the first three years of the study when we
had consistent enrollments without interruption, 1,476 MSD cases were enrolled. When strati-
fied by in-patient and out-patient type, children<12 months of age compared to children 23
to 59 months of age were at increased risk of rotavirus infection and the risk of infection
reduced by increasing child age regardless of patient type. During the three years period, dysen-
tery was significantly less commonly observed among any rotavirus positive (5/217 [2.3%]))
compared to negative (106/1,258 [8.4%]) MSD cases, odds ratio = 0.26; 95% confidence inter-
val (CI), 0.10–0.64, p = 0.003. Furthermore the pattern remained similar with dysentery being
observed to be less common among rotavirus-positive compared to negative MSD cases when
we stratified our analysis by in-patient and out-patient MSD cases. Among both in-patient and
out-patient MSD cases, the highest rotavirus isolation occurred in the first year of the study
with a decrease among in-patient but a stable rate of isolation among out-patient MSD cases in
the second and third years respectively (Table 1).
All dysentery cases from the four year study period were excluded from further analysis
including 8 (3.2%) rotavirus MSD cases, 132 (8.7%) rotavirus negative MSD cases and 1 rotavi-
rus-negative MSD case with unknown dysentery status (Fig 2). A total of 1,637 non-dysenteric
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MSD cases of whom 245 (15%) were rotavirus-positive and 1,392 rotavirus-negative were
included in further analyses as shown in Fig 2.
Breast feeding information presented in the current analysis was only available for the first
three years of the study and was available for 1,364 of the 1,476 MSD cases enrolled in that
period. In general 441 (32.3%) of the cases had stopped breastfeeding, 867 (63.6%) were par-
tially breastfed and 56 (4.1%) were exclusively breastfed. When we limited our analysis further
among 235 cases who at enrollment were aged<6 months and who were ideally expected to be
on exclusive breastfeeding, only 50 (21.3%) were exclusively breastfeeding, 180 (76.6%) were
partially breastfeeding and 5 (2.1%) had stopped breastfeeding. Exclusive breastfeeding was
less frequently reported among caretakers of rotavirus positive (8/59 [13.6%])) compared to
negative (42/176 [23.9%]) MSD cases, p = 0.095.
Factors associated with rotavirus infection
Compared with rotavirus-negative cases, rotavirus-positive cases were significantly younger
(median age; 8 vs 13 months p<0.0001). The majority (64%) of rotavirus-positive cases were
aged 0–11 months as shown in Table 2 and in Fig 3. Further patient demographics, clinical
characteristics and laboratory findings are listed in Table 2.
From birth prevalence increased to 20% at age 1 month and remained at more or less at the
same level through age 8 months, with a sharp drop-off in month 9, 10 and 11, see Fig 3.
Although some of the SHC did not have full in-patient facilities, patients in this study who
required more time for rehydration at the facility were retained in an improvised in-patient
unit sometimes called “ORS corner” for a few hours while undergoing further observation
while being rehydrated either through IV fluid or ORS. However in situations when further
complications or such patients required full hospitalization then they were referred appropri-
ately to the next level or superior health centers or hospitals with full in-patient services.
Table 1. Proportion of all rotavirus-positive vs negative stool samples from all GEMS children enrolled with MSD episodes within in-patient and
out-patient departments during the first 3 years of non-interrupted enrollment, western Kenya, Jan 2008-Feb 2011.
In-Patient MSD cases Out-Patient MSD cases
Characteristic Rotavirus
positive
Rotavirus negative P-value Rotavirus
positive
Rotavirus negative P-value
(N = 34) (N = 125) (N = 183) (N = 1,134)
n % n % OR95%CI n % n % OR95%CI
Child’s age stratum (in months)
0–11 23 67.6 54 43.2 † 0.01 114 62.3 482 42.5 5.41 [3.10–9.43] <0.0001
12–23 10 29.4 37 29.6 0.04 54 29.5 309 27.2 3.99 [2.21–7.23] <0.0001
24–59 1 2.9 34 27.2 Ref 15 8.2 343 30.2 Ref.
Median age in months 9 [IQR 6–13] 13 [IQR
8–24]
N/A 0.002 8 [IQR 5–15] 14 [IQR 8–27] <0.001
Dysentery
Yes 1 2.9 13 10.5 0.26 [0.03–2.05] 0.201 4 2.2 1041 91.8 0.25 [0.09–0.69] 0.007
No 33 97.1 111 89.5 Ref. 179 97.8 93 8.2 Ref.
Year of study
Year 1 15 44.1 65 52 Ref. 70 38.3 486 42.9 Ref. Ref
Year 2 10 29.4 37 29.6 1.17 [0.48–2.87] 0.755 56 30.6 390 34.4 0.99 [0.68–1.45] 0.987
Year 3 9 26.5 23 18.4 1.69 [0.65–4.40] 0.292 57 31.1 258 22.8 1.53 [1.05–2.24] 0.028
† Fisher`s exact test method used
doi:10.1371/journal.pone.0160060.t001
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Hospitalization was more commonly observed among MSD patients<1 year of age who were
rotavirus-positive versus negative (67.6% [25/37] vs. 46.3% [62/134], p<0.035) and among all
rotavirus-positive vs negative MSD cases regardless of age (15.1% [37/245] vs. 9.6% [134/
1,392], p<0.013). However, the overall length of stay in hospital was generally similar
(median = 2 days) for hospitalized rotavirus-positive and negative MSD cases. Other factors
that were associated with rotavirus MSD in univariable analysis include; vomiting3 times in
24 hours,7 loose stools in 24 hours, unable to drink, sunken eyes, irritability/restlessness,
lethargy, abnormal mental status and IV fluids given (Table 2).
Univariable and multivariable analysis
In univariable analysis, compared with rotavirus-negative cases, rotavirus-positive cases were
significantly more likely to present with sunken eyes (238/245 (97.1%) vs. 1,307/1,392 (93.9%),
OR = 2.21, 95%Confidence interval (CI): 1.01–4.84, p = 0.047); to be restless (179/245 (73.1%)
vs. 856/1,392 (61.5%), OR = 1.7,95%CI: 1.25–3.0, p = 0.0006); to have abnormal mental status
(186/245 (75.9%) vs. 874/1,392 (62.8%), OR = 1.87,95%CI:1.37–2.55, p<0.0001) and to be
unable to drink (16/245 (6.5%) vs. 44/1,392 (3.2%), OR = 2.14,95%CI:1.19–3.86, p = 0.011) and
to be hospitalized upon seeking care (37/245 (15.1%) vs. 134/1,392 (9.6%), OR = 1.67, 95%
CI:1.13–2.47,p = 0.01. Other factors associated with rotavirus infection included age, vomiting,
Fig 2. Flow diagram of enrollment of MSD cases in GEMS-Kenya, and the number of non-dysenteric MSD
rotavirus-positive and negative cases used for analysis, western Kenya 2008–2012.
doi:10.1371/journal.pone.0160060.g002
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number of loose stools, hospitalization and administration of IV fluids upon seeking care
(Table 2). Number of loose stools during the diarrheal illness were significantly correlated with
age, while intravenous fluid was correlated with fever, dehydration and admission. Receipt of
IV fluids and hospitalization were highly correlated and could not be included in the model
together. Only receipt of IV fluids was retained for model selection. In multivariable analysis,
younger age and vomiting3 times per day remained significantly associated with rotavirus
infection (Table 3). We found no statistically significant interactions between any of the vari-
ables that qualified for the multivariable model. In addition, sensitivity analysis of models
Table 2. Bivariate analysis of baseline characteristics of children with rotavirus-positive and rotavirus negative non-dysenteric MSD (n = 1637),
western Kenya, 2008–2012.
Rotavirus-positive Rotavirus-negative P-value
N = 245 N = 1,392
Characteristic n % n %
Child’s age stratum (in months)
0–11 156 63.7 626 45.0 <0.001
12–23 72 29.4 379 27.2 <0.001
24–59 17 6.9 387 27.8
Median age in months 8 [IQR 5–14] 13 [IQR 7–25] <0.001*
Gender
Female 120 49.0 591 42.5 0.058
Caretakers Education
R R
Formal education 125 51.0 606 43.6 0.118
Non-formal education 120 49.0 784 56.4
Clinical symptoms in the child at enrollment (% yes)
Vomiting3 times/24hrs 171 69.8 627 45.0 <0.001
Maximum no. of loose stools/24hrs
 7/24hrs 78 31.8 333 23.9 0.009
 6/24hrs 167 68.2 1059 76.1
Unable to drink 16 6.5 44 3.2 0.011
Sunken eyes 238 97.1 1307 93.9 0.047
Irritable/restlessness 179 73.1 856 61.5 <0.001
Lethargy 35 14.3 127 9.1 0.013
Child’s mental status abnormal§§ 186 75.9 874 62.8 <0.001
History of Fever (as observed by caretaker) 173 70.6 1076 77.3 0.024
Dehydration§
Moderate-to-severe‡ ‡ 55/241 22.8 250/1333 18.8 0.14
Mild ‡ 186/241 77.2 1083/1333 81.2
Child was admitted to hospital 37 15.1 134 9.6 0.01
IV ﬂuid given 43 17.6 155 11.1 <0.005
*p value based on Wilcoxon Rank Sums test
R R
= denominator = 1,635;
§§ = A child’s mental status was considered abnormal if restlessness or irritable or lethargy or unconsciousness was present or observed by clinician at
enrollment
§ A child was considered dehydrated if either mild or moderate to severe dehydration symptoms were present as described by the following classiﬁcations
‡ ‡ A child was considered moderately to severely dehydrated if 2 or more of the following were present: lethargic or unconscious on arrival/admission;
sunken eyes; drank poorly or unable to drink; skin pinch—goes back very slowly (>2 seconds)
‡ A child was considered mildly dehydrated if 2 or more of the following were present: Restless/irritable on arrival/admission; sunken eyes; thirsty, drank
eagerly; skin pinch—goes back slowly (1–2 seconds); ¶ = denominator is 1,574
doi:10.1371/journal.pone.0160060.t002
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excluding repeat enrollments and subsets of single and multiple pathogen positivity yielded the
same conclusions presented for the overall analysis, thus, data are not shown.
Finally using the GEMS modified Vesikari score at enrollment, we found that rotavirus-pos-
itive compared to negative cases were more likely to have a higher median Vesikari score (9 vs.
8), P<0.01 and were commonly observed to present with more severe disease symptoms.
(Table 4).
Mortality at sixty-day follow-up
Overall 1,580 (96.5%) of the 1,637 enrolled cases had their caretakers successfully interviewed
at 60-day follow-up. A higher proportion of rotavirus-positive (11/242 [4.5%]) compared to
negative (51/1,476 [3.5%]) cases died before the home visit follow-up interview, although the
differential in case fatality was not statistically significant (P = 0.36). VA cause of death infor-
mation was available for 60 MSD cases that including rotavirus-positive (10 [17%]) and nega-
tive (50 [83%]) cases that had died before follow-up. The causes of death among the 10
rotavirus-positive cases included: diarrhea 5 (50%), HIV 2 (20%), malaria 1 (10%), TB 1 (10%)
and parasitic disease 1 (10%). The causes of death among the 50 rotavirus-negative cases
included; diarrhea 13 (26%), HIV 13 (26%), malaria 13 (26%), malnutrition 5 (10%), pneumo-
nia 3(6%), TB 2 (4%) and measles 1 (2%). The median time from discharge to death was 12
(IQR) 7–18 days for rotavirus-positive MSD cases and 14 (IQR) 7–33 days for rotavirus-nega-
tive MSD cases P = 0.56
Fig 3. Rotavirus positivity among non-dysenteric MSD cases by age group, western Kenya 2008–2012.
doi:10.1371/journal.pone.0160060.g003
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Seasonality of rotavirus
For the first 3 years of the study, prevalence of non-dysenteric rotavirus-positive MSD cases by
year of study ranged from 14.2% (85/598) in the first year to 13.8% (63/457) in the second year
and finally to 20.7% (64/309) in the third year. Stool samples collected during usually warm
and dry months compared with usually cool and rainy months were twice as likely to be rotavi-
rus-positive, (142/691 [20.5%] vs 70/673 [10.4%]; OR = 2.16, 95%CI, 1.58–2.96). Although we
found that the proportion of cases positive for rotavirus was highest in August, December, Jan-
uary and February as shown in Fig 4, when we tested seasonality in a model using sine and
cosine functions of time, it revealed that the pattern of seasonality (probability that a stool sam-
ple would test positive for rotavirus) was significantly inconsistent across the 3 years of the
study period (P-value =<0.0001).
Discussion
In this study, we describe the epidemiology and factors associated with rotavirus infection
among patients<5 years of age in rural western Kenya, using comprehensive baseline and
60-day follow-up data. Our study finding that the risk of rotavirus infection was highest among
infants—an age group that accounted for more than 60% of rotavirus infections in our study is
consistent with other observations already made from other sub-Saharan African and Asian
countries [8, 29]. However, we did not detect any rotavirus cases in neonates but few neonates
with MSD were enrolled in our study.
Table 3. Crude and adjusted odds ratios of factors associated with rotavirus among children <5 years of age with non-dysenteric MSD, western
Kenya, 2008–2012.
Characteristic† Odds ratio (OR) for being ELISA positive for rotavirus diarrhea [95% conﬁdence interval (CI)]
Child’s age stratum (in months) Unadjusted Odds Ratio (OR) 95% CI Adjusted Odds Ratio (aOR) 95% CI
0–11 5.67 (3.38–9.51) 5.29 (3.14–8.89)
12–23 4.32 (2.50–7.47) 4.08 (2.35–7.07)
24–59 Ref †† Ref
Gender
Female 1.3 (0.99–1.71)
Male Ref Ref
Clinical symptoms in the child at enrollment
Vomiting3 times/24hrs
Yes 2.82 (2.10–3.78) 2.66 (1.98–3.57)
No Ref Ref
Maximum no. of loose stools/24hrs
 7/24hrs 1.49 (1.10–2.00)
 6/24hrs Ref Ref
Dehydration
Moderate-to-severe 1.28 (0.92–1.78)
Mild Ref Ref
IV ﬂuid given
Yes 1.7 (1.17–2.46)
No Ref Ref
† 6 variables initially entered into the model out of which 2 (above) were associated with rotavirus positivity. Variables dropped were 4 namely; Child offered
IV ﬂuid, dehydration, Maximum stool in 24hrs and gender
††Ref denotes the referent group
doi:10.1371/journal.pone.0160060.t003
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Clinical assessment, treatment and decision for admission of diarrhea patients to a hospital
can be influenced by differences in socio-economic factors, or by clinician’s attitudes. In the
current study, rotavirus cases among children<1 year also had an increased likelihood of hos-
pitalization compared to rotavirus-negative infants, an observation we argue may have not
been biased by test results, since stool testing is batched and results are not available to clini-
cians who decide on hospitalization and treatment until later in the clinical course. Our current
study demonstrates that the proportion of infants infected with rotavirus among out-patients
was higher compared to children 24–59 months of age. Furthermore among in-patient study
population, infants were at the greatest risk of hospitalization, followed by children 12–23
months of age compared to children 24–59 months of age. Consistent with other studies, rota-
virus diarrhea has been shown to be a major cause of hospitalization mostly in infants [30].
Table 4. Numerical (GEMSmodified) scoring system for severity of diarrhea among rotavirus-positive and negative children with non-dysenteric
MSD, western Kenya, January 31, 2008-September 30, 2012.
Child characteristics Points assigned Rotavirus-positive Rotavirus-negative p-value
(N = 17) N = 245 N = 1,392
N % n %
Duration of diarrhea (days)
1–4 1 221 90.2 1,247 89.6 0.954
5 2 14 5.7 85 6.1
6 3 10 4.1 60 4.3
Max no. diarrhea/24 hrs.
3–6 2 167 68.2 1,059 76.1 0.010
7 3 78 31.8 333 23.9
Vomited 3+ times/24 hrs.
Yes 3 171 69.8 627 45.0 <0.001
No 0 74 30.2 765 55.0
Fever †
<37.0 0 82 33.5 550 39.5 <0.001
37.1–38.4 1 128 52.2 534 38.4
38.5–38.9 2 17 6.9 112 8.1
> = 39 3 18 7.4 195 14.0
Dehydration††
Moderate/Severe‡‡ 3 55 22.8 250 18.8 0.156
Mild‡ 2 186 77.2 1,083 81.2
Treatment
Out-patient without IV ﬂuid 0 198 80.8 1,215 87.3 0.023
Out-patient with IV ﬂuid 1 10 4.1 43 3.1
Hospitalization with or without IV ﬂuid 2 37 15.1 134 9.6 0.013
Median Score ††† N/A 9 [IQR] 8–10 8 [IQR] 6–10 <0.001
† Denominator = 1,636
†† Denominator = 1,574
†††Median calculated for children not missing information (rotavirus-positive = 241 and rotavirus negative = 1,332)
‡ A child was considered mildly dehydrated if 2 or more of the following were present: Restless/irritable on arrival/admission; sunken eyes; thirsty, drank
eagerly; skin pinch—goes back slowly (1–2 seconds)
‡‡ A child was considered moderately to severely dehydrated if 2 or more of the following were present: lethargic or unconscious on arrival/admission;
sunken eyes; drank poorly or unable to drink; skin pinch—goes back very slowly (>2 seconds)
doi:10.1371/journal.pone.0160060.t004
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In our current study as seen elsewhere [11], clinically diagnosed fever by our study clinicians
was associated with rotavirus diarrhea. However, when we asked caretakers separately whether
they had observed history or presence of fever during their child’s diarrheal episode, the care-
takers reported fever was seen to be more common among rotavirus-negative compared to
positive MSD cases suggesting that caretakers may have not been either keenly observant of
fever or may have not recognized fever to be related to the diarrheal illness. Our previous
healthcare utilization and attitude survey, conducted before hospital-based surveillance began,
revealed that fever was not among the factors that prompted caretakers to seek care for their
child`s diarrheal illness[20]. This observation may in part explain the lack of appreciation by
caretakers in this community that fever and diarrhea may be related.
Our modified GEMS clinical scoring system adapted from the Vesikari score system [25]
enabled us to assess the severity of rotavirus compared to non-rotavirus MSD. As shown in our
study and consistent with findings across many settings, in young children, rotavirus disease is
characterized by diarrhea, vomiting, and severe dehydration [31]. The overall median severity
score was significantly higher among rotavirus positive than negative cases and similar obser-
vations have been made in other studies elsewhere [32, 33]. We also observed that diarrhea
severe enough to lead to hospitalization was prevalent among the infants and young children
diagnosed with rotavirus disease—a finding that is consistent with observations previously
made elsewhere[33] and also by the World Health Organization [31]. Overall our current
Fig 4. The seasonal distribution of rotavirus-positive compared with negative cases among children with non-dysenteric
moderate-to-severe diarrhea (MSD) in western Kenya, January, 2008- February, 2011.
doi:10.1371/journal.pone.0160060.g004
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study shows that there was generally very little exclusive breastfeeding, with almost 80% of
MSD cases aged<6 months either partially breastfeed or had stopped breastfeeding. Further-
more, although not statistically significant, exclusive breastfeeding was less frequently reported
among caretakers of rotavirus positive (13.6%) compared to negative cases (23.9%)—an obser-
vation which is not dissimilar to that made in other settings[33]. These findings may suggest
that maternal antibodies could be insufficient to protect against severe rotavirus illness. Second,
the age-associated differences observed in rotavirus prevalence, including the less common
rotavirus occurrence among breastfed children aged<6 months and those aged<4 months as
observed in our study is worth noting. Infants receive passive protection from trans-placental
and breastmilk antibodies for the first 6 months of life. Infants who continue to exclusively
breastfeed are less likely to be exposed to pathogens than infants on mixed feedings during the
six months of age [34]. The child’s first exposure to a rotavirus infection during the first six
months of life often results in severe disease due to lack of antibodies to fight the infection and
is more likely to lead to hospitalization as our current findings suggest since passive immunity
wanes and natural immunity acquired from such exposure builds up; subsequent infections
tend to produce milder illness which may be characterized by less severe disease and admission
to hospital as suggested by our data. Therefore as we have observed in this study and as shown
from other settings, the rate of illness declines as the child’s age increases and probably as chil-
dren acquire immunity increasingly from subsequent rotavirus infections[35].
Active, sentinel surveillance of rotavirus diarrhea could provide useful data that can guide
the interpretation of diarrheal disease trends following rotavirus vaccine introduction in set-
tings such as Kenya. During the first 3 years of year surveillance, we found rotavirus prevalence
rate of 14.2% in year 1 and which remained stable in year two (13.8%) but increased to 20.7%
in year 3 among children seeking care at a hospital or health center for non-dysenteric MSD.
Our prevalence rate of rotavirus among MSD patients <5 years in year one and two of the sur-
veillance is slightly higher but remains comparable to a prevalence of 12% reported from a pop-
ulation-based surveillance study conducted in both urban slums in Nairobi and rural western
Kenya [36] and to 13.5% from a similar study conducted in Nigeria [37]. Furthermore, our
observed prevalence especially in year 3 is similar to that observed in other hospital-based stud-
ies conducted in the neighboring countries like Tanzania (21%) [10]and Ethiopia (21%) [38].
However, our reported prevalence of rotavirus is relatively lower than other observations from
other studies conducted in Africa; for example 33% in Burkina Faso[9] and 45% in Uganda
[32]. The differences observed across these studies may be explained by differences in study
methodologies including variations in seasonality, study periods, study populations and possi-
bly laboratory techniques. However the observed variations in rotavirus rates further highlights
the need and importance of national and regional standardization of rotavirus surveillance
using different approaches and techniques that can support comparison and monitoring of
rotavirus trends post-vaccine implementation and to perform vaccine impact assessment and
cost-effective analyses.
Studies from other countries within and outside Africa have shown that rotavirus vaccines
are safe, effective and cost-effective interventions against severe rotavirus disease [29]. Follow-
ing implementation of rotavirus vaccination, remarkable declines in overall diarrhea occur-
rence and hospitalization associated with rotavirus diarrhea have occurred in a number of both
developed and a few developing countries [39–41]. Vaccination is currently the best way to
prevent severe rotavirus illness, particularly in settings such as our study area where access to
medical care is limited or sometimes unavailable [31] and ORT use is low[20, 39]. Furthermore
in countries with poor immunization programs, as in many African countries, administration
of vaccine doses may be delayed. The cost-effectiveness of the rotavirus vaccine declines rapidly
with a delayed administration of the first rotavirus vaccine dose which highlights the need for
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strong immunization programs. With support from GAVI, in July 2014, Kenya implemented
routine rotavirus vaccination under the country’s national infant immunization program. To
realize its full life-saving potential, rotavirus vaccination must reach all vaccine-eligible
children.
Although it has been estimated that rotavirus vaccine introduction in Kenya could prevent
more than 5,000 hospitalizations and over 800,000 clinic visits among children<5 years annu-
ally [42], results would be optimized when complementary interventions such as increasing
use of oral rehydration salts (ORS) and exclusive breastfeeding among children< 6 months
and those with diarrhea are also strengthened. Dehydration can be reversed through oral rehy-
dration therapy (ORT) (that is continued feeding and fluids including breastfeeding and ORS
use at home) or, if more serious, through hospitalization and IV fluids. Furthermore ORT is
important in management of rotavirus diarrhea as antibiotics or other drugs have no known
benefit on treating such an illness or acute watery diarrhea due to cholera, cryptosporidiosis,
and many other similar illnesses. Our finding that there was no difference between all-cause
deaths among children with rotavirus compared to non-rotavirus MSD at sixty day follow-up
is an important observation that could possibly highlight that mortality is not associated with
rotavirus in hospital based studies. This is possible because detection of rotavirus generally
requires a visit to clinic, which presumably would lead to rehydration, but non-detected rotavi-
rus cases that did not make it to a clinic would be less likely to access rehydration and may die
in the community without seeking care. When examining the verbal autopsy data, we were not
powered to compare diarrhea deaths between rotavirus and non-rotavirus MSD cases at the
60-day follow-up visits. However our VA data presented in this analysis has shown that deaths
from rotavirus-positive compared to those from negative MSD cases occurred a few days after
enrollment which further suggests that children who reach a healthcare facility with acute rota-
virus diarrhea may recover sooner than non-rotavirus MSD cases. Our findings further sug-
gests that diarrhea was the leading cause of death among children with moderate-to-severe
diarrhea in our study population—an observation that may suggest that diarrhea continues to
be a leading cause of morbidity and mortality in this setting.
Our study is subject to biases and limitations. Data from this study may not be generalized
to all children<5 years in Kenya as it was conducted in a single rural site in western Kenya.
Also, our modified Vesikari score needs to be interpreted with caution. In our study, informa-
tion on the duration of vomiting and the maximum number of episodes of vomiting over a
24-hour period was not collected because the caretakers were interviewed only at study enroll-
ment. The incomplete capture of information on vomiting in our study did not allow us to cal-
culate the full 20-point Vesikari score. We resolved this by modifying the Vesikari score based
on GEMS data and we were able to construct a 17-point scoring system instead.
As rotavirus vaccine is introduced into the Kenya national immunization program, moni-
toring its impact on diarrheal disease burden, clinical presentation, and seasonality will be
important.
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To describe the epidemiology of intussusception before introduction of the rotavirus vaccine, we reviewed the
records of 280 patients younger than 5 years who were hospitalized in Kenya between 2002 and 2013. The
patients who died (18 [6.4%]) had sought care later after symptom onset than the patients who survived
(median, 5 vs 3 days, respectively; P = .04). Seeking prompt care may improve therapeutic outcomes.
Key words. childhood mortality; intussusception; Kenya; risk factors.
Intussusception is a rare, life-threatening, acute intestinal ob-
structionwith which a segment of the bowel prolapses into a
more distal segment. Its causes are usually unknown, and
the disease has no clear seasonality [1, 2]. Intussusception
is the most common abdominal complication in infants
and children younger than 2 years [3].
Both internationally recommended rotavirus vaccines
have been associated with a low risk of intussusception,
but the beneﬁts of vaccination, including decreases in mor-
tality and hospitalization rates, outweigh the risk [4]. The
WorldHealthOrganization therefore recommends the glob-
al use of rotavirus vaccine [5]. As rotavirus vaccines are in-
troduced in low- and middle-income countries, we urgently
need to understand the prevaccine epidemiology and clinical
characteristics of intussusception and establish surveillance
to monitor the rates of intussusception prospectively [5–7].
Kenya introduced rotavirus (Rotarix; GlaxoSmithKline
Biologicals) vaccine in the routine immunization program
in July 2014. However, background data on intussusception
in Kenya and the sub-saharan African region are limited.
Here, we describe the pre–rotavirus vaccine epidemiology
and risk factors for intussusception-related mortality
among Kenyan children younger than 5 years who were
hospitalized between 2002 and 2013.
METHODS
Study Design and Setting
We retrospectively reviewed medical records to identify
pediatric patients hospitalized with intussusception at 12
geographically dispersed referral hospitals in Kenya from
January 2002 to November 2013. The exact review period
varied by hospital depending on the availability of patient
records.
Data Collection
In each study hospital, pediatric surgeons systematically re-
viewed hospital logbooks and treatment and discharge re-
cords to identify all pediatric patients clinically diagnosed
Brief Report
Journal of the Pediatric Infectious Diseases Society, Vol. 5, No. 4, pp. 465–9, 2016. DOI:10.1093/jpids/piv051
© The Author 2015. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society.
All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
with intussusception and conﬁrmed the diagnosis by using
Brighton Collaboration level 1 criteria [3] during the time
period in which records were available at the hospital.
Demographic and clinical characteristics, type of sur-
gery, and outcome information were abstracted by using
standard case-report forms.
Statistical Analysis
Fisher’s exact test was used to compare characteristics of
the patients who died and those of the patients who sur-
vived. Medians were compared by using the Wilcoxon
rank-sum test. For all statistical tests, a 2-sided P value of
<.05 was considered statistically signiﬁcant. Data were
entered into a Microsoft Access database and analyzed
by using SAS version 9.4 (SAS Institute, Inc, Cary, NC).
The study protocol was reviewed and approved by the
Kenyatta National Hospital (KNH) Ethics Review
Committee (protocol number P514/09/2012). Approval
from the US Centers for Disease Control and Prevention
Institutional Review Board (protocol number 6513) relied
on KNH approval.
RESULTS
Of the 305 records for children treated for intussusception at
the 12 referral hospitals during the study period, 25 (8.2%)
were excluded from further analysis because of missing age
(n = 12), because the age was >60 months (n = 12), or
because the episode occurred before 2002 (n = 1); thus,
280 (91.8%) patients were included. The majority of these
patients were <1 year of age (192 [68.6%]), male (186
[66.4%]), and referred from another district-level hospital
(165 [58.9%]). None of the referrals were from any of the
12 participating hospitals to another. Intussusception
cases were diagnosed throughout the year in October to
December (81 [28.9%]), July to September (75 [26.8%]),
January to March (65 [23.2%]), or April to June (59
[21.1%]), and no seasonal pattern was detected. During
the time period when all hospitals had records available
(2010–2013), 31 to 48 cases were identiﬁed annually.
Vomiting (88.2%), blood detected in stool or gross rectal
bleeding (81.1%), abdominal distension (75%), and diar-
rhea (74.6%) were the most common clinical symptoms
(Table 1). The overall median time to seeking care was
3 days (interquartile range, 2–6 days) after illness onset.
Overall, 97 (35%) of the patients underwent abdominal ra-
diographyonly, 36 (13%) underwent ultrasonographyonly,
and 55 (20%) underwent both ultrasonography and ab-
dominal radiography, whereas 92 (33%) underwent neither
ultrasonography nor abdominal radiography. Overall, sur-
gery was the most common treatment (73.2%); nonopera-
tive reduction was uncommon (only 5 [1.8%] patients
were treated with contrast-ﬂuid enema). For 26.1% of the
patients, the type of treatment was unknown.
Eighteen (6.4%) patients died during hospitalization
while undergoing treatment. Compared with the patients
who survived, those who died were more likely to be youn-
ger (7.0 vs 5.5 months, respectively; P = .04), to have
sought care late after symptom onset (median, 3 vs 5
days, respectively; P = .04), to have had fever on admission
(P = .004), and to have been treated by bowel resection
(P = .003) (Table 1).
DISCUSSION
We describe here characteristics of patients with intussus-
ception who presented for care at Kenya’s main referral
hospitals before the national rotavirus vaccine introduc-
tion. Compared with patients who survived, those who
died were younger and were more likely to have sought
care late after symptom onset (as characterized by the pres-
ence of fever at admission) and to have undergone bowel
resection. However, these observations need to be inter-
preted with caution, because the study was not designed
to assess prognosis, and the results may simply reﬂect dif-
ferences in age, gender, or severity at presentation among
those who sought care. In Kenya, most district- or lower-
level hospitals do not have specialized pediatric care for di-
agnosing or treating intussusception. More than half of the
cases were referrals to provincial or higher-level hospitals
from district-level hospitals, which is comparable with
ﬁndings from another study conducted at Moi Teaching
and Referral Hospital in Kenya [8].
Consistent with results from previous studies in Africa
[7], surgery was the most common treatment of intussus-
ception in our study. However, nonoperative treatment of
intussusception by using ultrasound-guided reduction
causes no radiation exposure and has been shown to result
in better success rates than surgery. Furthermore, nonsur-
gical treatment methods are safe, painless, and quicker
than surgery and have not been associated with complica-
tions or recurrence of intussusception [9, 10].
However, in our study, late care seeking may have been
associated with the use of surgery because patients may
have had progressive disease, as evidenced by the presence
of fever, a classical sign of severe disease. Our ﬁnding that
patients who died were more likely to have been treated
through bowel resection than manual reduction may also
have been a consequence of late presentation to a facility
where intussusception could be managed. Although refer-
ral was appropriate, it may have led to further delays in ap-
propriate management, potentially leading to fatal
outcomes. Prompt care seeking by the patient and early
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detection and treatment of intussusception at a primary- or
secondary-level facility could lead to better outcomes, as
observed elsewhere [11, 12]. Children with symptoms last-
ing >1 day before seeking care have been shown to be at
increased risk for requiring surgery [11]. Creating aware-
ness among parents and healthcare workers to recognize
the signs and symptoms associated with intussusception
could help to improve early care seeking, diagnosis, and
treatment [13].
The case-fatality rate in our study was low compared
with 14% reported from other regions in Kenya [8], 28%
in Rwanda [14], and 13% reported from other African
countries [7]. Although the in-hospital case-fatality rate
in our study was similar to that (4.2%) reported from a
multicountry surveillance study in Egypt, Kenya, India,
and Brazil [15], the difference in this rate may be a result
of methodological differences, because we were not able
to ascertain disease outcomes after discharge and records
of the children who died may have been less accessible.
Our ﬁndings are comparable with those of other studies
in which intussusception was reported to be more common
among patients aged 0 to 11 months [7] and among boys
[14]. The incidence of naturally occurring intussusception
is normally low in the ﬁrst 3 months of life, as observed in
Table 1. Comparing Characteristics of Children Aged 0 to 59Months Who Died Versus Those Who Survived After Treatment for
Intussusception at Referral Hospitals in Kenya, 2002—2013
Background Characteristic All (N = 280) Died (n = 18) Survived (n = 262) Pa
Demographic characteristics (n [%])
Child age
0–5 mo 81 (28.9) 9 (50) 72 (27.4) .195
6–11 mo 11 (39.3) 6 (33.3) 105 (40.1)
12–23 mo 43 (15.4) 2 (11.1) 41 (15.7)
24–59 mo 45 (16.1) 1 (5.6) 44 (16.8)
Median (IQR) age of patients (mo) 7.0 (5–14) 5.5 (4.0–9.0) 7.0 (5.0–14.0) .04
Gender (n [%])b
Male 186 (66.4) 11 (61.1) 175 (67) .611
Female 93 (33.2) 7 (38.9) 86 (33)
Days before seeking care (median [IQR]) 3 (2–6) 5 (3–9) 3 (2–5) .04
Days to death/discharge upon recovery after admission (median [IQR]) 5 (3–8) 2 (1–6) 6 (4–8) .01
Clinical features (n [%])
Fever 177 (63.2) 17 (94.4) 160 (61.4) <.01
Temperaturec
<37.0 38 (17) 1 (6.2) 37 (17.9) .01
37.0–38.4 125 (56.1) 5 (31.2) 120 (58)
38.5–38.9 21 (9.4) 3 (18.8) 18 (8.7)
39.0 39 (17.5) 7 (43.8) 32 (15.4)
Vomiting 247 (88.2) 17 (94.4) 230 (87.8) .71
Diarrhea 209 (74.6) 13 (72.2) 196 (74.8) .78
Blood in stool 227 (81.1) 13 (72.2) 214 (81.7) .35
Abdominal pain 178 (63.6) 10 (55.6) 168 (64.1) .46
Abdominal distension 210 (75) 16 (88.9) 194 (74) .26
Abdominal mass 111 (39.6) 5 (27.8) 106 (40.5) .33
Rectal mass 80 (28.6) 4 (22.2) 76 (29) .79
Type of intussusception (n [%])
Ileocolic 132 (47.1) 10 (55.6) 122 (46.6) .76
Colocolic 40 (14.3) 5 (27.8) 35 (13.4)
Ileoileal 22 (7.9) 2 (11.1) 20 (7.6)
Diagnosis method (n [%])d
Ultrasound 91 (32.5) 10 (55.6) 81 (30.9) .04
Abdominal radiograph 152 (54.3) 14 (77.8) 138 (52.7) <.05
Treatment method (n [%])e
Operative
Bowel resection 91 (32.5) 12 (66.7) 79 (30.2) <.01
Manual reduction 128 (45.7) 4 (22.2) 124 (47.3) <.05
Ileostomy 5 (1.8) 1 (5.6) 4 (1.5) .28
Nonoperative
Air reduction 0 (0) 0 (0) 0 (0) NA
Contrast-fluid enema 5 (1.8) 0 (0) 5 (1.9) >.1
Unknown 73 (26.1) 1 (5.6) 72 (27.5) .049
Abbreviations: IQR, interquartile range; NA, not applicable.
aSignificant P values are indicated with bold type.
bGender information was missing for 1 child.
cThe total number was 223. Died was 16. Survived was 207.
dMultiple diagnosis methods were possible.
eMultiple treatment methods possible.
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other countries such as Bangladesh [16]. Intussusception
among Kenyan children peaked at 4 to 6 months of age.
The higher occurrence of intussusception among children
4 to 6 months of age is important when interpreting trends
in intussusception after the introduction of rotavirus vac-
cine. The lack of information about the epidemiology of in-
tussusception in young children could lead some to suggest a
link to vaccination rather than a natural increase in cases co-
incidingwith the time periodwhen vaccine is typically given.
This study had limitations. First, given that intussuscep-
tion is rare and the availability of records varied over the
almost 11 years of our retrospective study period, we
were unable to systematically monitor trends in intussus-
ception over time. Furthermore, we may have underesti-
mated the number of intussusception cases, particularly
in the early years of the study when record keeping may
not have been as complete as in later years. Second, our
study methodology did not allow an observation window
beyond hospital discharge, possibly leading to an underes-
timation of the case-fatality rate. Third, we did not have
baseline population data for the catchment area of partic-
ipating hospitals given the large number of patient refer-
rals, which made the calculation of population-based
baseline incidence rates for intussusception impossible.
Finally, the method of treatment was not recorded in ap-
proximately one quarter of the cases. Although surgeons
reported that these cases met the Brighton Collaboration
criteria for conﬁrmed intussusception, we were not able
to verify this conﬁrmation, which may have led to an over-
estimate of the number of cases that met the level 1 criteria
for intussusception.
Despite these limitations, we made key observations in
this study that are important for setting up prospective sur-
veillance of intussusception in Kenya. First, wewere able to
identify the hospitals with the highest numbers of intussus-
ception cases to be targeted as sentinel sites for postlicen-
sure monitoring of rotavirus vaccine effects. Second,
understanding where and how intussusception cases pre-
sent and referral patterns will help us to identify cases
more efﬁciently.
Continued monitoring of intussusception in Kenyan
children and scaling up efforts targeted at reducing delays
in seeking care for intussusception may contribute to early
diagnosis and appropriate treatment for better outcomes in
this setting.
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